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vRésumé
L’objet de ce travail est de tester et caractériser un système microfluidique
d’électronébulisation pour l’analyse de biomolécules par spectrométrie de masse, et plus
particulièrement dans un contexte d’analyse protéomique. Etant donné que ce travail est
essentiellement analytique et technologique, le Chapitre 1 décrit le contexte
épistémologique qui a vu l’émergence de la protéomique et de la biologie systémique. Il est
démontré que ce nouveau paradigme n’est pas apparu ex nihilo, mais est le résultat de
basculements épistémologiques majeurs en médecine, physique et ingénierie. Par ailleurs,
ce changement paradigmatique s’inscrit dans la longue histoire des luttes entre conceptions
holistes et programmes réductionnistes en biologie et médecine. Finalement, le potentiel
biomédical de la biologie systémique est discuté.
Le Chapitre 2 présente l’état de l’art dans le couplage de systèmes microfluidiques à
la spectrométrie de masse par électronébulisation, tant du point de vue technologique
qu’applicatif. Les Chapitres 3 et 4 présentent la caractérisation du nouveau micro-
électronébulisateur polymère pour l’analyse de peptides, protéines et glycoconjugués sur
différents instruments. En particulier, une comparaison détaillée est faite avec des nano-
électronébulisateurs capillaires pour préciser les performances du nouveau système en
termes de sensibilité, de stabilité, de gamme de débits applicables et de compatibilité avec
les solvants organiques.
Le Chapitre 5 introduit un micro-électronébulisateur fonctionnalisé pour la
purification d’échantillons. En résumé, une membrane hydrophobe de fluoride de
polyvinylidène est interfacée à l’entrée du micro-électronébulisateur polymère pour servir
de phase solide de capture de composés hydrophobes; une fois capturés, ces composés
vi
peuvent être lavés, puis élués par la solution d’électronébulisation qui contient des solvants
organiques. Ce procédé est également évalué lorsque l’échantillon de départ contient des
composés courants en préparation d’échantillons protéiques, tels que chaotropes, agents
réducteurs, ou détergents.
Le Chapitre 6 décrit un développement plus important du système microfluidique
lui-même, qui permet d’électronébuliser deux solutions en même temps; de par la
conception du microsystème, les deux solutions ne se mélangent que dans le cône de
Taylor, où l’électronébulisation a lieu, et les débits des deux solutions peuvent être
contrôlés indépendamment. Cette particularité unique permet d’analyser des échantillons
purement aqueux, en intégrant un minimum de solvant organique pour permettre la
désolvatation et l’ionisation dans de bonnes conditions. De plus, des protéines peuvent être
analysées en conditions natives, comme l’atteste leur distribution de charge dans le spectre
de masse. En jouant sur le débit de solvant organique injecté directement dans le cône de
Taylor, on peut induire une dénaturation en ligne de la protéine analysée, et suivre cette
dénaturation par l’évolution de son état de charge dans le spectre de masse. Le potentiel de
cette technologie pour la caractérisation de la stabilité thermodynamique de protéines est
discuté.
Finalement, le Chapitre 7 présente une évaluation in silico de l’intérêt de deux
technologies développées au laboratoire: l’électrophorèse Off-Gel pour le fractionnement
isoélectrique de peptides et protéines, et le comptage en ligne des cystéines contenues dans
des peptides lors de leur analyse par spectrométrie de masse, pour l’analyse protéomique
rapide. Si l’on recherche dans un protéome entier digéré par protéolyse les peptides uniques,
la mesure de leur masse seule, même avec un spectromètre à très haute résolution et à très
vii
haute précision en masse, ne permet pas d’obtenir des identifications de protéines utiles. Le
but de ces simulations est d’évaluer dans quelle mesure l’ajout de l’information sur le point
isoélectrique de tous les peptides, ainsi que de leur contenu en cystéines, à la mesure de leur
masse, permet d’envisager des mesures protéomiques haut-débit.
MOTS-CLEFS: protéomique, spectrométrie de masse, microfluidique, biochimie
analytique
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Abstract
In the present work, a polymer microfabricated microsprayer is characterised
and tested for the mass spectrometric analysis of biomolecules, in particular in the context
of protein mass spectrometry and proteomics. As the core of this work deals with analytical
sciences and device development, Chapter 1 puts this work in perspective with the
emergence of proteomics and more generally systems biology. In particular, major
epistemological concepts that allowed the emergence of these new disciplines among life
science research are reviewed. It is shown that the new paradigm of integrative biology did
not emerge ex nihilo, but was preceded by major epistemological shifts in medicine,
physics, and engineering. As such, the rise of systems biology appears as a new episode in
the balance between reductionist and holistic approaches in the history of biology and
medicine, and its biomedical promises are discussed.
Chapter 2 reviews the state of the art in the hyphenation of microfluidic devices with
electrospray mass spectrometry, both from a technical and applicative standpoint. Chapter 3
and 4 present the characterisation of the new polymer microspray for the analysis of
peptides, proteins and glycoconjugates when coupled with various electrospray ion sources
and instruments. In particular, a detailed comparison with classical pulled nanospray
capillaries is performed, that established the performances in terms of sensitivity, stability
and applicable ranges of flow rates and solvents.
Chapter 5 introduces a functionalised polymer microspray for online sample clean-
up. Basically, a hydrophobic polyvinylidene fluoride membrane is interfaced at the inlet of
the polymer microspray to serve as a capture solid-phase of hydrophobic compounds; once
captured, they can be cleaned up, and further eluted by the spray solution containing
xorganic solvents. The process is further investigated in the presence of compounds usually
used in protein sample preparation, such as chaotropes, reducing agents or detergents.
Further microchip developments include the introduction of a dual channel
microsprayer in Chapter 6, that allows to spray two solutions at the same time; given the
microchip design, the two solutions are mixed only in the Taylor cone, where the
electrospray is generated, and their respective flow rates can be controlled independently.
This unique feature allows to analyse pure aqueous samples with integration of minimum
amounts of organic sheath flow to promote desolvation and ionisation. Moreover, when
proteins are analysed, it allows to measure them in their folded state, as demonstrated by
their charge state distribution in the mass spectrum. Further tuning of the organic sheath
flow allows to denature the protein within the Taylor cone, which can be monitored by the
evolution of the protein charge state distribution in the mass spectrum. Potential of this
technology for protein thermodynamic stability measurement is discussed.
Lastly, Chapter 7 presents in silico evaluation of two technologies developed in the
laboratory, namely Off-Gel electrophoresis for isoelectric fractionation of proteins and
peptides mixtures, and online counting of cysteine residues within peptides during their
analysis by electrospray mass spectrometry, to provide useful information to speed-up
proteome profiling: if one wants to seek within a whole digested proteomes for peptides that
are unique, measurement of their mass alone is hardly sufficient to perform useful protein
identification, even with very high resolution, high mass accuracy instruments. The purpose
of these simulations is to estimate how much information peptide isoelectric point and
number of cysteines within each peptide provide in terms of number of unique peptides
xi
(and hence unambiguous peptide identification without MS/MS). Applicability of this
strategy for high-throughput proteome profiling and its limitations are further discussed.
KEYWORDS: proteomics, mass spectrometry, microfluidics, analytical biochemistry
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Chapter 1. Introduction
In the last two decades, mass spectrometry has become a central analytical technique
in biochemistry and especially in protein analysis, due to its capability to provide not only
mass information, but also identification when combined with enzymatic procedures and
database search, as well as structural information. It is now established as the technique of
choice for protein identification from biological samples. This emergence stems back from
the development of two soft ionisation techniques, electrospray ionisation (ESI) [1] and
matrix-assisted laser desorption/ionisation (MALDI) [2-4] during the late eighties, that
allow gentle ionisation of large biomolecules. The importance of these new ionisation
techniques beyond the field of analytical chemistry was recently recognised by the
attribution of the chemistry Nobel Prize to John Fenn [5] and Koichi Tanaka [6] in 2002.
The advent of ESI and MALDI ion sources, together with other developments in mass
spectrometry, have largely contributed to the emergence of proteomics as a new field, by
allowing researchers to massively and rapidly identify proteins, with unprecedented
precision and comprehensiveness. However, electrospray ionisation sources suffer from
technological drawbacks: the most common technology consists in manually pulling fused
silica capillary, to produce capillaries with small outlets that are favourable for sample
delivery to mass spectrometers through electrospray ionisation. This manual procedure is
tedious and requires trained operators, have a limited success yield because of capillary
breakage during the procedure, and usually results in poorly reproducible capillaries.
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In the late nineties, Ramsey’s [7] and Karger’s [8, 9] groups introduced new
electrospray ionisation sources that were not based on pulled capillaries, but on microfluidic
chips produced with technologies imported from the microelectronic industry. The basic
underlying idea was to use technologies that could potentially produce reproducible
electrospray ionisation sources with dimensions in the low micron range, on an industrial
scale. The work presented in this manuscript follows the approach pioneered by Ramsey
and Karger, i.e. the development of microfluidic electrospray ionisation sources in a
proteomic context: chapter 2 reviews the state of the art in the coupling of microfluidic
electrospray ionisation sources with mass spectrometers [10, 11], chapter 3 describes the
development of polymer-based microfluidic electrospray sources and their characterisation
[12-14], chapter 4 reports their application in the particular field of glycoconjugate analysis
[15-17], chapter 5 introduces functionalised microchips for integrated sample desalting
prior to electrospray ionisation [18, 19], chapter 6 provides some perspectives for the use of
a dual channel microfluidic electrospray ion source, and chapter 7 briefly describes some
bioinformatic tools developed to investigate the integration of various analytical
technologies developed in our laboratory into a whole proteomic analysis platform.
As the work described in this thesis is mainly technologically oriented, it is worth
giving an overview of the scientific context in which it has been carried out.
1. What is proteomics?
The term “proteome” was first introduced by Marc Wilkins at the Sienna meeting in
1994, basically to replace the expression “all proteins expressed by a genome, cell or
tissue”. Since then, proteome analysis, or proteomics, has somehow gained in scope:
whereas no clear consensus definition exists, proteomics can be defined as the
“identification of all proteins expressed by a genome, cell or tissue, their quantification, and
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determination of their interactions”. Whereas the definition of proteomics given above does
not refer to any particular technique, proteomics is often understood as the set of techniques
used in proteomics, such as two-dimensional gel electrophoresis (2D-GE),
multidimensional liquid chromatography (LC), MALDI-Time-Of-Flight-Mass
Spectrometry (MALDI-TOF-MS), LC-MS/MS…
Basically, the goal of proteomic projects are of two different kinds: on one hand, the
purpose is to identify the whole set of proteins present in a given sample, which we propose
to call discovery proteomics, in the case where this set of proteins has never been observed,
or profiling proteomics, in the case where this set of proteins is investigated in a particular
case (such as a sample from a disease patient, or a cell line in given conditions of growth).
To a certain extent it is similar to genome sequencing, whose primary goal was to provide
biologists with the list of genes and their sequence (whatever the “political” claims of all the
genome sequencing projects were, it was clear from the beginning that the main output of
these projects would be “reference data” for biologists, and that biomedical discoveries
would be limited to some monogenic diseases, at least in the first decades after the release
of genome sequences). Subfields of discovery and profiling proteomics are post-
translational mapping (identification of phosphorylation, glycosylation, ubiquitination….
sites in the identified proteins, or identification of phosphorylated or glycosylated or
ubiquinated sub-classes of proteins from a sample), chemical proteomics, whose aim is to
identify proteins with a particular enzymatic function, and interaction proteomics, whose
goal is to identify the whole set of protein/protein interactions.
The other mainstream in proteome research is the search for disease biomarkers, i.e.
proteins or small sets of proteins that are present in much greater or much lower quantity in
patients with a given disease compared to healthy subjects, or which present given
alterations (such as different post-translational modifications patterns). In a way it is similar
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to classical biomedical research, in which typical levels of particular biomolecules (or their
modifications) are used to classify individuals between healthy and disease. The purpose of
biomarker research is first to develop diagnosis or prognosis tools. In a second step, it is
believed that if a particular protein is particularly over- or under-expressed in a disease
patient, this protein may play a role in the disease process, and thus may become a target for
therapy (see below for a discussion of the conceptual validity of this approach).
From a technical point of view, there are two main approaches in proteomics. One is
based on 2D-GE separation of all proteins present in a sample: proteins are first separated in
an immobilised pH gradient (IPG) strip according to their isoelectric points (in denaturing
conditions); once focused, detergent is added so that focused neutral proteins get capped
with charge surfactant molecules and acquire a charge proportional to their length (and thus
to their sizes in a first approximation). The IPG is then transferred on top of a
polyacrylamide gel, and electrophoresis is run in the second dimension to separate proteins
according to their mass; after electrophoresis, the gel is stained for example by Coomassie
blue or silver in order to visualise protein spots, as shown in Figure 1. In order to identify
proteins, spots are excised from the gel, proteins are in-gel digested by trypsin and the
resulted peptides are spotted onto a MALDI plate in order to measure their mass by
MALDI-TOF MS. Tryptic peptide masses constitute a fingerprint of the protein that can
then be identified through interrogation of proteins (e.g. SwissProt) or DNA (e.g. Trembl)
databases [20, 21]. Though 2D-GE suffers from a number of caveats (in particular in coping
with the high diversity of protein physico-chemical properties such as size, hydrophobicity
or charge) [22], it is still the workhorse for proteome research [23].
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Figure 1. 2D gel map of human platelet, as retrieved from Swiss2Dpage (August 2005).
This SWISS-2DPAGE entry is copyright the Swiss Institute of Bioinformatics.
The second analytical approach used in proteomics is a gel-free, shotgun apporach:
the whole set of proteins is first digested by trypsin to produce a peptide mixture; the basic
idea is that peptides have much more homogeneous physico-chemical properties than
proteins (in terms of size, hydrophobicity and charge) and thus can be handled more
efficiently by routine analytical procedures. The counterpart of this gain in properties
homogeneity is that each protein typically gives a few tens to a few hundreds of peptides; so
instead of separating a few hundred or a few thousand proteins, the challenge is to separate
up to a few hundred thousand peptides before delivering them to the mass spectrometer.
This approach has thus relied on the development of new and powerful liquid-phase
separation tools, such as the dual phase microcolumns introduced by Wolters et al [24] or
the solid phase capture of cysteine containing peptides prior to LC-MS/MS developed by
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Gygi et al [25]. In the shotgun approach, liquid chromatography is directly interfaced to
electrospray mass spectrometers in order to analyse the separated peptides online.
Obviously, the measurement of peptide masses alone (as done in the peptide mass
fingerprinting approach) is not sufficient to identify proteins through database interrogation
from such complex mixtures, because peptides originating from a single protein can span
over the whole chromatographic run (or conversely each peptide eluting from liquid
chromatography at a given time can originate from a different protein). In fact, online
peptide sequencing by tandem mass spectrometry is necessary to produce partial sequence
information; database interrogation is then based on peptide masses and on peptide partial
sequence information [26]. This need for peptide sequencing at the pace of the LC
separation imposes great constraints on the sampling rate and MS/MS capacity of mass
spectrometers. New instruments have been recently introduced to cope with this demand,
such as the linear ion trap [27]. Figure 2 shows the schematic workflow for a proteomic
shotgun experiment:
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Figure 2. Shotgun proteomics workflow: the whole protein mixture is digested; the resulting
peptide mixture is subjected to two-dimensional liquid chromatography (usually strong
cation exchange (SCX) and reverse phase (RP)); the mass of eluting peptides are measured
by the mass spectrometer, and in each spectrum, typically the three most intense peaks are
automatically subjected to MS/MS. The collection of MS and MS/MS spectra is then
submitted to database interrogation for protein identification.
The typical result of such experiments (whether by 2D-GE and MALDI-TOF-MS or
by LC-ESI-MS/MS) is a list of identified proteins, which is usually completed by a
repartition of the identified proteins by function or localisation, as shown in Figure 3.
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Figure 3. Left: top of the list of proteins identified in plasma (out of 325). Results consist in
the protein localisation, the SwissProt accession number, and identification parameters.
Right: Localisation of the identified proteins. From [28].
The work presented in the following chapters focuses on the design and
characterisation of microfabricated electrospray emitters. As such, its scope in a whole
proteomic platform concerns only the hyphenation of liquid phase analytical processes to
electrospray mass spectrometry. It is thus worth giving an overview of the concepts at work
in proteomics. The following sections trace back the origins of the paradigms into which
proteomics emerged recently and some aspects of the history of biological research whose
contribution are often underrated in the appearance of proteomics and more generally
systems biology.
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2. A brief and partial history of life science research
Proteomics is considered by many as a new paradigm [29]1. In a way, proteomics is
not a new paradigm as defined by Thomas Kuhn, because its status is highly debated: some
consider it as a simple continuation of the genome revolution, some others as a revival of
classical physiology [30]. In this section, I will try to show that proteomics, as a part of
systems biology, truly consists in a new paradigm, in the sense introduced by Thomas
Kuhn: it is a scientific field with its own subjects of study, questions, tools, instruments,
methodologies, laboratories, conferences, networks… However, the conceptual framework
that allowed its appearance is often ignored or disregarded. Most scientists currently
working in life sciences and analytical chemistry have been educated in the context of
molecular reductionism, whose methodology is to study all the parts of a living system
within their most intimate details in order to understand the functioning of the whole. This
research program is embodied in life sciences through the development of specialised
disciplines such as endocrinology, enzymology, protein biochemistry, molecular biology…
On the contrary, classical physiology does not aim at describing every molecule
present in a biological sample; physiology aims at a global understanding of living
organisms through analysis of their main functions. Through history, physiology has
developed into a molecular discipline based on the reductionism dogma (see below). At first
sight, systems biology positions itself somewhere between these two poles: on one hand it
aims at collecting molecular information on a large scale, which is a purely reductionist
scientific enterprise; on the other hand it aims at integrating this molecular information into
                                                 
1 A paradigm is here understood as defined by Thomas Kuhn in The structure of
scientific revolutions, i.e. as “a set of theories, attitudes, and procedures that scientists do
not question”.
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valuable knowledge to better understand living beings. Whereas for most scientists it may
appear as a similar goal, it fundamentally differs in the fact that for systems biologists,
molecular determinism cannot explain everything. A classical problem that reductionism
has always been unable to decipher is how a full organism with head, arms, antennas,
stomach, tail… can originate from a single cell dividing into two, four, eight…
undifferentiated cells. In a way, the Human Genome Organisation failed to fulfil its
biomedical promises (at least the public expectations), because its outputs were expected in
the context of molecular determinism: each disease was supposed to be fully explained by
one gene or in the worst case a small set of genes, that would account for all pathological
aspects. But despite the completion of human genome sequencing, no major breakthrough
in the understanding of disease has been obtained so far. Gene knowledge is now being
used in medicine as a predisposition diagnosis and treatment orientation and prognosis tool,
as is the case in breast and ovarian cancers with the BRCA gene family [31-33]. But very
limited progress has been made in the design of new drugs based on genomic information.
This limited success, and the claims made by proteomic or systems biology pioneers
seriously question the status of these disciplines into the history of life science research. To
put it into perspective, main conceptual aspects of the history of life science research are
highlighted below.
2.1. From Greeks to mechanistic biology
The Greek physicians Hippocrates (fourth century before Christ) and Galen (second
century after Christ) can be considered as the founders of scientific medicine. They
eradicated all the magical approaches of disease, and based their approach on empirical
healing procedures based on observation. Though very limited by the technical means
available at that time, they pioneered anatomy and surgery, elaborated physiological
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concepts based on their observations and introduced the rational use of plants as drugs.
Their influence was so seminal that in many occidental countries, the Hippocrates oath is a
ritual that symbolises the completion of medical training and ability to treat patients, and the
word “galenic” has passed into pharmaceutical sciences. During Middle Ages, Arabs took
over the Greek and Roman heritage: biology was still tightly associated with medicine, but
it was also tainted with philosophy through the contributions of Gnostic philosophers
Avicenne and Averroes. Arabs were also the first to try to analyse the living matter in terms
of chemistry, and can thus be considered as the pioneers of biochemistry. But scientific
biology and medicine made little progress till the seventeenth century mainly because of the
lack of experimental tools to study living beings and of a general scientific program. The
situation changed during the 17th century, mainly due to the scientific methodology
introduced by Descartes.
Descartes is often considered as the father of reductionism, defined as a
methodology to study and understand complex phenomena [34]:
“I believe that, instead of the multiplicity of rules that comprise logic, I
would have enough in the following four, as long as I made a firm and steadfast
resolution never to fail to observe them.
The first was never to accept anything as true if I did not know clearly
that it was so; that is, carefully to avoid prejudice and jumping to conclusions,
and to include nothing in my judgements apart from whatever appeared so
clearly and distinctly to my mind that I had no opportunity to cast doubt upon it.
The second was to subdivide each of the problems I was about to examine
into as many parts as would be possible and necessary to resolve them better.
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The third was to guide my thoughts in an orderly way by beginning, as if
by steps, to knowledge of the most complex, and even by assuming an order
among objects in cases where there is no natural order among them.
And the final rule was: in all cases, to make such comprehensive
enumerations and such general reviews that I was certainly not to omit
anything.
The long chains of inferences, all of them simple and easy, that geometers
normally use to construct their most difficult demonstrations had given me an
opportunity to think that all the things that can fall within the scope of human
knowledge follow from each other in a similar way, and as long as one avoids
accepting something as true which is not so, and as long as one observes the
order required to deduce them from each other, there cannot be anything so
remote that it cannot be reached nor anything so hidden that it cannot be
uncovered.” Discourse on method (1637). Descartes.
Following Descartes, physicians and biologists began to think about living beings in
terms of mechanisms made of parts. In this perspective living beings were seen as
mechanisms just a little bit more complex than clocks. The first triumph of this mechanistic
concept is the description of blood circulation by William Harvey in his treatise On the
motion of the heart (1628). Heart pumping, arteries and veins were depicted
macroscopically in terms of fluid mechanics and anatomy. Other attempts were made
during the 17th century to explain other physiological functions by dissecting their parts and
rebuild them (practically speaking or by experiment of thought) into true mechanical
systems. This approach is best exemplified by Vaucanson’s duck:
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Figure 4. Vaucanson’s duck. Automates Museum. Grenoble. France.
Vaucanson built a mechanical duck that was able to ingest, chew and “digest”
aliments. Though anecdotic, this automata accounts for the scientific program of the 17th
century in life sciences: physiological processes could be understood by dissecting and
mimicking them by mechanical devices. This concept was largely based on the fact that the
smallest observable biological units were organs and tissues that resemble much mechanical
devices such as pumps, springs, or pipes. But this purely mechanistic approach remained
largely unsuccessful and main physiological functions such as breathing, digestion,
movement… remained unexplained.
Interestingly, at the same time another school of thoughts initiated by Paracelsus
attempted to study biological processes in terms of chemistry. They benefited from the Arab
alchemists’ heritage and built a theory into which life was considered as a pure chemical
process, and disease as a disequilibrium of this process. As for Paracelsus, medicine was not
only a matter of understanding and curing, but was also based on philosophy and ethics:
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“Medicine rests upon four pillars—philosophy, astronomy, alchemy, and
ethics. The first pillar is the philosophical knowledge of earth and water; the
second, astronomy, supplies its full understanding of that which is of fiery and
airy nature; the third is an adequate explanation of the properties of all the four
elements—that is to say, of the whole cosmos— and an introduction into the art
of their transformations; and finally the fourth shows the physician those virtues
which must stay with him up until his death, and it should support and complete
the three other pillars.” Das Buch Paragranum (1529-1530). Paracelsus.
During all the 17th century, there was a conceptual fight between Descartes’ and
Paracelsus’ heirs: mechanistic view of living beings was opposed to a more holistic view of
life as a chemical process. But probably due to the depth of the scientific and philosophical
Cartesian program, reductionism (and especially its mechanistic aspect) dominated the 17th
century.
The 18th century witnessed a considerable evolution by the development of
chemistry and discovery of electricity. Lavoisier discovered the theory of combustion of
gases and studied breathing as a particular kind of oxidation processes. At the turn of the
century, Galvani discovered that electric current was associated with nerve function, and
Volta pioneered electrophysiology by demonstrating that an electric current could induce
muscular action (and reversibly). These discoveries of entirely new processes at work in
living beings questioned the mechanistic approach that dominated the 17th century.
Moreover, as gases and electricity could not be regarded at that time as “cartesian parts” or
elemental devices, these new discoveries should have questioned the reductionist program.
In practise, the discovery of the role of electric currents in neural and muscular systems and
of oxidation in breathing, were perceived as steps that could not yet be reduced to elemental
processes at the time, and reductionism (including its mechanistic program) continued to
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dominate the occidental life sciences and philosophy. It culminated in the book Man a
machine (1748) by De La Mettrie who postulated that human beings were pure machines
and that even thought and mind would eventually be reduced to a mechanistic description.
The 19th century witnessed an enormous development of biology and medicine, and
the true advent of classical life sciences. One revolutionary contribution is the recognition
that all living beings are made of cells; first discovered by Hooke in the 18th century through
the development of the microscope, only during the 19th century was a true cellular theory
elaborated by Schwann:
“The elementary parts of all tissues are formed of cells in an analogous,
though very diversified manner, so that it may be asserted that there is one
universal principle of development for the elementary parts of organisms,
however different, and that this principle is the formation of cells”. Microscopic
researches into the accordance in the structure and growth of animals and
plants (1839). Theodor Schwann.
Though the development of the microscope played a seminal role in the cellular
theory, it cannot account solely for the discovery of cells (for a detailed study of the
conceptual requisites needed to observe something with a microscope, the reader is referred
to reference [35]). The 19th century was marked by the genius of Louis Pasteur who studied
bacteria in various contexts; its major contribution was to demonstrate that self-generation
does not exist, but that the turbidity that can appear in liquids originates from the growth of
originally undetectable microorganisms. The philosophical implications of the impossibility
of self-generation were so deep that the controversy about it continued well after the
experimental demonstrations carried out by Pasteur. After twenty years of research about
bacteria in the context of what would be now called industrial biotechnologies (i.e. the milk,
beer and wine industries at that time), Pasteur also demonstrated that many diseases could
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be explained by the presence of specific microorganisms in the ill host. By directly relating
disease to the proliferation of micro-organic intruders, Pasteur delineated the biomedical
research program for the next century, which culminated by the world-wide vaccination
campaigns during the 20th century.
The identification of cells as elementary building blocks of living beings, as well as
the link established by Pasteur between microorganisms and diseases constituted the most
striking successes of the reductionist scientific program, and gave strength to it to an
unprecedented level. Historically, these successes corresponded to the rise of scientific
positivism that claimed that everything could be understood for the general benefit of
Mankind. Unfortunately, this mainstream scientific and philosophical school of thought
eclipsed a theory introduced a little before by Claude Bernard, considered as the father of
modern physiology. Whereas Bernard was truly faithful to reductionism, its physiology was
based on the existence of an inner medium, in which there were organs and tissues. He
observed that this inner medium was remarkably constant, independently of the external
conditions. He thus postulated that existence and constancy of this inner medium (now
called homeostasis) was a condition for life, and that disease was associated with
disequilibrium of this inner medium. Though the medical methodology introduced by
Bernard in the Introduction to the study of experimental medicine (1865) established him as
a commanding figure in the history of biomedical sciences, his elaborated concept of health
and disease was largely disregarded by biologists and physicians till its rediscovery during
the 20th century.
One of the major contributions of the 19th century to the history of ideas is the
Darwinian theory of evolution. Darwin’s theory describes living beings as systems in
perpetual evolution and transformation. The world was no more a perfect Newtonian
machine created by God, but a system whose components were evolving from one another.
Microfluidic front-end technologies for protein electrospray mass spectrometry
17
However Darwin’s theory did not have any molecular or elementary explanation, and all
attempts to describe it in terms of hereditary units failed; for example, Darwin thought that
each offspring inherited approximately half of its parents’ traits. As evolution was due to
random mutations, inheritance mechanisms would then result in quick disappearance of
new traits. Ironically, only at the beginning of the 20th century was the work of Gregor
Mendel rediscovered by William Bateson, which provided the first elements of a
reductionist explanation of mutations and evolution.
The 19th century was the golden era of the reductionist program: the establishment
of the cellular theory, the role of bacteria (an later of viruses) in disease, and the subsequent
development of vaccination, and the early developments of molecular biology, testified for
the strength of the program and eclipsed all other concepts of life, health and disease.
2.2. The century of doubts
The successes obtained during the 19th century by the reductionist approach to life
sciences problems marked the early developments of molecular biology; in particular,
whereas the molecular structures of heredity were not elucidated yet, the first central dogma
of molecular biology became: “one hereditary unit, one trait” [36]. However, following the
Mendelian approach of hereditary mechanisms, it was soon discovered that one gene could
affect several traits or conversely that one trait could be under the control of several genes.
Nevertheless, progress in biochemistry let envisioned a full explanation of life processes in
terms of their molecular components:
“When the biologist is confronted with the fact that in the organism the
parts are so adapted to each other as to give rise to a harmonious whole; and
that the organisms are endowed with structures and instincts calculated to
prolong their life and perpetuate their race, doubts as to the adequacy of a
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purely physicochemical viewpoint in biology may arise. The difficulties
besetting the biologist in this problem have been rather increased than
diminished by the discovery of the Mendelian heredity, according to which each
character is transmitted independently of any other character. Since the number
of Mendelian characters in each organism is large, the possibility must be faced
that the organism is merely a mosaic of independent hereditary characters. If
this be the case the question arises: What moulds these independent characters
into a harmonious whole? […] The theory of natural selection invokes neither
design or purpose [as contrary to vitalism], but it is incomplete since it
disregards the physicochemical constitution of living matter about which little
was known until recently.” The organism as a whole: from a physicochemical
viewpoint (1916). Jacques Loeb.
As summed up by Jacques Loeb, this tension between the early results of Mendelian
genetics and the reductionist program was attributed to an insufficient knowledge of
molecular components of heredity. Successes of the reductionist program continued to
accumulate in the first half of the 20th century, with the discovery that enzymes carry out
chemical reactions in living beings and are homologous in many different species (which
was in line with the universal elementary units of the reductionist program), and later on
that genes were at the origin of the synthesis of enzymes [37]. But biology was still
confronted with the lack of information about the intimate structure of the molecules
involved in these processes.
The situation dramatically changed during the forties, with the incursion of
physicists into biology. Major figures of this trend were Francis Crick, James Watson,
Maurice Wilkins, Rosalind Franklin, Linus Pauling, Salvador Luria and Max Delbrück.
Beyond biological research, the interest of physicists for biology is best exemplified by the
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work of Niels Bohr, who questioned the applicability of the uncertainty principle in biology,
and even more by Erwin Schrödinger in his popular book What is life?. Schrödinger
hypothesised what the molecular basis of heredity should be from very general physical
considerations of permanence and information storage. Interestingly, though Schrödinger’s
goal was to deduce the molecular structure of heredity, his reasoning was based on very
general considerations about hereditary processes and a holistic approach of living
organisms. But it seems that the only methodological lesson learned from his work was that
physical sciences had much to provide to biological reductionism. And major contributions
were obtained in the following years thanks to X-ray crystallography: Linus Pauling
elucidated the three dimensional structure of proteins [38-40] (Nobel prize in chemistry
1954) and Watson and Crick [41] that of DNA (Nobel prize in medicine and physiology
1962). Within the next decade, the mechanism by which nucleic acids direct protein
synthesis were elucidated, and were found to be essentially the same from bacteria to homo
sapiens. These results constituted the triumph of the reductionist program in life sciences,
and molecular biology  became the new frontier of life sciences, with a clear established
program:
I present them [the Sequence Hypothesis and the Central Dogma] here in
the hope that others can make similar use of them. Their speculative nature is
emphasised by their names. It is an instructive exercise to attempt to build a
useful theory without using them. One generally ends in the wilderness.
The Sequence Hypothesis. This has been already referred to a number of
times. In its simplest form it assumes that the specificity of a piece of nucleic
acids is expressed solely by the sequence of its bases, and that this simple
sequence is a (simple) code for the amino acid sequence of a particular
protein…
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The Central Dogma. This states that once “information” has passed into
protein it cannot get out again. In more detail, the transfer of information from
nucleic acid to nucleic acid, or from nucleic acid to protein may be possible, but
transfer from protein to protein, or from protein to nucleic acid is impossible.
Information means here the precise determination of sequence, either of bases
in the nucleic acid or of amino acids residues in the protein. This is by no mean
universally held —Sir Macfarlane Burnet, for example, does not subscribe to
it— but many workers now think along these lines. As far as I know it has not
been explicitly stated before”. On protein synthesis, symposia of the Society for
Experimental Biology: the biological replication of molecules, 1958, 12:152-
153. Francis Crick.
The full paradigm of molecular biology is contained in this quotation from Francis
Crick: first, for nucleic acids, the sequence only carries information, and secondly, DNA is
at the origin of proteins, and in a more specific way, the Central Dogma of molecular
biology (which has been taught to all students since then) can be rephrased as “one gene,
one protein”. The clearness and the power of these dogmas in light of the reductionist
approach successfully drove the booming of molecular biology in the first decades after
World War II. Interestingly, Crick called them “Hypothesis” and “Dogma”, which implies
that at that time they were not established facts supported by solid experimental data and
integrated into a coherent theory, but more a research program, or to express it differently, a
paradigm to be tested. But the hypothesis was so seducing, and the prospect of explaining
every life process through molecular biology seemed so close, that it was rapidly accepted
and taken as granted.
However, the molecular biology program eclipsed some major problems in biology,
or otherwise stated, moved the centre of the various disciplines, which was to understand
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physiological functions, to molecular biology in order to understand how genes were
involved in life processes. This left behind some cardinal problems, such as embryogenesis,
i.e. how an undifferentiated cell gives rise to differentiated progeny cells, or how a skin cell
transfer the “skin nature” to daughter cells, or the structure of the nervous system whose
basic components’ behaviour alone cannot explain complex functions, or even some
problems pertinent to molecular biology, such as the high number of duplicated genes
throughout the genome (especially for higher organisms).
2.3. Reductionism under attack
The first half of the 20th century was marked by the revolution in physics. The
violent controversies that accompanied the elaboration of quantum mechanics shed light on
uncomfortable aspects of epistemology2: following Louis de Broglie, Schrödinger
established a vision of matter as waves, whereas primarily the Copenhagen school led by
Niels Bohr thought of matter as particles with quantified energy states. The unification of
these two theories that were also two visions of Nature occupied all major physicists till the
end of the thirties. This unification was done at the cost of huge epistemological
compromises or revisions, and produced unexpected results, such as Heisenberg’s
uncertainty principle, which states that “the more precisely the position is determined, the
less precisely the momentum is known in this instant, and vice versa”. For many scientists
and philosophers, the clear consequence of this principle is that the most intimate details of
nature cannot be known at any desired precision. At the same time, the unified theory
                                                 
2 The concepts about quantum physics exposed in this paragraph may be
oversimplified and provocative, but stress is put on their impact (or the impact of how they
were perceived) on the history of ideas.
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imposed a duality in Nature: objects can be particles or can be waves, and the way we
observe them determines their wave or particle nature. This uncomfortable situation is
summed up by Einstein himself:
“Quantum mechanics is certainly imposing. But an inner voice tells me
that this is not yet the real thing. The theory says a lot, but does not bring us any
closer to the secrets of the ‘Old One’. I, at any rate, am convinced that He is not
playing at dice.” Letter to Max Born (1926). Albert Einstein.
Not only did quantum physics pose fundamental problems about the nature of
atoms, but dramatically questioned the determinism program that occupied a very strong
position in the thirties:
“It is not absurd to suppose that psychological laws may eventually be
explained in terms of the behaviour of individual neurons of the brain; that the
behaviour of individual cells —including neurons— be explained in terms of
their biochemical constitution; and that the behaviour of molecules —including
the macromolecules that make up living cells— may eventually be explained in
terms of atomic physics.” Oppenheim and Putnam (1958) [42].
Cybernetics: influence, misconceptions and promises
Molecular biology did not evolve independently of other disciplines, and was deeply
influenced by other branches of research, including information theory: the concepts of
information, message, program, are still currently used in molecular biology to explain the
respective functions of DNA, RNA and proteins and their interplay (see below for a
discussion about the implications of considering DNA as a program). But information
theory and cybernetics provided much more to biology than simple vocabulary and
metaphors.
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Information theory was pioneered by Shannon in the late forties [43]; its major
achievement was to provide a mathematical framework for the quantitative evaluation of
information, and its modifications through coding and transmission. His concepts were
rapidly taken up in the field of biology, primarily to evaluate the information content of
whole living beings [44, 45], and a few years later that of DNA [46, 47]. Though relatively
unfruitful in practise, these approaches influenced the way molecular biologists perceived
DNA as an information-rich message.
During the same period appeared new fields such as computer sciences and
cybernetics: computer sciences were developed by people such as von Neumann and Turing
during World War II. Not only were they interested in the building of computing machines
to break German secret codes, help design nuclear weapons or do weather forecasting
through the Pacific Ocean, but they also laid down the principles of theoretical computation.
For example, Von Neumann designed the so-called “Von Neumann architecture”, in which
the computer consists in a set of instructions, a program that will be interpreted by the set of
instructions, and data (both input and output of the program). This architecture is still the
one used in usual computers. It is worth examining in some details these early fundamental
developments in computer sciences, because their influence on molecular biology and
genetics is so deep that even in the general audience, DNA is perceived as a computer
program for the building of living beings. One of the fundamental aspects of these early
developments in computer sciences took over the idea pioneered by Gödel in Über formal
unentscheidbare Sätze der Principia Mathematica und verwandter Systeme for the
demonstration of his incompleteness theorem: the basic idea is that formulations about
number theory can be themselves formulated as numbers. This trick thus induces a
recursivity that is the core of Gödel’s proof [48]. Turing and Von Neumann applied this
idea to computer architecture: the set of instructions, the program and data share essentially
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the same structure and need not be differentiated. Only does the external a priori knowledge
of what a set of instructions is, what a program is and what data is (i.e. the hardware
structure of the computer) differentiate them.
The popular perception of DNA as a program has grown on these developments of
computer sciences as well as on the underlying belief that there need be a master architect
to organise living processes. However, no syntax has ever been identified in DNA so far.
The only clear established fact is that DNA codes for proteins. As pointed out by Henri
Atlan [49], if DNA is to be seen as a program, the cellular machinery must be the set of
instructions that interprets the program. Algorithm theory specifies that the set of programs
interpretable by a given set of instructions cannot be known a priori, and that only
experiments can tell if a program is interpretable. Interestingly, molecular biology has
extensively proven that a given cellular system can “interpret” DNA from various
organisms, given proper molecular support is provided. The set of results (structures of the
cellular system) is defined by the program; so if each DNA is a program, it will produce its
own set of results. Conversely, if DNA is to be considered as data, the cellular machinery
must be the program. The set of DNA accepted as input is defined by the program; in
practise, the cellular machinery can accept a wide variety of DNA inputs. But this time, the
set of results (the cellular structures) is defined by the program that is unique. The set of
results will thus be limited to a single class, independently of the input data (the DNA).
Remarkably, cellular structures and major biological functions are the same in the whole
living kingdom, and the variations depend on the DNA, which corresponds well to the
situation in which the program is unique (the cellular machinery) and thus all possible
results belong to the same class, the variations depending on the input data. The purpose
here is not to show that DNA is a program, or data, but that metaphors from computer
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sciences do not describe the reality: the metaphor of DNA as data is as pertinent as that of
DNA as a program (and in fact better corresponds to the reality).
The development of computing machines, able to make complex operations, gave
rise to the idea that some concepts used in computer science and automate control could be
useful to model or interpret biological phenomena; in one of the seminal book about
cybernetics [50], Ross Ashby adopts the definition of Wiener, as “the science of control and
communication, in the animal and in the machine”. It is thus from the very beginning a
transversal approach to process control, be it a living process or a man-made process. The
main contributions of cybernetics to molecular biology have been summed up by Henri
Atlan [51]:
• Life processes can be viewed as information processing channels
• Molecular processes are regulated by feedback loops
• Redundancy provides robustness and information can arise from noise
• Collections of simple units can self-organise into complex systems
As already mentioned, the first point has been relatively unfruitful, except by
providing a conceptual framework and a language to molecular biologists. The second point
has clearly fostered the models for gene regulation. Figure 5 shows a simplified model of
the lactose operator as described by Jacob and Monod [52-55]. This model explains how
bacteria express enzymes responsible for lactose metabolism only in the presence of
lactose: in the absence of lactose, the repressor gene Lac 1 “produces” a repressor protein
that assembles into a tetramer unit. This repressor tetramer unit has a high affinity for the
operator DNA portion that is situated just between the promoter site (where RNA
polymerase binds) and the genes to be expressed (Lac Z for for -galactosidase that
metabolises lactose, Lac Y for lactose permease, a membrane protein that permits the entry
of lactose into the cell, and Lac A for thiogalactoside transacetylase, whose function is not
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well documented). In the absence of lactose, the RNA polymerase cannot thus move from
the promoter site to the genes themselves and transcription is inhibited. In the presence of
lactose, its intracellular form allolactose binds to the repressor tetramer unit that loses its
affinity for the operator site. The RNA polymerase can thus move from the promoter site to
the genes, and Lac Z, Lac Y and Lac A are transcribed and expressed. Lactose is then
consumed, and if not supplied to the cell, its concentration diminishes and it is released
from the repressor that can thus bind again to the operator site and inhibit gene
transcription.
Figure 5. Structure of the lactose operon as described by Jacob and Monod.
(This model is simplified in the sense that it does not explain the metabolism when
both glucose and lactose are present. In fact, the RNA polymerase has a relatively low
affinity for the lactose promoter site, so that the glucose metabolism machinery is
preferentially expressed. When glucose rarefies, the intracellular concentration of cAMP
levels up, and cAMP complexes with CAP —the Catabolite Activator Protein—; the
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complex CAP-cAMP then binds to the promoter site, which enhances the affinity of the
RNA polymerase for the lactose promoter site by a factor of 50.)
 This kind of models of feedback regulation where -galactosidase metabolises
lactose, whose disappearance inhibits the production of the enzyme, was already well
known in process control and cybernetics [50]. It is hard now to evaluate the cross-
fertalisation of cybernetics and molecular biology; gene regulation mechanisms may have
been well discovered without any culture in process control, but what is sure is that
cybernetics formalism was early applied to molecular biology problems, for example by
Griffith [56, 57]. Unfortunately, the utility of such approaches beyond metaphors
necessitated reliable time-resolved quantitative data about RNA and protein levels. Only
relatively recently were convincing matches between theoretical models and experiments
published [58, 59], as shown in Figure 6:
Figure 6. Evolution of -galactosidase activity in response of lactose supplementation.
Open circles and plain diamonds are from two different datasets from the literature. Solid
line is the modelled activity. Reprinted with permission from [59].
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Cybernetics has also directly contributed to the understanding of biological
robustness to external factors through the concept of redundancy. This is probably the
domain into which there are the most numerous misconceptions about the influence of
cybernetics on biology. In man-made objects and machines, robustness is guaranteed by
duplication of key elements (such as triplication of flying commands on an airplane). The
fact that living organisms are usually robust to exposure to different growth conditions,
stressing environments and mutations has driven many researchers to take for granted that
their robustness is due to duplication of essential metabolic pathways or enzymes. This is a
very anthropomorphic view of life processes and evolution, which comes from the
confusion between species survival and individual survival. As summed up ironically by
Nicolas Le Novère:
“If I am an oyster, how then can I be sure to preserve my offspring from
negative deviations? If my critical subsystems are redundant, I'll be able to
survive minor deleterious variations, and I'll pass those variations to my
offspring. Following the neutral theory of molecular evolution (Motoo Kimura),
these variations can invade the population by genetic drift. Now if my species
encounter situation where an optimal function of the subsystem is required, it
will be wiped-out from the surface of the earth. Too bad. Another scenario: The
redundancy of my critical subsystems has been kept at its minimum. If any of my
offspring experience a small deviation in one of those subsystems, it will die
quickly. Well, you know what? I don't care. I'm an oyster. I can spawn ten
millions eggs. I can afford to loose 90% of them.” [60]
In fact, observation has proven that critical elements are not duplicated in cells; for
example, there is a single RNA polymerase to transcribe DNA into mRNA. If there is a
mutation in the gene coding for such an essential enzyme, the organism dies before it can
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transmit this mutation to an offspring. Wagner has recently investigated possible sources of
robustness in living organisms [61]: there are a lot of experimental evidences that key genes
(in all species and in all kind of genes, enzymatic, structural or regulatory) can be silenced
or deleted without dramatic effect, which for many molecular biologists is a proof that these
genes are actually duplicated, or that other gene-products can take over the deleted function.
This is again a too reductionist approach to gene function: for example, Zoli et al have
shown that a mice model lacking the 2 subunit of the nicotinic acetylcholine receptor,
which is an essential component of signal transduction, and which was known
experimentally to be non essential to proper development, turned out to develop dramatic
neurodegeneration during aging [62]. So even asymptomatic knock-out organisms can
demonstrate complex physiological behaviours that cannot be explained by single gene
deletion. But Wagner investigated another source of robustness, namely the distributed
robustness [61]: many parts of a system contribute to its overall function, but all of these
parts have different functions. When one part fails or is mutated, the system can compensate
for this failure, but not because a back-up redundant part takes over the failed part’s role.
An example of such a robustness is the role of the enzyme glucose-6-phosphate
dehydrogenase (part of the pentose phosphate shunt) in the metabolism of NADPH/NADP
in Escherichia Coli. In the wild type organism, two thirds of NADPH is produced by the
pentose phosphate shunt . Most of NADH is produced by the tricarboxylic acid cycle. If the
gene for the glucose-6-phosphate dehydrogenase is mutated or silenced, the oxidative
branch of the pentose phosphate shunt is blocked, and thus production of NADPH should be
blocked. But an increased flux is observed through the tricarboxylic acid cycle, which
generates NADH. This increased NADH is then transformed into NADPH via a massively
increased flux through the transhydrogenase reaction. In summary, NADPH can still be
produced by recruiting some other pathways of different metabolic networks. This is an
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inherent feature of complex distributed systems to be able to compensate for blocked
pathways by recruiting different, complementary biochemical networks. This kind of
robustness cannot be explained by molecular reductionism alone, and its concept directly
comes from cybernetics theory [50].
The example above showed how robustness can appear as an emergent property of a
complex system. The concept of emergence3 has been pioneered in engineering by Alan
Turing through the development of neural networks [63]: by mimicking neurons function,
Turing proposed new computing machines based on the following elementary units:
Figure 7. Schematic of an artificial neuron.
Where x1…..xn are external inputs or outputs of other neurons, w1….wn are the
weights of the connections and the output is whether an external output or one input to
another neuron. The function f is usually whether a threshold or sigmoid function. When
assembled into networks, these artificial neurons can demonstrate relatively complex
behaviours, such as pattern recognition abilities (the Perceptron [64]) that are hardly
feasible by classical computers. The striking feature of neural networks is that complex
responses can be generated by collections of very simple computing units such as the one
depicted in Figure 7. As for example, Hopfield et al described an elegant computation of the
                                                 
3 Emergence is here defined as the appearance of properties that cannot be attributed
to parts of the system, but arise from a collective behaviour of these parts.
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classical travelling salesman problem (which is a canonical NP – non deterministic
polynomial – problem, a class of problems whose solution cannot be computed in a
polynomial time): a salesman has to visit n cities while minimising the distances travelled;
all the problem is to determine in which order the cities have to be visited [65]. There are
still no “classical” algorithm to solve this problem because of the combinatorial complexity
of testing all possible pathways, but Hopfield et al obtained a solution in a convergence
time 1023 faster that the combinatorial exploration of all possibilities (if it were possible).
With the particular network developed by Hopfield for this problem, a neuron
corresponding to the city i (row i) is activated in column j if it has to be visited in jth position
in the travel:
Figure 8. Neural computing of the travelling salesman problem. All dots are artificial
neurons. The size of each black box depicts the activation (the output value) of each neuron.
Cities are lettered A to J (vertical axis); the order in which they are to be visited are on the
horizontal axis. A is the random initial state of the network, B-C intermediary states
through computation, and D the final state. Reprinted with permission from [65].
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The development of neural networks was a breakthrough in computing science, as
well as in biology: in fact the initial ideas for the development of neural networks were
taken from biology, and their practical implementation showed biologists how collective
properties can emerge from collections of simple units. Interestingly, the concept of
emergence had been introduced in the second half of the 19th century by the natural
philosopher George Lewes [66], but only in the second half of the 20th century received
attention from the biological community [67].
At the beginning of the second half of the 20th century all these approaches at the
interface between computer science, process control and biology gave rise to a new
discipline: system theory, which was founded by Norbert Wiener, William Ashby and
Heinz von Foerster (cybernetics), von Neumann and Alan Turing (connectionist
approaches), Jay Forrester (computer sciences), Ludwig von Bertalanffy and Henri Atlan
(theoretical biology), Warren McCulloch (neurophysiology), Edgar Morin (sociology)… As
popularised by Joël de Rosnay [68], system theory is a holistic approach that consists in
looking at interactions between components of a system in order to understand the
behaviour of the system as a whole. Whereas its advent may have been relatively unnoticed
in the general scientific audience, it consists in a radical paradigmatic change, which can be
explained by examining neural networks: a reductionist examination of a neural network
would end-up with the description of a single neuron such as the one depicted in Figure 7
together with its activation function, which tells very little on the potential of the whole
network, as all the important features are implemented in the connections of the neurons
(i.e. in the weights of the connections). Joël de Rosnay further proposed a conceptual
instrument called the Macroscope: it can be described as a marriage between the
microscope and the telescope that allows to look at systems from far away and get a general
picture and zoom into the most intimate details of the system. The holistic approach is thus
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characterised by zooms in (that allow molecular, reductive description of biological
systems) and zooms out (to put all the molecular information into perspective with other
levels of organisation).
3. The rise of large-scale biology
3.1. Early history of genome sequencing projects
The discussions about possibilities to sequence whole genomes started in the
beginning of the eighties and crystallised in 1985 in a meeting organised by Robert
Sinsheimer (chancellor of the University of California at Santa Cruz) featuring John Sulston
(Cambridge University) and Robert Waterston (Washington University in Saint Louis) who
were already involved in the genome mapping of C. Elegans, Bart Barrell (head of large-
scale sequencing at the UK Medical Research Council), David Botstein (MIT), Helen
Donis-Keller (Collaborative Research Inc.) Walter Gilbert (Nobel Prize in chemistry in
1980 for the development of DNA sequencing methods) and George Church (Harvard
University, and Leroy Hood (California Institute of Technology). Whereas the conclusion
of the meeting was that large-scale DNA sequencing was not feasible, it triggered Walter
Gilbert’s interest in taking the lead of assembling a genome sequencing initiative. He soon
gained support from Francis Crick and Maurice Wilkins (Nobel Prize in 1953 for the
discovery of the DNA double helix) as well as Charles DeLisi, a cancer biologist who was
heading the Office of Health and Environmental Research at the Department of Energy
(DOE). Several meetings held out in the course of 1986 led to the conclusion that large-
scale genome sequencing might be doable, but questions about how desirable it was were at
the heart of the building of real projects: scientifically speaking, many “traditional”
Chapter 1. Introduction
34
molecular biologists were convinced that conventional approaches were more fruitful that
brute-force DNA sequencing:
“An approach that included mapping, genetics and biochemistry makes a
lot more sense”. Maxine Singer (National Cancer Institute, Bethesda), 1986.
[69]
In parallel, the scientific task to be accomplished was questioned by many as a non-
scientific enterprise; Sydney Brenner (Nobel Prize in Physiology and Medicine 2002 for the
elucidation of genetic regulation mechanisms) joked that sequencing is so boring that it
should be done by prisoners and not by scientists [69]. Lastly, there was a reasonable
concern that a nation- or worldwide effort for genome sequencing would drag all funding
for biomedical research and cut out all other projects.
The situation was unblocked by the investments of the US Department of Energy
into its own genome sequencing effort at the end of 1986, due to the commitment of Charles
DeLisi, the need for DOE to redesign its activities after the decline of military activities,
and to its know-how in large scientific projects management. Soon after, a nation-wide
genome sequencing effort received political appraisal as a multi-phase project: first
establish physical maps of human chromosomes, second evaluate and develop the
sequencing technologies on model organisms, and lastly sequence the human genome [70].
The National Institutes of Health (NIH) took the lead over DOE by appointing James
Watson as the head of its new Office for Human Genome Research in 1988 [71]. Under the
auspices of James Watson, genome sequencing projects clearly took a “basic science”
orientation, whose goal was to decipher the Book of Life.
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3.2. Speeding up the race for genome sequencing
But in 1991, Craig Venter, who was then heading a large-scale sequencing lab at the
National Institute for Neurological Disorders and Stroke came out with the technology of
Expressed Sequenced Tags (ESTs), which would enable to focus on the discovery of
biomedically relevant genes at high speed but with less precision than other sequencing
technologies. This technological strategy together with the aggressive patent filing of Craig
Venter created a huge controversy between genome sequencing pioneers that eventually
cost his job to James Watson. He was replaced by Francis Collins, an atypical physician by
training, who somehow redesigned the objectives of the Human Genome Project to put
emphasis on biomedical aspects. But DNA sequencing technologies were still relatively
slow, with only incremental progress on the technological side, and Francis Collins chose to
focus the efforts on the development of physical and genetic maps that could already be
useful to geneticists and physicians. But in 1995 the situation changed radically, when Craig
Venter announced that the genome of Haemophilus Influenzae had been sequenced in a year
by a brand new technique called shotgun sequencing (a technology that has always been
rejected by NIH) [72]. From that demonstration, the race between publicly-funded programs
(NIH, DOE and MRC) whose aim was to produce a high-quality consensus sequence of the
human genome, and Venter’s initiative which was more “gene-identification” oriented,
raged. The first consequence of that competition was the biomedical claims made by the
two project leaders, Francis Collins for the NIH and Craig Venter, in the urge to maintain
the money flowing into their own projects. In 1998, the competition received a second kick
when Craig Venter announced the creation of Celera Genomics in partnership with Perkin-
Elmer who would single-handedly sequence the human genome within three years. This
announcement made Francis Collins reshape the NIH Human Genome Project once again:
in order to keep the pace imposed by Celera Genomics, the public project would now
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produce a lower quality sequence. The goal was two-fold: first to keep in the race imposed
by Craig Venter, and second, to publish as much sequence as possible before Celera
Genomics could patent it. Finally the incredibly violent rivalry between Craig Venter and
Francis Collins found an end in the decision to publish the results of the human genome
sequencing efforts the very same day in Nature for the publicly funded project [73] and in
Science for Celera Genomics [74]. The beneficial aspect of this competition is clearly the
efficiency in genome sequencing efforts: Figure 9 shows the number of genomes sequenced
per year.
Figure 9. Number of sequenced genomes per year. Information is from
http://www.genomesonline.org Data for year 2005 are extrapolated from the first ten
months.
There is a clear speed up after 1999 due to technological developments performed
during the previous years. In 2005, the number of completed genomes is expected to be the
same as in 2004, but there are 760 ongoing sequencing projects for prokaryotes and 531 for
eukaryotes.
As summed up by Leroy Hood [75], the Human Genome Project has resulted in four
striking features:
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• There are approximately 25000-35000 genes in human beings, which is just
one third more than in Caenorhabditis Elegans, a small worm. How to
account for human complexity from this relatively small number of genes is
still an unanswered puzzle.
• There are no race-specific genes: the genomes of two Black people may
differ more than those of a Caucasian and Black persons. The concept of
Race is cultural, not genetic.
• There is a unity throughout the living beings: many fundamental biological
systems are similar from bacteria to human beings.
• All living beings are connected: in the human genome, there are 200 or more
genes derived from other organisms that cannot be accounted for by
evolution (they would have evolved), which means that living beings can
incorporate information from surrounding organisms.
These four features were very striking in the sense that they show the unity and
similarity of all living beings, contrary to the classical pyramidal view of evolution
that places human beings at the top of all living creatures.
3.3. So what?
With the sequence of the human genome (and many other species) being available
for more than four years now, claims over its direct biomedical relevance can be re-
evaluated: whereas in its first phase, James Watson put the sequencing projects under the
auspices of basic research in a philosophical perspective to read the Book of Life, from
1993 Francis Collins put the emphasis on potential biomedical applications. But still today
it is hard to find direct biomedical applications of genomics. For example in 2002, Francis
Collins pointed out two examples of treatment orientation based on genomic knowledge
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[76]: a case of a pregnant woman with predisposition for deep venous thrombosis whose
predisposition could be confirmed by genetic testing and thus could be treated with
anticoagulants to avoid any problem in the course of pregnancy. The second case cited was
that of a four-year old boy treated for lymphoblastic leukaemia with mercaptopurine (a
highly toxic compound with potential deadly side effects). Genetic testing revealed that the
boy was homozygous for a mutation in the gene that encodes thiopurine S-
methyltransferase, an enzyme that inactivates mercaptopurine; drug doses could thus be
decreased to levels where no side effects appeared [76]. Francis Collins cited these two
examples as canonical of benefits brought about by the genomic revolution. However, this
paper rapidly raised criticisms from the medical community, as the two cases would have
been treated exactly the same way without any genetic testing [77].
The purpose here is not to claim that genomics has no biomedical value: already
demonstrated applications range from the identification of new pathogens (such as the
severe acute respiratory syndrome SARS [78-80]), prognosis and therapy guiding in breast
cancer [81], stratification of patients with long QT syndrome [82] or myocardial infarction
[83]… But genomic testing has proven informative mainly in monogenic diseases, or in
diseases in which mutations on one or two genes play a dominant role. However in most
diseases or disorders, genetic causes are not so clear or a great number of genes are
involved in the disease. For example, whereas most genetic studies on Alzheimer disease
have focused on four genes (those coding for presenilin 1 (PS1), presenilin 2 (PS2),
amyloid precursor protein (APP) and apolipoprotein E (APOE)) [84], a number of other
genes have been reported to play a role in the disease: a simple full text query of Entrez
Gene from the National Center for Biotechnology Information [85] (“Alzheimer AND
Homo Sapiens”) retrieves 125 entries; complementarily, a similar search in SwissProt (All
Text: Alzheimer and Organism: Homo Sapiens) retrieves 57 different proteins that have
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been documented to be involved in Alzheimer disease. Whereas genetic analysis may allow
prognosis of the age at onset and progression of the disease [86-88], no breakthrough in
disease treatment or curing has been provided yet by genomics; in contrary most studies
focus in a reductionist approach to the four genes coding for presenilin 1 and 2, amyloid
precursor protein and apolipoprotein E, even when genomic technologies are used.
Besides the reductionist approach that are often at work even when genomic
technologies are used, there is a clear limitation of genomics: genes code for proteins, but
do not bear any physiological functions by themselves. Proteins embody functions, such as
catalysis, structure, transport, signal transduction… This limitation of genomics was early
recognised by Charles DeLisi, an early pioneer of genome sequencing at DOE:
“But, perhaps, an even more fundamental change has begun. The high-
throughput computational and experimental methods of the post HGP [Human
Genome Project] era are forcing molecular biology away from its spectacularly
successful reductionist roots back toward the integrative systems physiology
required to understand cell behavior. High-throughput genomic methods, which
are a revolution for global characterization, are a start in that direction. The
long leap from characterizing to understanding, however, will be possible only
after analogous technologies are developed for proteins.” Charles DeLisi.
Human Genome Program, U.S. Department of Energy, Human Genome News
(v11n3-4), July 2001.
This quotation positions well the situation of genomics: first it opens the way for
integrative biology by whole organism study. Secondly, it will achieve its promises only
through the advent of proteomics, which is the true level at which functions are embodied.
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4. What is proteomics?
Proteomics can now be seen not only as the high-throughput study of proteins or a
set of techniques to study proteins, but as a discipline that is complementary and
indispensable to genomics. Because many events can occur in the pathway from genes to
proteins, one can not necessarily predict that a function (a protein) be present because a
gene is expressed. Many different processes regulates protein production even downstream
RNA, such as post-translational modifications (PTMs) that can act as a trigger for function
(such as is often the case for phosphorylation), truncation, targeting, involvement in multi-
protein complexes… As a consequence, genomic or transcriptomic information cannot be
taken as a marker of function. Many studies have investigated the correlation between
mRNA levels and protein levels, without clear answers:
Figure 10. Correlation between protein and mRNA levels in S. Cerevisiae. (a) for 106 genes
in yeast. The inset shows the low-end portion of the main figure. The Pearson product
moment for the entire data set was 0.935 and 0.356 for the inset. Reprinted with permission
from [89]. (b) Correlation of protein abundance with adjusted mRNA levels in yeast. The
Pearson product moment is 0.76. Reproduced with permission from [90].
As shown in Figure 10, protein and mRNA levels are often poorly correlated, and
relying on transcriptomics to assay functions can be totally misleading due to downstream
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regulations of the protein expression process. It is thus essential to characterize organisms at
the protein level also, which is again the level of biological processes.
In paragraph 1, proteomics was defined as “the identification of all proteins
expressed by a genome, cell or tissue, their quantification, and determination of their
interactions”. After the detour of paragraphs 2.2 and 2.3 about paradigmatic changes
imported from cybernetics and systems theory into biology, the definition can be rephrased
in terms of systems biology: proteomics is the study of biological systems at the level of
proteins. It consists only in a single-level description of a system, and as such cannot claim
to be the necessary description of a living being. It is not more pertinent per se than
genomic, metabolic, anatomical, physiological… descriptions. Above all it is not the
cataloguing of proteins present in a given sample. It is one part of systems or integrative
biology, which consists in putting in perspective all the molecular information collected at
the DNA, RNA or protein level with more physiological information to answer a particular
question. Whereas this definition may read trivial and sound like “systems biology is the
science of everything”, it truly consists in a radical change in the way biological research
proceeds.
One difficulty of this new approach is to choose the pertinent level of description to
investigate a particular problem. Is Alzheimer disease to be explained at the gene level?
This is still an unanswered question: some properly designed genomic studies may unravel
complex genomic predispositions that account for a large proportion of disease
appearances. Proteomic studies may elucidate that the disease appear as a consequence of
the accumulation of particular proteins in a particular state that have nothing to do with
genes but depend only on altered protein processing mechanisms. Environmental studies
may prove that there are external factors that are essential for the onset of the disease.
Further studies may conclude that there are genetic, epigenetic and environmental factors
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that must act together for the disease to appear; in this case, only system approaches have a
chance to explain the disease. It is highly probable (or at least the conviction of many) that
many systemic and multifactorial diseases such as diabetes, cardiovascular diseases,
cancer… will be explained only when investigated by systemic approaches: one of the most
convincing biomedical progress in genomics is the predisposition for breast cancer: if a
woman has a given mutation in the gene BRCA1, she has a probability of 70% of
developing a breast cancer before the age of 60. Even with such a monogenic trait, the risk
of getting cancer is not 100%, because there are other factors at work that prevent or
promote the appearance of a breast cancer.
The choice of the right level of description of an organism in perspective of a
particular problem is a difficult task. In April 2004 was held in London the Second
conference of the Centre for Economic and Social Aspects of Genomics; a large number of
talks was devoted to the field of nutrigenomics, whose interest is to develop new foods or
new diets to improve general health based on genomic information. Beyond all biological
aspects, all studies were somehow inconclusive because they missed a more social
dimension: what is health? Is health the absence of disease? Is health a feeling of wellness?
The concept of health is highly cultural and very personal [91], and any strategy to improve
health must comprise this social aspect in order to properly target the desired effect. As
such, integrative biology is not limited to biological sciences, but may also incorporate
social sciences approaches in particular cases.
As outlined by Leroy Hood [75] and Francis Collins [92], the biomedical promises
of integrative biology lie in predictive and preventive medicine. It is already possible to test
for disease predisposition, such as genetic tests for BRCA1 mutations. It may soon be
possible to test for many disease predispositions through genetic testing or more
conventional protein-based assays. But prediction without cure is an anathema to medicine.
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“Cures” can be envisioned of two different classes: preventive medicine may be able to
perform individual counselling to limit exposure to environmental of behavioural factors
that may contribute to the onset of a predisposed disease. At the other end, there is a strong
hope that integrative biology will allow early diagnosis of disease onset, and the design of
more efficient treatments. The rise of proteomics has (re)opened the quest for disease
biomarkers. Most studies focus on the detection of biomarkers in easily accessible
biological fluids such as plasma or urine.
Whatever the technology used, the strategy is always the same: samples from
patients with the disease under investigation are compared with samples from control
individuals (both healthy individuals and patients with related diseases). Molecules (DNA
in genomic studies, mRNA in transcriptomic studies or proteins in proteomic studies) are
measured and quantified in the search for quantitative differences between disease and
control samples. When a statistical difference is found, the corresponding molecules
become disease biomarkers than can potentially be assessed in routine clinical labs for
diagnosis. In classical reductionist approaches, molecules under investigations are usually
subclasses of biomolecules that have an a priori relevance to the disease. In systems
biology, all molecules are investigated; this poses a fundamental problem, as no (or very
little) a priori knowledge of the disease is incorporated in the study to keep a chance to
identify radically new biomarkers. The drawback of the approach lies in its blindness: the
identified biomarkers may or may not have a clear deterministic link with the disease. A
now classical example is the discovery of ovarian cancer biomarkers by Petricoin et al: the
authors used a recently developed analytical strategy called surface-enhanced-laser-
desorption-ionisation (SELDI) mass spectrometry to get protein profiles of plasma from
women diagnosed with different types of ovarian cancers and compare them from serum
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samples of healthy women. The experimental outputs of the study are quantitative protein
profiles such as the ones presented in Figure 11.
Figure 11. SELDI-TOF-MS protein profile of controls (Unaffected 1 and 2) and patients
with ovarian cancer (Cancer 1 and 2). Peptide and protein m/z ratios are on the horizontal
axis; intensity is proportional to the normalised protein abundance. Reprinted with
permission from [93].
Computer algorithms are then used to identify statistically significant differences in
protein abundances between unaffected and cancer patients. Five peaks at m/z values of
534, 989, 2111, 2251 and 2465 were sufficient to discriminate between disease and control
samples. In a second step, this set of five biomarkers was measured in other samples in a
blind study; the diagnostic power of the test is shown below:
Microfluidic front-end technologies for protein electrospray mass spectrometry
45
Classification by proteomic pattern
Cancer Unaffected
Unaffected women
No evidence of ovarian cysts 2/24 22/24
Benign ovarian cysts < 2-5 cm 1/19 18/19
Benign ovarian cysts >2-5 cm 0/6 6/6
Benign gynaecological disease 0/10 1/10
Non gynaecological
inflammatory disorder
0/7 0/7
Women with ovarian cancer
Stage I 18/18 0/18
Stage II, III, IV 32/32 0/32
Table 1. Classification of serum samples by SELDI-TOF-MS. From [93].
As shown in Table 1, the test classifies correctly all patients with ovarian cancer
(100% sensitivity over 50 patients, with correct segmentation between Stages I and II-IV),
as well as non-cancer patients (95% selectivity with further good segmentation between
different gynaecological disorders). In total, the positive predictive value is 94%; in
comparison, the state-of-the-art immunoassay for ovarian cancer performed on this second
set of samples yielded a positive predictive value of 35%, which means that this test
generates a lot of false positives. These results of course appeared as a breakthrough in
diagnostics, in particular in the correct detection of stage I cancers, and a magnificent
demonstration of the power of proteomic approaches. This work won immediate acclaim: in
addition to the congressional resolution urging further funding for this research, the
consumer magazine Health named the test one of the ten top medical advances of year
2002. However, a somehow unsatisfactory point is that the identified biomarkers are indeed
not identified: only their m/z ratio is known, but their identity and functions are unknown.
This blind approach turned out to be full of pitfalls: the paper by Petricoin et al [94]
received early critics: several authors contested the statistical analysis of data and
biomedical conclusions raised from it in the context of general screening programs [95-97];
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more importantly, Diamandis raised fundamental questions about the methodology used by
Petricoin et al: “classical” cancer biomarkers (such as prostate-specific antigen (PSA), -
fetoprotein, carcinoembryonic antigen) are known to be present in blood at concentration in
the range of 1-10 ng/mL (corresponding to 35-350 pM for PSA, 15-150 pM for -
fetoprotein, and 0.2-2 nM for carcinoembryonic antigen), which are usually way below the
sensitivity of mass spectrometers. Even when solid-phase fractionation is used as is the case
in SELDI, it is highly doubtful that this low concentration tumour-derived proteins can be
isolated from high-abundant proteins and concentrated enough to be detectable by mass
spectrometry. Diamandis thus hypothesised that the biomarkers used by Petricoin et al are
epiphenomena of metabolic changes due to the presence of the tumour (such as
inflammatory proteins expressed by liver as a systemic response to the tumour) [98].
Unfortunately the results presented by Petricoin in his two seminal papers about ovarian
[93] and prostate [99] cancers turned out to be flawed by methodological and experimental
biases [100-104]. The situation was further complicated by patenting and marketing issues
of the test for ovarian cancer (OvaCheck™) [105]. Despite the controversy about
Petricoin’s work, there are now tens of publications about proteomic diagnosis of various
types of cancers, mainly focused on analytical developments; unfortunately there are no
large-scale clinical study to validate potential biomarkers, and new biomarkers discovered
by this approach are rarely properly identified and characterised. A noticeable exception is
the work of Koomen et al [106]: they used solid-phase capture of pancreatic cancer and
control  plasma samples with sequential elution to fractionate proteomic samples (not the
SELDI approach) before analysis by MALDI-MS. After selection of peaks that allowed
discrimination between disease and control samples, corresponding biomarkers were
identified by subsequent proteomic characterisation. The six biomarkers that allowed
classification of samples were identified as -1-antitrypsin, apolipoprotein A-I, hemoglobin
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, inter--trypsin inhibitor, serum amyloid A, and haptoglobulin. Among these, serum
amyloid A and haptoglobulin relates to acute phase response of the host, but do not have
any connection with pancreatic cancer. Conversely, plasma protease inhibitors have been
documented to be linked to pancreatic cancer, but are also associated with acute phase
response, which cast doubts about their specificity as diagnostic markers of pancreatic
cancer. These results revived the controversy about the potential of proteomics for
biomarker discovery: Diamandis and van der Merwe explained their doubts about the
potential of the methodology by pointing out that each identified biomarker shows small
differences in abundance between healthy and disease samples compared to classical cancer
biomarkers used in diagnostics [107]. At the same time, Petricoin’s position is that:
“Perhaps the best biomarkers for early detection [of cancer] will not even
be tumor-derived molecules. […] Diamandis claims that proteomic patterns
should be based on proteins of known identity. Our data show, to the contrary,
that the diagnostic usefulness of proteomic pattern technology is independent of
the underlying identity of the proteins. This finding may constitute a new
paradigm, in which proteomics coupled to bioinformatics could have direct
clinical impact in the clinic.”[94]
The fact that Petricoin’s data turned out to be flawed complicates the settlement of
the controversy. On one part, the controversy lies in the opposition between reductionist and
holistic approaches that are exemplified in the differences by proteomic-based diagnostic
approaches and classical immunoassays. It is unlikely that the case be settled rapidly; the
validation of proteomic-based diagnostic procedures will most probably necessitate large-
scale studies where not only disease and healthy samples will be compared, but other
disease samples will be also included: as proteomic-based biomarkers seem to be systemic
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responses to disease in most cases, they will have to be specific for the disease under
investigation. This means that their specificity will have to be tested on samples from very
different diseases producing general systemic responses.
5. Can proteomics identify new biomarkers?
As discussed above, the quest for new biomarkers has been boosted by the advent of
genomics and proteomics. Large research programs have been launched in the diagnostics
and pharmaceutical industry (whose pipeline is running short of new viable drugs [108]) to
identify diagnostic biomarkers, therapy targets, and biomarkers for drug validation and
treatment follow-up. The major driving force for such programs is the ability to look at all
kinds of genes (in a genome) and all kinds of proteins (in a proteome) at the same time, and
thus to potentially discover unexpected biomarkers, or identify sets of biomarkers that can
serve together for patient discrimination, and treatment follow-up. Unfortunately, even in
the simplest case  the search for diagnostic biomarkers, these blind approaches have
proven to be full of pitfalls (like the ovarian cancer diagnosis by plasma profiling presented
above), and it is now more or less consensual that biomarkers need be identified and their
physiological function need be documented in order to provide some security in diagnostics
[109], even to be used in diagnostics. The case is even more complex when biomarkers
become potential therapeutic targets: the background concept is that if a molecule is present
in significantly higher or lower amounts in a disease samples compared to healthy samples,
the molecule probably plays a role in the disease. The weakness of this concept has been
early recognised in the drug discovery process; Figure 12 lists cases when a biomarker fails
to be used as a disease target.
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Figure 12. Causes of failure of biomarkers. A. The biomarker is not in the causal pathway
of the disease. B. The biomarker is on one of the causal pathways of the disease. C. The
intervention (drug) affects one pathway to which the biomarker does not belong to: the
treatment cannot be followed. D. The intervention does not have any effect on any causal
pathway. Adapted from [110].
When –omics technologies are used only because of their wide capacity to analyse
all molecules present in a sample (be it DNA, RNA, proteins or metabolites), they do not
bring anything new in terms of biomarker identification, target validation and drug
development process. All potential biomarker may eventually fall into one of the categories
depicted in Figure 12, and the only benefit of –omics technologies is to provide much more
candidates to be tested with the very same approaches that have been used in drug discovery
in the last decades; as the limiting step is the drug discovery process lays in clinical trials,
identifying more potential biomarkers and targets without significant additional choice-
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making information may just overflow drug pipelines. This limitation has been identified as
the major cause for drug development failure in the recent years [111].
On the contrary, there is a strong conviction that basic research empowered by
–omics technologies may eventually lead to identification of more biomarkers and treatment
targets, but more importantly provide more rationale for decision making in order to select
the most promising targets based on sound biological knowledge early in the drug
development process. More precisely, one of the promise of systems biology is the
description and identification of all physiological pathways; when this information will be
available, researchers will be able to screen putative biomarkers and drug targets in terms of
their role in the disease mechanism: biomarkers that are consequences of the disease but not
directly involved in pathways central to the disease (Figure 12 A.) may be used in
diagnostics but would be a priori rejected as potential drug targets. The identification of
parallel disease pathways (Figure 12 B. and C.) would lead to better drug targeting or better
treatment efficacy assessment. Again, as was the case a few years ago at the rise of
genomics, decision makers have to rely on technological and scientific promises of systems
biology paradigm.
6. Conclusion
In this chapter, a very brief and partial history of life science research was provided.
Its purpose was to show that whereas reductionism has been the mainstream conceptual
framework for scientific research for more than three centuries, other approaches have been
introduced through ages in medicine or life science research: Paracelsus’ view of disease
(disease is a disequilibrium in systemic chemical processes), Claude Bernard’s theory of
inner medium, Darwin’s theory of evolution, are good examples of reactions to
reductionism and more holistic approaches to biological processes. The recent advent of
Microfluidic front-end technologies for protein electrospray mass spectrometry
51
large-scale systems biology is a new example of paradigmatic change; it is definitely not the
first one in the balance between reductionism and holism. Its revolutionary aspect lies in the
development of new tools and methodologies to acquire large-scale molecular data at the
DNA, RNA and protein level.
At the same time, systems biology did not appear ex nihilo: it emerged in a context
when several epistemological attacks had weakened the reductionist dogma: quantum
physics had dramatically changed the vision of Nature as composed of simple elementary
units. Cybernetics and systems theory have introduced a science of complexity, through
concepts of regulation of elaborated systems, emergence of complex behaviours from
connectionist systems, or modelling of biological responses. But systems biology could not
have emerged without the success of genome sequencing programs, that showed that large-
scale biology was feasible and provided the basic information that was necessary to
empower transcriptomics and proteomics.
However, the biomedical outputs of genomics and proteomics have been relatively
limited to date; as genes do not actually embody functions, they may be only indicators for
a predisposition for disease. On the other hand, proteomics has the potential to detect
disease at the true level where molecular processes occur. Unfortunately, proteomic
technologies are not mature enough to evaluate the real potential of proteomic diagnostics:
though the controversy is not completely settled, it seems relatively clear that tumour-
derived proteins are detectable in blood at very low concentration (fM to pM) that are out of
reach of current proteomic technologies, at least in routine without massive
preconcentration strategies. Conversely, higher abundance proteins that are systemic
responses to the disease may serve as biomarkers; but establishing their specificity as
diagnostic biomarkers will require much more work than for testing the specificity of a
tumour-derived molecule, because these biomarkers will have to be validated against many
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other diseases that the one for which they may serve as biomarkers. At the same time, in
order for a tissue-specific alteration (such as prostate or ovarian cancer) to induce a
systemic host response will probably preclude early stage diagnosis. Efforts in analytical
technologies will probably take many more years before proteomics can reveal its potential
as a diagnostic and drug discovery tool.
With the relatively limited success of genomic technologies to produce biomedical
outputs to date, rises the question about the role of analytical chemistry in the new systems
biology. Is systems biology and all its analytical developments just the new hype in basic
research, or is there a real promise of systems biology in terms of general health? The
answer to this question is still to be determined, and it is probably the role of academic
institutions to explore the potential of these technologies. What is sure is that systems
biology will rely on molecular information, the quality of which will be crucial to further
interpretation and modelling. The example of ovarian cancer diagnosis by plasma proteome
profiling shows how crucial experimental design, properly operated instrumentation and
critical data analysis are to bring biomedical relevance to proteomic data. At the same time,
the discussion about biomarker research (paragraph 5) shows that large-scale analytical
technologies do not bring much to biomarker discovery per se, but that more fundamental
knowledge, interpretation and modelling will be necessary to exploit the true potential of
systems biology’s paradigm.
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Figure 13. Collaboration between analytical chemistry/omic technologies and modelling.
Top is reprinted from [111] with permission.
Figure 13 illustrates the whole disciplines range involved in systems biology: on the
left, information is molecular; in this domain, analytical chemistry plays a major role in
designing experiments, acquiring data, curing and analysing data to produce, for example, a
list of differentially translated proteins. While integrating data into more holistic
information such as interaction networks, biological pathways… bioinformatics and
modelling play a more and more important role whereas molecular information becomes
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less visible. Only by the alliance between the wet and dry labs will systems biology be able
to provide sound information about putative diagnostic biomarkers and drug targets.
The goal of this first chapter was to give a brief and partial overview of the concepts
at work in proteomics. This thesis work concerns a very focused aspect of one possible
analytical strategy used in proteomics, namely the hyphenation of microfluidic devices with
electrospray mass spectrometry. As such, it could be integrated in the traditional shotgun
approach depicted in Figure 2 to hyphen liquid-phase separations with ESI-MS/MS. As
discussed in the next chapter, the main beneficial aspect of using microfluidic systems in
place of classical electrospray sources is the potential reproducibility and disposability
provided by microtechnological processing. Chapter 3 and 4 provides experimental
evidence that polymer microfluidic electrospray sources can be used in various aspects of
proteomic research. But microtechnological processing also allows to produce electrospray
sources with additional analytical functions, such as on-line sample desalting (Chapter 5)
and integration of a tunable sheath flow (Chapter 6). Finally, bioinformatic simulations
demonstrate how two analytical technologies developed in our laboratory, namely Off-Gel
electrophoresis for isoelectric separation of peptides, and on-line electrochemical tagging of
cysteine residues during electrospray ionisation from a microfluidic electrospray source, can
be integrated to provide a whole proteomic analytical platform for higher throughput
proteome profiling (Chapter 7).
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Chapter 2. State of the art in the
hyphenation of microfluidic devices with
electrospray mass spectrometry
1. Introduction
Analytical biochemistry is undergoing a general trend toward miniaturisation, due to
expected better analytical performances (e. g. in terms of sensitivity, time-to-result, and
throughput), lower solvent and sample consumption, and disposability [1, 2]. This
continuous effort has begun way before the advent of microfluidics, with downsizing of
HPLC columns from 4.16 mm state-of-the-art packed columns down to 50 μm
nanocolumns [3, 4]. With the emergence of microfluidics, analytical scientists could benefit
from decades of developments in the microelectronics and microtechnology industry [5, 6]
to build an entirely new generation of analytical devices [2, 7-15] that comprises DNA
microarrays [16-18], high speed electrokinetic separations [19-23], biosensors for affinity
sensing [24], immunoassays [25-28]… Because of their relative ease of implementation,
most detection systems were based on optical techniques. However, the pioneering works of
Ramsey’s [29] and Karger’s [30, 31] groups have dragged a lot of attention to the
hyphenation of microfluidic devices with electrospray mass spectrometry [32-34]. The
primary goal was to bring the analytical power of mass spectrometry to previously
developed on-chip separations that reached very high efficiencies (from ten to hundred
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thousands plates with low to sub-micron plate heights, with plate generation rates up to
hundreds per second [11]), with additional advantage of disposability, potential low cost
and reduced sample and solvent consumption. At the same time, the flow rate range
typically encountered in microfluidics (from nano- to microlitres per minute) made them
perfect candidates for hyphenation with electrospray ionisation mass spectrometry. A
relatively straightforward way to hyphen microfluidic devices with mass spectrometry is to
couple the microchip with a classical electrospray source, or to directly paste a micro- or
nanospray device at its outlet. Though very successful, this approach suffers from a number
of limitations, such as increased dead volumes, poor reproducibility and limited possibility
of industrial production. A more difficult approach is to generate electrospray directly from
the microchip, without any complementary transfer lines or pulled capillary nanosprays.
Despite very successful proof-of-principle, designing a direct microfluidic interface for
electrospray mass spectrometry turned out to be a difficult technical task; thanks to decades
of developments in the microelectronics and microtechnology industry, almost any
combination of size (down to a few microns or less), shape, material (originally silicon or
glass but more recently also polymers) is available. It is thus of utmost importance to
properly understand the main parameters that affect the formation of a stable electrospray
from a microchannel, nozzle or capillary outlet. However, though it is known for long that
capillary outlet size, flow rate and solvent composition can have dramatic effects on mass
spectrometric signals, no clear scaling laws are established for electrospray ionisation, and
most developments are still based on empiric rules and trial-and-error approaches. So after
briefly reviewing the coupling of microfluidic devices with ESI-MS through classical
electrospray sources or pasted nanosprays, some elements of electrospray theory pertinent
to electrospray downscaling are highlighted, and we review herein all the technological and
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analytical approaches for the coupling of microfluidic devices with electrospray mass
spectrometry.
2. Hyphenation of microfluidics with ESI-MS through
classical electrospray interfaces
The primary goal of microfluidics hyphenation with mass spectrometry being to take
benefit of previously developed microchip separations with additional mass spectrometric
detection, the most straightforward approach was to couple the microfluidic device with an
existing electrospray ion source. Figeys et al introduced a multi-channel glass microchip for
sequential sample delivery to ion-trap MS [35]: sample ports of the microchip could be
automatically loaded with 2D-GE separated and digested proteins. Samples were then
sequentially electroosmotically driven into a common microchannel connected to a classical
microspray interface. This device allowed identification of proteins through MS/MS with
limited cross contamination. Similarly, the same team developed an electrokinetic gradient
generator [36]: the microchip had two reservoirs (one containing acidified acetonitrile, one
containing acidified water) connected to a transfer capillary. A small solid-phase extraction
(SPE) cartridge was first loaded with tryptic digests, and then connected in one extremity to
the transfer capillary from the microchip and in the other extremity to a microsprayer. By
varying the voltages applied to the two microchip reservoirs, authors were able to generate
gradients, mainly driven by the transfer capillary acting as an electroosmotic pump. Upon
increasing acetonitrile concentration, peptides eluted from the SPE cartridge, and were
analysed by MS and MS/MS for protein identification. More recently, the same authors
presented a more robust device including a filtration system in sample ports, and capillary
coatings to kill the electroosmotic flow in transfer lines [37]. In a similar way, Meng et al
tested the robustness and chemical compatibility of poly(methyl methacrylate) (PMMA)
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microchip for coupling with Fourier Transform - Ion Cyclotron Resonance - Mass
Spectrometer (FT-ICR-MS) [38]. In a more refined approach, Li et al directly connected a
glass capillary electrophoresis microchip with a MicroIonSpray interface for the analysis of
tryptic digests [39]; plate heights of 25000-600000 were obtained, which is less than state-
of-the-art capillary electrophoresis (CE) with 90 cm glass capillaries, and it is highly
probable than part of the separation took place in the fused silica capillary used to connect
the chip to the MicroIonSource. Vrouwe et al also coupled a CE microchip with ESI-MS
through a classical nanospray source for the analysis of small -agonists [40]: though a
simple three-components mixture was reproducibly separated with good sensitivity
(nanomolar range on a single quadrupole instrument), the separation efficiency remained
questionable, probably because the same voltage was used for the CE separation and for
electrospray generation. Sample clean-up steps were also coupled to ESI-MS following this
approach, such as on-chip microdialysis [41, 42] or free-flow electrophoresis to couple cIEF
with mass spectrometric detection [43]. The most elaborated device coupled to ESI-MS
through a classical electrospray interface was presented by Gao et al [44]: a PVDF
membrane with immobilised trypsin was sandwiched in a PDMS microchip, and coupled
through a transfer line to a microdialysis junction for direct injection into ESI-MS.
Alternatively, transient cITP/CZE was performed downstream the microdialysis junction
for separation of tryptic peptides. Though the separation efficiency may remain
questionable, the approach provided a complete platform for protein digestion, peptide
separation and analysis by ESI-MS.
In a more developed approach, Wachs et al introduced an electrospray interface
dedicated to the hyphenation of microfluidic devices with electrospray mass spectrometry
[45]. Shown in Figure 14 is a schematic of the liquid junction device, allowing the addition
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of a makeup flow, a sheath gas, and a final electrospray from a 31 gauge (226 μm) stainless
steel tubing.
Figure 14. Micro ion spray source designed for interfacing with chip-based separations,
incorporating a self-contained liquid junction. (A) 31 gauge stainless steel tubing, (B) 0.020
in. i.d.  0.0625 o.d. stainless steel tubing, (C) and (G) 23 gauge stainless steel tubing, (D)
makeup liquid entrance, (E) seal, (F) 0.0625 in Teflon tubing, (H) hole and (I) gas inlet.
Reprinted with permission from [45].
This device was further used to hyphen a polymer capillary electrophoresis
microchip with a triple quadrupole mass spectrometer for the detection of carnitines [46-
48]; the electrospray voltage was directly applied to the microsprayer (typically 3 kV), and
a higher voltage was applied at the upstream reservoir of the microchip (typically 5 kV); the
separation was performed in pure aqueous solution. In a first demonstration, 0.3 pmol of
carnitines were separated within 30 s, and detected both in full san mode and in single
reaction monitoring. Optimisation of the separation conditions (separation field strength)
resulted in quicker separations (down to ten seconds) with plate counts ranging from 4800
to 18000. The same micro-liquid junction was also used more recently to investigate P450
drug metabolism on a chip [49]: one flow containing cytochrome P450 and NADPH-
cytochrome P450 reductase and one flow containing small drugs were mixed on-chip in a
stopped flow manner, before the mixture was further desalted and analysed by triple
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quadrupole thanks to the micro-liquid junction. Variation of the on-chip incubation time
coupled to mass spectrometric detection allowed a straightforward determination of
degradation products of the drugs studied. Complementarily, the same group used this
micro-liquid junction to characterise acrylate-based monolithic solid-phase adsorbents
synthesised on-chip [50]. Basically, this approach provides an elegant way to couple
microfluidic devices to ESI-MS without the need for transfer capillary that usually alters
separation efficiencies, and requires chemical treatments for electroosmotic flow
suppression; moreover, sheath gas and make up flow can be tuned for optimal ionisability
and desolvation of analytes of interest.
Another way to hyphen microchips with electrospray mass spectrometry is to glue
micro- or nanospray needles at the outlet of a microchannel for direct electrospray
generation. This approach was followed by numerous authors for simple sample delivery
[51-54]; even without on-chip separation or sample clean-up, these devices already provide
the benefit of loading the nanospray tip by electroosmotic flow instead of manual pipetting
or centrifugation. Nanosprays were also pasted to microchips for on-chip flow injection
analysis through a double T injector for the analysis of subattomole amounts of peptides
and proteins [55, 56]. It is worth highlighting that as soon as voltages are used to move
samples electrokinetically, proper decoupling of electrospray and “driving” voltages must
be accomplished: Lazar et al proposed a glass membrane to apply electrospray voltage near
the outlet of a glass microchip, without any further dilution of samples coming from the
main microchannel, as is the case with a direct T junction. With this device authors were
able to detect less than 4 attomoles of Gramicidin S on a TOF instrument, with a pasted
microspray [56]. Direct pasting of nanospray tips at the outlet of microchannels was also
used by Wu et al to couple a PDMS microreactor with immobilised trypsin with MS
detection for protein identification [57].
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But pasting micro- or nanosprays at the outlets of microfluidic channels has been
mainly used to hyphen previously developed on-chip separations with ESI-MS. For
example, Sung et al used a PDMS CE microchip coupled to ESI-Q-TOF to analyse model
peptides, and tryptic digests [58]; though separation efficiencies were not thoroughly
investigated, online MS/MS was demonstrated for protein identification. Similarly, Lazar et
al developed a glass microchip for capillary electrochromatography coupled to ESI-MS
[59]: a monolith phase based on methacrylate derivatives was photopolymerised within the
separation microchannel and further chemically modified with N-ethylbutyl amine to
control electroosmotic flow and provide hydrophobic interactions with peptides. Porous
glass membranes in the reservoirs also allowed voltage delivery without parasite fluid
movements. This device allowed analysis of tryptic digests on a TOF instrument in full scan
mode.
Harrison’s laboratory probably presented the most integrated and successful proofs-
of-principle of the hyphenation of on-chip sample preparation and separation to ESI-MS
through glued nanosprays; Figure 15 shows the generic design of the glass microchip used
for CE separation of peptides and on-line sample delivery to ESI-MS:
Figure 15. Design of the glass microchip used for CE separation and nanoelectrospray.
Reprinted from [60] with permission.
Sample is loaded in microchannel A, then driven electrokinetically to microchannel
C, the voltages in B and D being left floating. At a certain point, voltages are switched, so
that sample migrates into the separation channel (pushback voltages being applied to A and
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C to avoid sample leakage during separation). In parallel, a standard compound was infused
continuously through microchannel D for mass calibration of the Qq-TOF instrument used.
Model protein digests were analysed, with plate numbers ranging from 4100 to 7400 with
plate heights of 9-17 μm and plate generation rates in the range 50-100 plates per second;
moreover, peak capacity could be estimated to be in the range 20-25 from the
electropherograms shown [60]. When combined with on-line sample stacking, this
methodology reached sub-nanomolar limit of detection for peptides. This device was further
applied to the identification of membrane proteins from H. Influenzae separated by 1D-GE
[61]. In a more integrated approach, microchannel C shown in Figure 15 was made bigger
to accommodate a microbead bed, whether for trypsin immobilisation and online protein
digestion [62], or for solid-phase extraction on C18 material: in this case, the SPE bed could
be sequentially loaded by an autosampler with tryptic digest of proteins from N.
meningitidis separated by 1D-GE; peptides were then separated by on-chip CE and analysed
by MS: 67 gel bands were analysed at a pace of 2 min/samples, resulting in 55 proteins
identified and 5 additional gene variants identified [63]. In its most accomplished
demonstration, the same device was used for identification of proteins from human prostatic
cancer cells (LNCap) separated by 2D-GE: authors were able to analyse typically 200 fmol
of in-gel protein digests in an automated way. Alternatively, they successfully replaced the
C18 material by Immobilised Metal Ion Affinity Chromatography (IMAC) microbeads for
isolation and enrichment of phosphorylated tryptic peptides prior to on-chip CE and MS
analysis [64].
The main drawback of this approach is that nanosprays must be manually inserted
into the exit microchannel and somehow pasted or sintered, which compromises the
robustness, reproducibility and possibility of mass production of the approach.  Tashibana
et al presented an elegant alternative to hyphen a nanospray tip to a quartz CE microchip
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[65]: the extremity of the microchip was machined so that it can accommodate a PEEK
screw; a 370 μm O.D. nanospray tip could then be directly connected or replaced without
any glue or sintering, while incorporating a liquid junction on the microchip to apply the
electrospray voltage. In a further study with this device, separation conditions (separation
channel length and coating) were optimised, so that a mixture of 19 amino acids, or a
cytochrome C tryptic digest, could be separated and analysed by MS [66].
3. Microfluidic devices with direct electrospray generation
As discussed above, the hyphenation of microfluidic devices with ESI-MS through
classical electrospray sources requires the use of capillary connections and transfer lines
that complicate the control of electroosmotic flow, add dead volumes, usually requires
sample dilution with sheath flows for efficient ionisation and desolvation, and may lower
separation efficiencies through diffusion processes. The use of pasted micro- or nanosprays
just at the outlet of the microchip addresses some of these drawbacks by diminishing dead
volumes and usually increasing the sensitivity of the mass spectrometric detection
compared to classical electrospray sources. However, reproducibility of nanospray ESI-MS
analyses remains questionable, and the gluing process cannot be transferred to industrial
scale. Direct generation of electrospray from a microchip without any additional device has
thus been investigated by numerous teams using different materials for microchip
production, different designs and analytical strategies.
3.1. Elements of electrospray theory
Electrospray establishment requires a well-defined solution/air interface at the outlet
of a capillary or microchannel. Without any applied field, a meniscus establishes, the
geometry of which is governed by the outlet geometry and the liquid surface tension. When
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the electrospray voltage is applied to the solution, charges accumulate at the solution/air
interface and the interface shape is then governed by the equilibrium between surface
tension and electrostatic pressure. If the applied voltage is high enough, the interface takes
the shape of a cone, the so-called Taylor cone. At a certain potential UT, the apex of the
Taylor cone is destabilised and charged droplets are emitted. The formation of gas-phase
ions from these electrospray droplets was the subject of active debates. Two theories
emerged, namely the charge residue model, in which electrospray droplets shrink and
explode under solvent evaporation till only one ion sits at the centre of each droplet and is
finally desolved, and the ion evaporation model, in which ions can be directly expelled
from electrospray droplets through charge repulsion mechanisms [67]. It has been know
since the very beginning of electrospray ionisation that for a given capillary size, the
electrospray current (and thus the number of analyte ions detected by the mass
spectrometer) is highly dependent on the flow rate, as shown by Pfeifer and Hendricks for
spray in vacuum [68]:
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where  and 0 are the permittivity of the solvent and of vacuum respectively,  the
surface tension of the solvent,  its conductivity, E the electric field and  the solution flow
rate. Similarly, de la Mora found that the electrospray current was proportional to the square
root of the sample flow rate [69]. But in the early nineties, Emmett and Mann introduced in
parallel micro- [70] and nano- [71] electrospray ionisation respectively; both approaches
showed that the use of smaller capillaries (associated with lower solution flow rates)
resulted in much higher ionisation efficiencies. The reason for that is that more and smaller
electrospray droplets are formed when a smaller capillary is used, and that gas phase ion
formation is much more favourable when starting from smaller droplets. The size of
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electrospray droplets is thus of utmost importance in the final sensitivity of an electrospray
interface. Unfortunately, their size (a few tens of nanometres to a few microns) and
dynamics make them poorly amenable to observation. To our knowledge, no in-depth study
has been conducted on the dependency of electrospray droplet size on capillary outlet
dimension. Wilm and Mann introduced an estimate for the radius of the droplet emitting
zone from relatively simple geometrical considerations [71]:
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where  is the density,  is the Taylor cone angle, Ua is the applied electrospray
voltage, UT is the threshold voltage at which electrospray appears, and all others as in
Equation (1). Figure 16 shows the value of the droplet-emitting zone radius versus the
applied flow rate for water ( = 1000 kg/m3,  = 72.8 10-3 N/m) in typical electrospray
conditions (UT = 1000 V, Ua = 1500 V).
Figure 16. Size of the droplet-emitting zone versus the applied flow rate (solid line).
This quantity is obviously a rough overestimate of droplet radius, but qualitatively
gives an indication of the outlet diameter necessary to generate a stable electrospray at a
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given flow-rate, as shown by comparison with experimental results [71]. Interestingly, this
estimate is in qualitatively good agreement with empirically recommended flow rates (grey
zone in Figure 16, from [72]), especially for low flow rates.
3.2. Different design approaches
Influence of material
The role of the capillary or microchannel outlet is to confine the liquid to be sprayed
to a definite size and geometry, so that a stable Taylor cone can establish under the
application of the electrospray potential. This implies that the spray solution should not wet
the outer surface of the capillary or microchannel. The hydrophobicity of the material used
to build the microfluidic electrospray emitter is thus of utmost importance; for example,
Xue et al found it difficult to generate electrospray directly from the edge of a glass
microchip such as the one shown in Figure 17.
Figure 17. Scheme of the glass microchip and set-up used by Xue et al in [31].
In fact the spray solution had tendency to moisten the edge surface of the chip,
which prevented any stable spray. The authors had to coat the edge of the chip with a
hydrophobic reagent such as n-octyltriacetoxysilane to avoid any wetting of the edge
surface of the chip and obtain a stable electrospray. On the contrary, Ramsey et al did not
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find any improvement in spray operation when silanising the microchannel outlet of a very
similar glass microchip [29]; this difference may be due to differences in glass material, and
surface state after microtechnological processing. However, at least qualitatively speaking,
it is necessary to choose a material that is hydrophobic enough to avoid wetting of the edge
surface (or nozzle outer surface). Whereas the values presented in Figure 18 may depend a
lot on the microtechnological processing (exposure to plasmas, oxidising agents…), it
clearly shows that polymer materials are usually much more hydrophobic than glass or
silicon dioxide. They thus appear as good candidates for electrospray emitter design.
Figure 18. Static contact angle measurements of various materials.
Another way to properly design the outlet wall hydrophobicity is to modify the
surface properties by a chemical treatment: as mentioned above, Xue et al used a n-
octyltriacetoxysilane coating, but found it relatively unstable under operation [31]. Tang et
al  used a CF4 radio frequency plasma treatment to increase the hydrophobicity of
polycarbonate electrospray emitters [73], but rf plasma treatments are usually of short
longevity through exposure to air or aqueous solutions. Wang et al introduced recently an
elegant way to modify the electrospray outlet hydrophobicity on polymer electrospray
Chapter 2. State of the art in the hyphenation of microfluidic devices with electrospray mass
spectrometry
74
emitters [74]: a poly-tetrafluoroethylene (PTFE) hydrophobic membrane is pasted over the
outlet polycarbonate surface of an electrospray emitter. Due to this surface modification,
very stable electrosprays were established at flow rates as low as 10 nL/min.
Importance of electrode design
In order to generate electrospray, high voltage has to be applied to the solution to be
analysed. Charge separation then occurs within the electrospray emitter, leading to
electrospray droplet generation. The electrospray set-up can thus be described in terms of
electrical circuit [75], as depicted in Figure 19.
Figure 19. Electrical circuit equivalent to the electrospray process. Velectrospray is the potential
applied on the electrospray electrode, Celectro. and Relectr. are the capacity and charge transfer
resistance of the electrospray electrode, RS the solution resistance, Ccone and Rcone are the
capacity and charge transfer resistance of Taylor cone where charged analytes accumulate,
Rgap is the resistance of the air gap between the apex of the Taylor cone and the mass
spectrometer inlet, Cneutr. and Rneutr. are the capacity and charge transfer resistance of the
detector where ions are neutralised.
The electrospray emitter can be viewed as a particular type of controlled-current
electrochemical cell [76] in which the electrode potential auto-adjusts to sustain the
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electrospray current dictated by the emission rate of charged droplets at the Taylor cone
apex: in positive ion mode, the electrode potential will rapidly increase up to the oxidation
of the first oxidable specie; at this point, the current will be limited by the mass transport of
this specie to the electrode and remain stable. When this specie is fully consumed, the
electrode potential will increase again up to the oxidation potential of the second oxidable
specie and remain constant. Only in the case of solvent oxidation is the current not limited
by mass transport to the electrode.
In most cases, one wants to avoid any electrochemical reaction of analytes of
interest on the electrospray electrode. It is thus of particular importance to properly design
the electrode material, size and position respective to the Taylor cone. In this instance, it is
obviously desirable to choose an inert material for the electrode, such as platinum, gold or
graphite. Moreover, for a given electrospray potential applied and a given microchannel
outlet/mass spectrometer distance (i.e. for a given current), the current density through the
electrode, and thus the kinetics of the electrochemical reactions at the electrode surface will
be defined by the electrode effective area; more precisely, reaction rates are inversely
proportional to the electrode effective area [77], which means that the use of larger
electrodes results in globally lower electrochemical reactions. Lastly, when reactive species
are potentially created at the electrospray electrode, their residence time within the
electrospray emitter determines how probably they can react in the homogeneous phase
with analytes of interest. Placing the electrospray electrode as close as possible to the
Taylor cone can thus limit adverse electrochemical degradation of analytes.
3.3. The off-axis, nozzle-like approach
Microtechnological processes rely essentially on planar technologies, where
substrates are perpendicularly exposed to light or etching agents through masks, or lasers
are scanned over the substrate surface to produce microfeatures [5, 6]… Most simple
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processes thus allow only to produce holes or microchannels through a substrate,
perpendicular to its surface (off-axis design), or features patterning on a planar surface,
parallel to its surface (on-axis design). Though historically the most recent approach, the
off-axis strategy has given rise to the first commercially available product from Advion: the
ESI-Chip™ [78]. It basically consists in a silicon substrate in which arrays of nozzles are
etched by a relatively complex process (around fifteen elementary operations are listed in
[78], not including the final surface treatments). The elementary nozzle, shown in Figure
20, is a 10 μm i.d., 20 μm o.d., 50 μm long silicon cylinder; arrays of 100, 200 and 400
nozzles are commercially available.
Figure 20. Left: scanning electron microscope image of an Advion nozzle (10 μm i.d., 20
μm o.d.); reprinted from [78] with permission. Right: the ESI-Chip comprising 100 nozzles
(reprinted from [79] with permission)
The ESI-Chip™ is operated thanks to a dedicated instrument, the Nanomate™,
which basically pipets the sample from a 96 well plate with a single-use conductive pipette
tip; the pipette is then pushed against the back side of the ESI-Chip™ and the sample is
pneumatically pushed through the nozzle, at typical flow rates between 50 and 300 nL/min.
The electrospray voltage (typically 800-1500 V) is applied to the solution through the
conductive pipette tip, while the front side of the ESI-Chip™ is grounded. In its initial
demonstration [78], the device was shown to allow the analysis of pure aqueous samples
with better stability (2.1% RSD vs 9.8% RSD over five minutes)  and sensitivity than pulled
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capillaries of comparable dimensions. Moreover, nozzle-to-nozzle reproducibility was
evaluated to be 12.1% RSD within 10 nozzles. In a second development stage, nozzles of 8
μm i.d., 30 μm o.d. were produced.
The ESI-Chip™ in combination with its robotic system, the Nanomate™ was
interfaced to a wide variety of mass spectrometers, including time-of-flight [78, 80-85], ion
traps [86, 87], triple quadrupoles [79, 88-91] and Fourier Transform- Ion Cyclotron
Resonance- Mass Spectrometer (FT-ICR-MS) [92], in both positive [78, 79, 81, 82, 86-91]
and negative [83-85, 87, 92] ionisation polarity, and for simple MS as well as more
complex experiments, such as in-source fragmentation [82], selected reaction monitoring
(SRM) [79, 88-91], collision induced dissociation [83-87] and sustained off-resonance
irradiation collision induced dissociation [92].
The advantages of the automated Nanomate™ system are clear: first it allows
automated nanospray sample delivery to the mass spectrometer. For example, Van Pelt et al
showed the quantitation of drugs from Caco-2 permeation assay [79]: the duty cycle used
was 100 s (40 s for sample handling and 1 min of MS analysis), which corresponds to 2h40
for the analysis of 96 samples. Interestingly diminishing the MS analysis time to 5 s would
make 72 min for the analysis of 96 samples. Kapron et al even claims the possibility of
analysing 120 samples per hour with this system [89]. As such, the Nanomate™ system can
be seen simply as a high-throughput sample delivery system to electrospray ionisation mass
spectrometry. It is particularly interesting when coupled off-line to upstream separations for
the analysis of complex samples. For example, Van Pelt et al used the system for the
identification of proteins separated by 2D-GE, stained by Comassie blue or silver, excised
from the gel, digested by trypsin and solubilised [86]: 140 proteins from a crude cell extract
of Saccharomyces cerevisiae were identified with a duty cycle of 210 s per sample (8h10 of
unattended analysis). This study highlighted the possibility to use the Nanomate™ system
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just as MALDI ionisation would be used, with additional benefit of being interfaced to an
ion trap allowing tandem MS at high speed. Similarly, Bindila et al used off-line capillary
electrophoresis coupled to the Nanomate system for sample delivery to a Q-TOF instrument
for the analysis of complex carbohydrates mixtures [84]. This kind of analytes is
particularly challenging because they are poorly ionisable. In this study, analytes could be
directly analysed in the CE buffer thanks to the quality of the ESI-Chip nozzles, and
MS/MS experiments could be conducted for structural elucidation of carbohydrate
compounds without being hampered by the CE pace. Complementarily, Staack et al used
classical online LC/MS/MS while collecting part of the LC effluent for off-line
interrogation through the ESI-Chip of specific parts of the chromatogram and structural
analysis of minor components, in the context of drug metabolism studies [93].
Nozzle quality and electrospray conditions optimisation are known to be crucial for
the analysis of non-covalent complexes [94]; the Advion analytical platform has been
successfully applied to the qualitative screening of ligands to fatty acid binding proteins,
with analysis throughput of 430 samples per working day and protein consumption around
100 pmol per ligand assay [95]. Keetch et al also demonstrated the usefulness of the ESI-
Chip for the analysis of large protein multimers and qualitative investigation of inhibitor
binding to these large multi-protein complexes [82]. More interestingly, quantitative
information could be obtained about the binding of small ligands to proteins: De Vriendt et
al showed that the binding constant between cellobiohydrolase I and cellulose as well as
inhibitors could be measured by direct visualisation of non-covalent complexes in the mass
spectrum [96], and Zhang et al similarly calculated the binding constants for different
systems, such as RNAse A with monophosphate nucleotides [81].
 But the nozzle quality may also allow to completely suppressing upstream sample
separation. For example, Kapron et al were able to quantify small drugs from human
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plasma with very limited sample preparation and no separation at all, whereas the state-of-
the-art method consists in LC/MS/MS [89], as well as Dethy et al in a similar study [90].
This approach has even been validated recently in the context of Food and Drug
Administration regulatory guidelines and Good Laboratory Practices [97]. The benefit of
eliminating the LC separation for certain applications is clear: first the throughput depends
only on sample delivery to the MS and not on separation efficiency and pace. The extension
of this approach outside the drug quantitation field will probably require more mass
spectrometry developments such as the ones presented by Kalkum et al for the detection of
target peptides from crude biological extracts [98], but it could lower the demand on
upstream separation efficiencies that is currently seen in proteomics for example.
Interestingly, the laboratories of Stemme and Roeraade followed an approach
similar to that of Advion for the design of silicon-based arrays of electrospray nozzles [99].
They tested two different nozzle designs, based whether on pure silicon or on silicon
dioxide. Figure 21 shows the two types of nozzles:
Figure 21. Silicon and silicon dioxide nozzles. The silicon nozzle consists in a straight
cylinder hole with wall of variable thickness, whereas the silicon dioxide nozzle is made of
a 1.5 μm layer of silicon dioxide of constant thickness. Reprinted with permission from
[99].
The one made of silicon consists in a straight cylinder with wall of variable
thickness, and the one in silicon dioxide is made of a structure of constant thickness (the
internal shape is the same as the external one). The main difference with ESI-Chips from
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Advion is that for both designs, the outlet has a very sharp surface, whereas in ESI-Chips,
the nozzle outlet has a flat surface (see Figure 20). Silicon dioxide nozzles were further
tested for peptides, proteins and non-covalent complexes analysis [100].
3.4. The planar, nozzle-less approach
As discussed above, most microtechnological processes allow microprocessing
through substrates (off-axis design), which Advion used to produce the ESI-Chip, or
microprocessing on the substrate surface (on-axis design), parallel to its plane, to produce
microchannels. Historically, this kind of devices has been developed first for on-chip
separations [19-22]. The most straightforward way to couple such devices to electrospray
mass spectrometers was to cut the microchip perpendicular to the microchannel, so that the
microchannel outlet is located on the edge of the chip. This solution was pioneered by
Ramsey’s [29, 101] and Karger’s [30, 31] groups. As mentioned in paragraph “Influence of
material”, it rapidly appeared that the electrospray stability was somehow compromised
with such an interface. But several teams simultaneously introduced a triangular-shaped
microspray emitter [102-107], a design that was rapidly adopted by other groups. The
rationale for a better stability of electrospray in such designs was never fully explained, but
one can reasonably argue that having a microchannel outlet just at the extremity of a
triangular microchip (instead of a flat edge) results in a better confinement of the solution /
air interface by limiting the wetting of microchip outer walls by the solution. A lot of
different designs have been proposed on PDMS [103-105], PET [107], polyimide [108],
PMMA [106, 109], polyester [110]… Some other groups worked on alternate designs:
Licklider et al compared “blunt tips” with oval apertures and “sharp tips” made of parylene,
as shown in Figure 22;
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Figure 22. Parylene “blunt tip” (left) and “sharp tip”. Reprinted with permission from
[102].
Basically both devices showed the same analytical properties as a classical pulled
capillary microsprayer. Alternatively, Kameoka et al sandwiched a parylene triangle
between the two plastic layers forming the microfluidic chip, so that the liquid coming out
from the microchannel wetted the parylene triangle, at the tip of which electrospray was
generated [111]. This device was further used for methylphenidate (Ritalin) quantitation
from human plasma [112].
Most designs were demonstrated as stand-alone devices for sample delivery to ESI-
MS, whether under infusion at flow rates from 0.1-1 μL/min, or with reservoirs under
electroosmotic flow. Interestingly, Lion et al showed that polyimide microspray emitters
with half moon cross sections of 12045 μm can be used from 250 nl/min up to 5 or 7
μl/min in a wide range of solvent compositions with better stabilities and comparable
sensitivities than pulled capillary nanospray, whose applicable flow rate range is much more
limited for a given aperture size (see Figure 16) [113]. This is somehow contradictory to the
general consensus that the smaller the electrospray emitter, the more sensitive the analysis.
The same device was applied to the analysis of proteomic samples [114], and glycoconjgate
screening [115] when coupled with FT-ICR-MS or with Q-TOF-MS [116].
But other analytical functions can also be performed on-chip prior to MS analysis,
such as solid-phase extraction (SPE) for sample desalting and clean-up: Lion et al placed a
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small piece of PVDF membrane at the inlet of the microsprayer to capture drugs, peptides
and proteins, that can be further washed and eluted by the spraying solution [117, 118].
More interestingly, Rohner et al introduced a new concept for online electrochemical
tagging of cysteine residues [119]: a neutral probe from the hydroquinone family is
introduced with the proteinaceous sample to analyse; hydroquinone being the first oxidable
specie, it is converted into benzoquinone on the carbon-ink electrospray electrode, which is
selectively reactive toward free cysteine residues via a Michael addition. In conditions
where this mass-tagging is non-quantitative, the presence of each free cysteine in the
analyte is revealed by an adduct peak in the mass spectrum, and thus a direct counting of
the number of cysteines in a given peptide. After elucidation of the electrochemical
mechanism [120], optimisation of the microchip design [121] and of the electrochemical
probe reactivity [122], this process was applied to protein identification through peptide
mass fingerprinting [123]: when the number of cysteine is added to the peptide masses
during database interrogation, the identification score is greatly increased, thus providing
more confidence in protein identification. Though this process might be equally feasible
with classical electrospray emitter on the principle, microfabrication provides unique
possibilities of adjusting the electrode size and position, and the microchannel dimensions
so that the overall electrochemical conversion rate of the probe on the electrode, and contact
time between the converted probe and analytes of interest can be controlled [124].
3.5. The planar, nozzle-like approach
Whereas the planar, nozzle-less approach proved to be successful, alternative planar
devices were introduced to mimic nozzles at the outlet of microchannels. For example, Wen
et al early introduced a microchip with a cone-shape electrospray emitter made of
polycarbonate [125]: this device was used to perform isoelectric focusing of proteins in
broad range carrier ampholytes (pH 3-10). Once focused, proteins were chemically
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mobilised while a sheath liquid was provided close to the electrospray emitter through a
side microchannel. The same approach was followed by Svedberg et al to design hand-
polished or machined-drilled cone-shaped electrospray emitters in PMMA microchips
[126]. More recently, the same group designed an opened PDMS electrospray tip with a U
profile for simple sample delivery through capillary aspiration, and demonstrated its use
with model proteins [127]. Similarly, Rolando’s group designed micro-nib electrospray
sources, first made of SU-8 photoresist [128-132] and later of poly-silicon [133, 134], as
shown in Figure 23. Basically, the sample solution is deposited in the nib reservoir and
flows toward the nib tip where the electrospray is generated [135].
Figure 23. Nib-like electrospray emitter, made of SU-8 photoresist. Reprinted from [128]
with permission.
The most comprehensive and successful planar, nozzle-like microfabricated
electrospray emitter has been introduced recently by Agilent for on-chip HPLC/MS: three
polyimide layers are first photoablated to produce microchannels, sample ports and
restrictions for further microchannel packing. Electrical contacts are then deposited and the
three layers are assembled to form the HPLC-chip. The end of the main microchannel is
then laser-machined in a conical shape, with 35 to 100 μm outer diameter at its extremity
(the microchannel outlet having typical dimensions of 5 μm), as shown in Figure 24.
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Figure 24. Left: Naked polyimide HPLC-MS microchip from Agilent, showing the inlet
ports for the valving system, the electrical contacts and the electrospray tip. Right:
magnification of the conical electrospray tip. Courtesy of Agilent Technologies, R&D and
Marketing, Waldbronn, Germany.
The sample enrichment and separation microchannels are then packed with reverse
phase microparticles, and the chip is mounted between the stator and the rotor of a two-
position HPLC rotary switching valve [136]. In the initial demonstration, 20 fmol of BSA
digest were analysed at 100 nL/min with satisfactory retention times and peak areas
reproducibility. It is noteworthy that the microchip design was supported by detailed study
of chromatographic dynamics in non-cylindrical microchannels [137]. In a second study,
the same device was validated with more realistic samples: with an eight model protein
mixture digest, peak capacity of 141 was observed over a 50 minutes gradient together with
decent peak symmetries and excellent reproducibilities (average RSD values of 0.5% on
retention time, 0.003 % on m/z and 9.1% on peak intensities over 10 replicates of the
separation of 626 peptides). Authors also checked the potential of the device in the context
of expression profiling by spiking 0 to 250 fmol of the same eight proteins digest in 100 ng
digested rat plasma. Whereas at 1.2 fmol spiking, only four peptides among the expected
626 were detected, the number of identified peptides reached 604 for spike levels of 120
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fmol. Moreover, the peptide intensities showed very good linearities in the tested range.
Finally, rat plasma was analysed whether by 1D HPLC-MS (55 minutes gradient) or by 2D-
HPLC-MS by inserting cation exchange material into the sample inlet port of the switching
valve (eight salt fractions with 55 minutes reverse phase gradients). 47 nonreduntant
proteins (111 in 2D-HPLC-MS) were readily identified with detection limits down to less
than 80 ng/ml. Moreover, sequence coverages were two to three times higher in 2D-HPLC-
MS [138]. More recently, a similar HPLC-MS microchip was used in the context of
oligosaccharides analysis [139]: Ninonuevo et al replaced the  reverse phase packing
material by a graphite porous carbon phase, validated the device on model oligosaccharides
and analysed O-linked oligosaccharides from mucins and oligosaccharides mixtures from
milk. Authors obtained time retention variations of less than 0.5% on 40 minutes gradients,
and peak area reproducibilites in the order of 5%. Moreover, the high mass accuracy of the
TOF analyser used allowed direct assignment of most structures observed. Though this
device is still at the validation stage, it seems that the unique combination of resources in
microtechnological processing and mass spectrometry on an industrial scale resulted in a
very promising analytical microdevices family; though the use of microchips did not result
in this case in a dramatic increase of analytical performances (whether in sensitivity or in
analysis time) compared to classical nanoLC columns, the clear improvement lays in
robustness and reproducibility, that was already shown to be far better than with classical
systems.
4. Conclusion
The coupling of microfluidic devices with ESI-MS has been pioneered in the early
nineties to bring the analytical power of mass spectrometry to previously developed CE
microchips. Though most early works were realised in glass microfluidic devices for
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proofs-of-principle demonstrations, through years the field crystallised around two kinds of
platforms: first, microchips that are devoted to high-throughput sample infusion such as the
ESI-Chip from Advion; in this case, many nozzles (at present up to 400 on the ESI-Chip)
have to be integrated on the same chip. At the same time, integration of many nozzles
requires high manufacturing precision and reproducibility in order to be able to compare
nozzle-to-nozzle results. Fabrication of such devices is thus naturally oriented toward
silicon-based technologies, that usually have a relatively high cost, but better precisions that
polymer based technologies. The other type of devices consists in more integrated ones that
embed a liquid-chromatography stage, such as the platform that is being launched by
Agilent. Due to the relatively high area of the device, it can hardly be made in silicon at a
reasonable cost, and polymer microtechnologies appear as the most viable option from an
economic point of view.
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Chapter 3. Coupling of microfluidic devices
with electrospray mass spectrometers
1. Introduction
In this chapter, polymer microfluidic chips are validated as microsprayers for the
analysis of peptides and proteins by ESI-MS. In the first part, chip microsprayers are used
as stand-alone devices: a sample reservoir is pasted on the chip to allow sample loading,
which generates a gravity-induced flow within the microchannel. The chip has been used in
this configuration to analyse peptides and proteins by Fourier Transform-Ion Cyclotron
Resonance mass spectrometry through a collaboration with Pr Przybylski’s group
(University of Konstanz, Germany) [1]. Alternatively, in the second part chips are coupled
to infusion lines in order to better control the sample flow rate [2], or ultimately be coupled
to liquid-phase separations to serve as interfaces for LC-MS or CE-MS.
2. Microchips used as stand-alone microsprayers
2.1. Material and methods
Microchip fabrication
Microchips used in this work were kindly provided by DiagnoSwiss (Monthey,
Switzerland). They consist in polyimide foils in which microchannels (120 μm wide, 45 μm
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deep, 1 cm long with a half moon cross section, see Figure 26 below) are ablated. Five
gold-coated microelectrodes sit at the bottom of each microchannel. The microchip
fabrication process has been described in [3, 4]. Briefly, the process starts with 30 x 40 cm
polyimide foils which are coated on each side by a 5 μm copper layer.
Figure 25. Scheme of the fabrication process of polyimide microchips by plasma etching.
A photoresist is patterned, and exposed and developed to expose copper where
microelectrodes and access holes will be etched. The copper layer is then chemically etched
with an aqueous solution of CuCl2 and H2O2. Polyimide is then exposed to a low pressure
plasma formed in an O2/CF4 gas mixture with an O2 content of about 80%. Isotropic
polyimide etching occurs at an ablation rate of about 1-2 μm.min-1. A second photoresist is
patterned, exposed and developed to expose copper where microchannels and access holes
will be etched. A second stage of chemical etching (to remove the exposed copper) and
plasma etching (to ablate polyimide) results in the structure depicted in the last row of
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Figure 25A. The remaining polyimide over the microelectrode is laser ablated to expose
copper, on which gold is subsequently electroplated. The resulting gold-coated
microelectrodes are 50 μm in diameter. Finally, microchips are laminated with a 35 μm
thick polyethylene/ polyethylene terephthalate foil with a standard lamination device
(Morane, Oxon, UK), the top roll being heated at 130°C and the bottom one at 52°C, the
lamination layer being rolled over the microchip at a pressure of 2 bars.
Figure 26. Left: Scanning Electron Microscopy of a polymer microchip. Right: Polymer
microspray emitter showing the tip shape outlet, the gold conductive tracks to the five
embedded microelectrodes, and the pasted sample reservoir.
In order to open one end of the microchannel, one extremity of the microchip is cut
in a tip shape, the microchannel outlet being at the apex of the tip, as previously described
[5, 6]. In order to load the microchip, a polystyrene reservoir is pasted over the
microchannel inlet: the reservoir is first dipped into chloroform to melt its bottom and then
manually applied on the microchip surface till it is pasted. The reservoir itself has an inner
diameter of 7 mm.
Samples and reagents
Oxidised bovine insulin B-chain, human angiotensin I and bovine ubiquitin were
obtained from Sigma (Saint Louis, MO, USA) and sequencing grade modified trypsin from
Promega (Madison, WI, USA). Single peptides and peptide libraries comprising the mucin-
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2 epitope motif, TQTXT, were synthesized by solid-phase peptide synthesis (SPPS) on a
chloromethylated polystyrene resin with the portioning-mixing method, using Boc/benzyl
(Boc1/tert-butoxycarbonyl) protection chemistry [7]. Coupling steps were monitored by
ninhydrin and the Boc group removed with 33% trifluoroacetic acid (TFA). Final cleavage
from the resin was performed by treatment with anhydrous HF for 1 h, and crude libraries
and single peptides were purified by HPLC before analysis by MALDI-TOF-MS and ESI-
FT-ICR-MS.
Mass spectrometry
The chip-ESI-FT-ICR-MS coupling interface was constructed in a self-built chip
holder, prepared for fixation of up to five chips. The holder is equipped with x,y,z-fine
adjustment screws for movement and positioning of the chips in front of the capillary
entrance. The ESI voltage was applied onto the chip contacts or by using a platinum
electrode plunged in the chip reservoir. The standard entrance of the ESI ion source was
removed, and placed 1-2 mm in front of the capillary entrance.
Mass spectra were obtained with a 7T Bruker Daltonik Apex II FTICR mass
spectrometer equipped with an APOLLO electrospray nano-ESI source. Sample solutions of
0.5-5 μL (0.0005-0.01 μg.mL-1) were applied to the chip reservoir, and the chip fixed into
the sample holder. The spray voltage was slowly increased from 0 V to the working voltage
of 1000-2300 V, and the onset of the spray inspected with a microscope. Mass spectra were
obtained by acquisition of typically, 4-32 single scans at 45-70 V capillary exit voltage,
9.14 V of skimmer 1, 8.82 V of skimmer 2, 2500 ms ionization pulse time, 0.001 s
ionization delay time, 1.2 ms excitation sweep pulse. Oxidized bovine insulin B-chain was
dissolved in water/methanol/acetic acid (49.5/49.5/1) to a final concentration of 0.0071
μg.mL-1. Bovine ubiquitin was dissolved in a solution of 3% aqueous acetic acid/methanol
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(1/1) to yield a final concentration of 0.002 μg.mL-1. In-gel digestion with trypsin (2 h) and
sample preparation of human tau protein was performed as previously described [8-10].
Infrared multiphoton dissociation (IRMPD) experiments were performed with Ar as the
cooling gas at the following experimental steps: 5000 ms empty ESI source, empty ICR
cell: 5000 ms hexapole accumulation; 1800 ms ion injection, 40000 ms IR laser in cell; 30
ms detection delay. The collision-induced dissociation (CID) experiments were performed
at a capillary exit voltage of 70±120 V.
2.2. Results
Fluid mobilisation
Fluid mobilisation in polymer microfluidic channels depend on electroosmotic flow,
and externally imposed flow. As well known, electroosmotic flow is highly dependent on
pH:
Figure 27. Dependency of the electroosmotic velocity vs applied electric field curves on pH.
Reprinted with permission from [11].
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With the microchannel sizes used in this study, these values correspond to flow rates
in the range 10 nL/min (pH 4 at 100 V/cm) up to 2 μL/min (pH 10, 500 V/cm). In most
cases, the solutions used in this chapter are acidified to pH 2.6 (1% acetic acid), which
means that there is virtually no electroosmotic flow present.
Flow rates within the microchannels can also be induced by the height of liquid
present in the reservoir. The height of liquid is directly related to the volume of sample
loaded:
H =
V
 d
2
4
(1)
Where V is the volume of sample loaded, d the reservoir diameter and H the height of liquid
within the reservoir. Pascal’s law relates the pressure induced by the height of liquid:
P = gH (2)
Where  is the fluid density (kg.m-3), g is the gravity acceleration (m.s-2). Finally Poiseuille
equation relates the flow rate induced by a given pressure P to the geometrical parameters:
Q =
PR4
8l (3)
Where Q is the induced flow rate, R the microchannel radius,  the fluid viscosity (Pa.s),
and l the microchannel length. Combining equations (1)-(3) gives the relationship between
the sample volume loaded into the reservoir and the flow rate in the microchannel:
Q =
R4g
2ld 2 V (4)
The validity of equation (4) has been validated experimentally by Rossier et al [4, 12].
Physical parameters for methanol/water mixtures are given Table 2:
Density (1000
kg.m-3)
Viscosity (Pa.s) R4g
2ld 2 (s
1)
Water at 20°C 0.998 1.0010-3 1.2910-4
Methanol at 20°C 0.792 5.8410-4 1.7610-4
Methanol/water (50:50) 0.895 7.9210-4 1.4710-4
Table 2. Physical parameters for methanol/water solutions.
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With the given geometry, gravity-induced flow rates within the microchannel are shown in
Figure 28:
Figure 28. Gravity-induced flow rates versus sample volume loaded in the reservoir.
Unless otherwise stated, sample volumes loaded into the reservoir are of 20 μL,
which correspond to flow rates of 155 nL/min (pure water), 211 nL/min (pure methanol)
and 176 nL/min (50:50 methanol:water mixture).
Peptide mass spectrometry
Examples of chip-ESI-FT-ICR spectra are shown in Figure 29 for bovine insulin B-
chain and ubiquitin. The chip FT-ICR-MS measurements provided mass determination
accuracies of 1.4 ppm for insulin and 2.0 ppm for ubiquitin by using routine broad band
(BB) mode and side-kick (SK) trapping method, at mass resolutions in the BB mode of
57000 (ubiquitin) and 91000 (insulin B-chain).
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a) b)
Figure 29. Chip-ESI-FT-ICR mass spectra of a) oxidized bovine insulin B chain, (7.1 μg/mL
in 2% aqueous acetic acid/methanol (1/1), b) bovine ubiquitin (20. μg/mL in 3% aqueous
acetic acid/methanol (1/1).
However, mass resolution is readily increased up to >106 by using the high-
resolution mode. At standard resolution (BB mode) the charge states of ions were readily
defined from the mass difference of two adjacent isotopes, without the necessity of
deconvolution techniques. This situation is of importance, for example, for the analysis of
noncovalent complexes where a low charge distribution may yield only few peaks that are
difficult to deconvolute. The high resolution of the chip-FT-ICR spectra routinely provides
monoisotopic peaks with mass-determination accuracies around 1 ppm. The
characterization of complex mixtures, such as from natural products and combinatorial
libraries, often requires preliminary fractionation or separation (e.g. by HPLC or CE). In
such applications the high resolution and accuracy of FT-ICR-MS proves to be extremely
useful, for example, to detect mixture components with closely adjacent masses [13, 14].
The feasibility of the chip-ESI-FT-ICR system is illustrated in Figure 30 for a combinatorial
peptide library derived from the core epitope of mucin-2 gastrointestinal glycoprotein, a
marker protein for colon cancer [7].
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Figure 30. Chip-ESI-FT-ICR mass spectrum of the combinatorial peptide sub-library
TQTXT (where X = all proteinogenic amino acids except Cys). The peaks corresponding to
the isobaric peptides TQTIT and TQTLT overlap. The insert shows the base-line separated
peaks corresponding to the protonated molecular ions of peptides TQTQT and TQTKT (see
Table 3).
In a combinatorial peptide sub-library of the epitope motif TQTXT, the chip-ESI-
FTICR-MS analysis was capable of distinguishing, and provided identification of all
components of the library at monoisotopic resolution. Protonated molecular ions were
observed with a relative-abundance distribution reflecting the composition of components,
except for the peptide TQTHT, whereas the ion signal of the two isobaric peptides, TQTIT
and TQTLT, were twice as abundant as the other components. The chip-ESI spectrum
provided unequivocal resolution of the “isobaric” peptides, TQTKT and TQTQT with
experimental molecular masses, 578,31271 and 578.27636 (m=0.03635 amu). The
accuracies of mass determinations yielded the elemental compositions of all the library
components (Table 3).
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Amino acid
X
[TQTXT+H]+calc [TQTXT+H]
+
exp m
Mass
accuracy
(ppm)
Elemental
composition
A 521.25712 521.25547 0.00165 3.1 C20H37N6O10
D 565.24695 565.24558 0.00137 2.4 C21H36N6O12
E 579.26260 579.26044 0.00216 3.7 C22H39N6O12
F 597.28842 597.28656 0.00186 3.1 C26H41N6O10
G 507.24147 507.23953 0.00194 3.8 C19H35N6O10
H 587.27891 587.27640 0.00251 4.3 C23H39N8O10
I 563.30407 563.30182 0.00225 4.0 C23H43N6O10
K 578.31497 578.31271 0.00226 3.9 C23H44N7O10
L 563.30407 563.30182 0.00225 4.0 C23H43N6O10
M 581.26049 581.25877 0.00172 3.0 C22H41N6O10S1
N 564.26293 564.26118 0.00175 3.1 C21H38N7O11
P 547.27277 547.27080 0.00197 3.6 C22H39N6O10
Q 578.27858 578.27636 0.00222 3.8 C22H40N7O11
R 606.32111 606.31884 0.00227 3.7 C23H44N9O10
S 537.25203 537.24984 0.00219 4.1 C20H37N6O11
T 551.26768 551.26583 0.00185 3.4 C21H39N6O11
V 549.28842 549.28628 0.00204 3.7 C22H41N6O10
W 636.29932 636.29657 0.00275 4.3 C28H42N7O10
Y 613.28333 613.28049 0.00284 4.6 C26H41N6O11
Average 0.00210 3.7
Standard deviation 0.0004 0.5
Table 3. Elemental compositions of components of the TQTXT library determined by chip
ESI-FT-ICR-MS.
Similar results were obtained for a number of polypeptides and proteins within an
approximate molecular-weight range between 1 and 35 kDa (data not shown). The chip
ESI-FT-ICR-MS interface provides a stable spray of 20 μL sample solutions for at least 15
min, which enables analysis of low sample concentrations, that is, attomole sensitivity for
oligopeptides as shown previously for nano-ESI-FT-ICR-MS [15-17]. However, for
peptides in the lower mass range a significant advantage of the chip-ESI-system was found
in the absence of the background and/or contamination that is frequently found with nano-
ESI capillaries. Furthermore, spraying times with the chip are sufficient to carry out the
complete range of fragmentation experiments, one of the key features of FT-ICRMS [18-
25]. Fragmentation experiments of the model peptide angiotensin were carried out in the
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ESI source low vacuum region (source CID), as well as in the ICR-cell, after isolation of
ions using 1) Ar as collision gas (SORI-CID), or 2) IRMPD. The MS/MS feasibility of the
chip-ESIFT- ICR system was demonstrated by IRMPD fragmentation of angiotensin
yielding results comparable to those obtained using the nano-ESI source.
MS/MS
fragmentation
Isolated ions
Sequence
determined
Resolution Accuracy (ppm)
IRMPD
[M+2H]2+
[M+3H]3+
VYIHP 50000 6
Source CID  IHPFHL 60000 3
Table 4. Fragmentation of angiotensin I (DRVYIHPFHL) by in-source SORI-CID and in-
cell IRMPD.
First multistage (MSn) experiments were performed up to the MS3 level by using
both SORI-CID and IRMPD. A first application of the chip- FTICR system to a complex
multicomponent mixture in proteome analysis is shown in Figure 31 with an in-gel digested
tryptic peptide mixture of the human microtubule associated tau protein which has recently
aroused interest as a target protein in neurofibrillary tangles characteristic of Alzheimer
disease. The pathophysiological aggregation of tau in fibrillary tangles has been shown to
be associated with structural changes by multi-(hyper)- phosphorylation which has therefore
become the subject of recent studies.
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Figure 31. Chip-ESI-FTICR mass spectrum of tryptic digest mixture of multiphosphorylated
human neurofibrillary tau protein. Mass assignments with m/z detection range, 200-2500,
and partial sequences are shown for phosphorylated peptides. The insert shows the peptide
fragment of the phosphorylation domain (512-538); the seven phosphorylation sites,
identified using information from the NiceProt View of Swiss-Prot database (primary
accession number P10636), are indicated in red (C113H191N36O61P7, doubly protonated;
calculated: 1622.55513; found: 1622.60435, =30 ppm).
In the chip-ESI spectrum the complete primary structure including 18 serine- and
threonine-phosphorylations could be directly identified from the tryptic peptides, partially
with very low abundances, which clearly demonstrates the high analytical performance of
the chip-FTICR-MS. Mass determinations yielded accuracies of 5-20 ppm within the
phosphorylated peptide sequences; this provided the direct identification of 7 and 5
phosphorylation sites in the multi-phosphorylation domains, (512–538; see insert in Figure
31, and (382–398; T386, S388, T395, T396, S397).
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2.3. Conclusion
The goal of this first study was to validate the use of stand-alone microfluidic
microsprayer on an ESI source different from the one that had been used in our laboratory,
namely the heated capillary ion source of the LCQ Duo (Thermo Electron, San Jose, USA)
[5, 6]. The coupling with the Appolo source of the FT-ICR-MS instrument (Bremen,
Germany) appeared to be relatively easy, though it required the removal of the entrance cap
of the heated capillary and that the microchip positioning in front of the heated capillary
inlet proved to be more critical than on the LCQ Duo.
The second validation consisted in the analysis of more complex mixtures (the
TQTXT library) than previously analysed, and of real life samples (Tau protein digest from
2D-GE). In both cases, no reversible adsorption of analytes could be observed: even
extensive washing of the microchip did not revealed elution of potentially adsorbed analytes
(data not shown).
The microfluidic microsprayer used as a stand-alone device appears to be
particularly promising when combined with high-resolution FT-ICR-MS, where analytes
are delivered to the mass spectrometer without prior separation, and where relatively long
analysis times are needed to perform complex MS acquisitions or MS/MS fragmentation
processes. In this instance, the low flow rates generated by the height of liquid present in
the sample reservoir (below 200 nL/min) combined with stable ion currents shows great
promise.
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3. Microfluidic microsprayers under infusion
3.1. Materials and methods
Chemicals and reagents
Analytical grade methanol (MeOH) and trifluoroacetic acid (TFA) are from Riedel
de Haen (Darmstaadt, Germany), acetic acid and propranolol-S-hydrochloride are from
Fluka (Buchs, Switzerland), and HPLC grade acetonitrile (ACN) is from SDS (Peypin,
France). Deionised water (18.2 MW.cm) is obtained from a MilliQ unit (Millipore, Bedford,
USA).
Microchip fabrication
Microchips were kindly provided by DiagnoSwiss (Monthey, Switzerland). They are
exactly the same as the one used in the previous section. Instead of pasting a reservoir on
top of the microchip for sample loading, the microchip was sandwiched into a home-built
polycarbonate holder that integrates a low dead-volume microfluidic connection to couple
the microchip to a syringe pump (KD Scientific, New Hope, PA, USA). The whole device
is shown in Figure 32.
Figure 32. Scheme of the chip holder used to connect an infusion line with the microspray.
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Mass spectrometry
Mass spectrometer is a LCQ Duo ion trap from Thermo Electron (San Jose, CA,
USA). All experiments were done in full scan mode (50-2000 m/z) without any averaging,
the heated capillary is kept at 200 °C, and ion optics parameters are optimized on the
studied compound. In the polymer microspray experiments, the chip holder is placed in
front of the heated capillary inlet, typically 3-5 mm away. The electrospray voltage is
applied through the integrated microelectrode, and typically set between 2 and 3 kV. For the
pulled nanospray experiments, borosilicate nanospray capillaries (50 μm inner diameter, 3
to 5 μm outlet diameter, from Polymicro, Phoenix, AZ, USA) are mounted on the
commercial nanospray source, connected to the syringe pump, and electrospray voltage is
applied through a liquid junction on the infusion line, and typically set between 1 and 2.5
kV. In each experiment, the flow rate is varied with all other parameters unchanged (chip or
nanospray position, electrospray voltage). Experiments were done whether in 50% MeOH:
49% water: 1% acetic acid, or in X% ACN: (100-X-1)% water: 1% TFA.
3.2. Results and discussion
For planar microsprays that do not have a nozzle-like outlet, the hydrophobicity of
the microspray material plays a significant role in its ability to accommodate a stable Taylor
cone: if the spray solution can wet easily the outer microspray walls, the Taylor cone will
spill over on the edge of the microchip, and potentially delocalize away from the
microspray outlet, as shown in Figure 33: liquid coming out from the microchannel spilled
over on the edge of the chip till it reached an asperity, where the Taylor cone stabilised.
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Figure 33. Delocalisation of the Taylor cone
on the edge of a PET microspray. Reprinted
with permission from [5].
On the contrary, if the spray solution cannot wet the microspray material, the Taylor
cone will be confined at the outlet of the microchannel, and its size will vary with the flow
rate applied, but it will not collapse easily. Figure 34 shows the contact angles measured for
water and two classical spray medium (acidified methanol: water and acidified acetonitrile:
water): glass is easily wet by water, methanol and acetonitrile spray media; whereas some
authors did not find any improvement in the spray stability with hydrophobic treatments of
the outlet of the glass microspray [26], some others found it compulsory for good operation
[27, 28].
Figure 34. Contact angles of water (black bars), 50% MeOH: 1% acetic acid: water (grey
bars), and 50% ACN: 1% TFA (white bars) on bare glass, polyimide (outer surface of the
microspray), and polyethylene terephthalate (outer surface of microsprays comparable to
those used in our laboratory [5, 29-33]). Error bars represent one standard deviation over
triplicate measurements.
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Moreover, most glass microfluidic devices incorporate a pasted nanospray tip or are
connected to a microelectrospray needle for easy operation [34-37], which may indicate that
spraying directly from a glass microchip is not easy. On the contrary, both polyimide and
polyethylene terephthalate (PET) show high contact angles for water and decent contact
angles for the two spray solutions tested, which makes then particularly suitable materials
for polymer microsprays.
The first goal of this study was to explore the flow rate range that can be applied on
the microchip. To characterize the flow rate dependency of spectral signal, a solution of 10
μM propranolol in 50% MeOH: 49% water: 1% acetic acid (v:v) is infused at different flow
rates. The propranolol concentration was chosen to have high signals without any saturation
of the MS detector (saturation in the chosen conditions would be around 108 ion counts on
our instrument under the chosen conditions). Figure 35 shows the evolution of propranolol
ion intensity (measured as peak area at m/z = 260.1) when increasing the flow rate of the
infused solution.
Figure 35. Evolution of the propranolol ion count (m/z = 260.1) with increasing flow rates.
Error bars represent one standard deviation of the propranolol peak area over 10 min.
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The electrospray signal obtained from the microchip increases smoothly from 250
nL/min up to 7 μL/min while the signal generated from the nanospray capillary becomes
more erratic, and never reaches the value obtained from the microchip. Above 7 μL/min, it
was impossible to generate electrospray from the nanospray capillary, while spraying was
still possible from the microchip with compromised stability; in fact at higher flow rate, a
droplet slowly formed at the outlet of the microchannel till electrospray became impossible
to maintain. The flow-rate dependency of the propranolol intensity is found to be of the
form I=A.Vf
x where Vf is the flow rate, with A=3.45.106±1.17.105 ion counts / μL/min and
x=0.43±0.02 (see Figure 35). This dependency is in good agreement with the empirical
expression for the electrospray current proposed by Pfeifer et al [38]:
ies =
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where  and 0 are the permittivity of the solvent and of the vacuum respectively,  is the
surface tension of the solvent,  is the conductivity of the infused solution and Vf is the
volumic flow rate, as well as with the simplified relationship derived by de la Mora et al
[39]:
ies = f r( ). Vfr( )
0.5
(6)
On the contrary, no global dependency can be outlined for the nanospray capillary
because of its instability; this difference in behaviour can probably be attributed to the
hydrophobicity of the polymer surface as well as to the shape of the microchip outlet: a big
Taylor cone can indeed expand on the microchip outlet walls without spilling over, while
the sharp edges of the nanospray capillary cannot accommodate large Taylor cones.
Whereas obviously only the lower flow rates are relevant for use with the nanospray
capillary, the results are given for the whole flow rate range.
Microfluidic front-end technologies for protein electrospray mass spectrometry
115
Qualitatively, the signal generated from the microchip was found to be more stable
through time than the one generated from the nanospray capillary, especially at high flow
rates, as illustrated by Figure 36.
a) b)
c) d)
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e) f)
Figure 36. Propranolol ion counts (m/z @ 260.1) for signals generated from the nanospray
capillary at 0.2 (a), 1.5 (c) and 7 μL/min (e), and from the microchip at 0.2 (b), 1.5 (d) and
7 μL/min (f). Round square deviations (RSD) are estimated over the more stable 10 minutes
in all cases.
In order to quantitatively compare the signal stabilities when increasing the flow
rate, the temporal signal to noise ratio was calculated as:
SNR = 20.log
I(propanolol)
 (propanolol) in dB (7)
The mean propranolol intensity and standard deviation were calculated from peak
area over 10 minutes in each case. As can be seen from Figure 37, the temporal signal-to-
noise ratio shows a 10 dB increase from 0.2 μL/min to 1 μL/min for the signal generated
from the microchip, and remains more or less constant for higher flow rates.
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Figure 37. Evolution of the temporal signal-to-noise ratio with increasing flow rates.
On the contrary, the signal generated from the nanospray shows the same increase in
temporal signal-to-noise ratio up to 0.7 μL/min but becomes really irregular at higher flow
rates. The typical ranges where the microchip and nanospray show best stability are above 1
μL/min and below 0.7 μL/min respectively.
Furthermore, the limit of detection (LOD) was estimated as:
LOD =  noise + 3. noise in dB (8)
where noise mean and noise standard deviation were calculated between m/z = 500 and m/z
= 2000 in each spectrum (no analyte peak present). Figure 38 shows the absolute limits of
detection for the microchip and the nanospray.
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Figure 38. Theoretical limits of detection (LOD) of the microchip and nanospray, in ion
counts.
Not surprisingly, the nanospray shows much lower limit of detection at each flow
rate (by an approximate factor of four). But a more important feature for mass spectral
characterization of the micro- or nanospray emitters is the spectral signal-to-noise ratio,
which is estimated as:
SNR = 20.log
I propanolol( )
I noise( )
in dB (9)
where the propranolol intensity is the peak area at m/z = 260.1, and noise mean intensity
calculated as above. This spectral SNR basically reflects the ratio between the analyte
signal and spectral noise. Figure 39 shows the evolution of the spectral signal-to-noise ratio
for both microchip and nanospray.
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Figure 39. Evolution of the spectral signal-to-noise ratio with increasing flow rates.
Remarkably, the microchip and the nanospray behave pretty much in the same way,
except at the highest flow rates tested, where the nanospray shows better SNR (but a poor
temporal stability in this domain, see above). Surprisingly, the higher the flow rate, the
better the spectral signal-to-noise ratio.
3.3. Compatibility with acetonitrile
In order to investigate the compatibility of the microspray emitter with acetonitrile-
containing spraying solution, the same kind of experiments was performed and resulted in
comparable results: signals from propranolol in 50% ACN: 49% water: 1% TFA were
generated at flow rates between 0.250 and 4 μL/min, as shown in Figure 8. Propranolol
intensity increases smoothly up to 4 μL/min; at this point, the sprayed solution began to wet
the outer walls of the microchip, so that a small drop slowly formed before being sprayed,
resulting in a kind of pulse-mode spray (data not showed).
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Figure 40. Evolution of the propranolol intensity with increasing flow rates in 50% ACN:
49% water: 1% TFA. Error bars represent one standard deviation of the peak area over 10
min.
This difference of behaviour between methanol and acetonitrile can be attributed to
differences in hydrophobicity of the two solvents: acetonitrile wets the hydrophobic
polyimide walls more easily than methanol (see Figure 34). The spectral signal-to-noise
ratio also increases smoothly with flow rate (see Figure 41), with optimal values above 1
μL/min, as is the case with methanol.
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b)
a)
c)
Figure 41. a) Spectral signal-to-noise ratio of propranolol spectra versus flow rate. b) and
c) are corresponding spectra at 0.250 and 4 μL/min respectively
Moreover, acetonitrile can be used in high amounts, as shown in Figure 42: the
single scan of 10 μM propranolol in 99% ACN: 1% TFA shows the single peak of
propranolol and no contaminant from the chip itself even if the spray is operated for 20
minutes, resulting in a spectral SNR of 41.2 dB.
Figure 42. Single spectrum of 10 μM propranolol in 99% ACN: 1% TFA infused at 2.5
μL/min.
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On the opposite, satisfactory spray can be obtained even in 10% ACN: 89% water:
1% TFA, as shown in Figure 43.
a) b)
Figure 43. Microchip performances in 10% ACN: 89% water: 1% TFA. a) Stability of the
spray over 12 minutes, showing a temporal SNR of 13 dB. b) Single scan showing a spectral
SNR of 38.5 dB.
A temporal SNR of 13 dB is obtained for an infusion at 2.5 μL/min, corresponding
to the lowest value obtained with 50% MeOH: 49% water: 1% acetic acid over the whole
flow rate range (see Figure 37). Nevertheless, the spray is stable and results in a spectral
SNR of 38.5 dB, corresponding again to the lowest value obtained with methanol solutions
(see Figure 39). Below 10% acetonitrile, it was impossible to spray continuously. The
microchip can thus be used in a wide range of solvent compositions (from 10% to 99% of
acetonitrile).
3.4. Conclusion
In this section the flow rate behaviour of the microfluidic microsprayer was tested.
Despite its relatively large dimensions (12045 μm) compared to classical pulled nanospray
capillaries that have outlet diameters of 3-10 μm typically, the microsprayer shows good
sensitivities in the low flow rate range. Additionally, it can accommodate much larger flow
rates (up to 7 μL/min) that cannot be used with pulled nanospray capillaries. In summary,
the microsprayer shows equivalent performances to pulled nanospray capillaries in terms of
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signal stability and sensitivity, and better performances at higher flow rates. It can also be
used in a wide range of solvent conditions, from 10% to 99% of organic solvent. It thus
appears as a particularly promising interface for LC-MS hyphenation: the flow rate ranges
tested here is fully compatible with nano- and capillary LC systems, the range of solvent
composition corresponds to gradient conditions of LC separation of peptides and proteins in
reverse phase liquid chromatography. From a practical point of view, microfluidic
microsprayers have the advantages of robustness and disposability compared to pulled
nanospray capillaries. Additionally its larger dimensions prevent any clogging problems
that are often encountered with small nanosprays.
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Chapter 4. Glycoconjugate analysis
1. Introduction
This chapter presents the collaborative work accomplished with the laboratory of Pr.
Jasna Peter-Katalinic, Biomedical Analysis Group, Institute for Physics and Biophysics,
University of Münster, Germany. The primary goal of this work was to test the suitability of
the microfabricated microsprayers developed in our laboratory for the mass spectrometric
analysis of glycoconjugates. As explained in section 4 (Oligosaccharides mass
spectrometry), mass spectrometric analysis of carbohydrates and glycoconjugates is
challenging in terms of ionisability, spray stability to allow investigation of structural
features, and sensitivity. These are the parameters that are studied in sections 5 (Q-TOF
analysis of O-glycopeptides and gangliosides) and 6 (FT-ICR analysis of O-glycopeptides).
Whereas the goal of this study was purely to assess the potential of microfabricated
microsprayers, section 2 describes the basics of oligosaccharides and glycoconjugates
biochemistry, and section 3 gives a few elements about the biomedical context of such
studies.
2. Basics of glycoconjugate biochemistry
The term glycoconjugate refers to hybrid molecules where carbohydrate chains are
covalently linked to other structural entities, such as peptides or proteins, lipids or
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extracellular components. The carbohydrate chain itself is often referred to as glycan.
Depending of the nature of the molecule the glycan is linked to, glycoconjugates can be
classified into:
1. glycopeptides and glycoproteins, among which proteoglycans specifically refer to
extracellular proteins.
2. glycolipids in which glycans are linked to a lipid moiety.
2.1. Monosaccharides and the glycosidic bond
The glycan chain itself is made of monosaccharide units; a monosaccharide is a
polyhydroxyaldehyde or polyhydroxyketone of general formula (CH2O)n that cannot be
hydrolysed into simpler units. Compounds with the same formula can be found in various
cyclic forms, namely the pyranose form (6 carbon ring) and furanose form (5 carbon ring):
-D-glucopyranose (-D-Glcp) -D-glucopyranose (-D-Glcp)
-D-glucofuranose (-D-Glcf) -D-glucofuranose (-D-Glcf)
Table 5. The four D-isomers of general formula C6H12O6
Additionally to the number of carbon atoms involved in the ring (pyranose or
furanose form), the position of the hydroxyl group of carbon 1 gives additional isomers (
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and ), as well as L and D conformation. For a ring saccharide of general formula C6H12O6,
there are thus 8 possible isomers [1].
The most common monosaccharides in higher organisms are listed in Table 6:
Family Most commons monosaccharides
Sialic acids
(Sia)
N-acetyl neuraminic acid (Neu5Ac)
Hexoses
(Hex)
glucose (Glc) galactose (Gal) mannose (Man)
Hexosamines
(HexA)
N-acetylglucosamine (GlcNAc) N-acetylgalactosamine (GalNAc)
Deoxyhexoses
(dHex)
fucose (Fuc)
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Pentoses
(Pen)
xylose (Xyl)
Uronic acids
glucoronic acid (GlcA) iduronic acid (IdA)
Table 6. Ten most common saccharide units found in higher organisms (in their -pyranose
form).
Table 6 lists only the most common monosaccharide units in higher organisms. For
example, the sialic acid family comprises tens of different molecules; additionally, the set of
monosaccharides that can be found in various organisms can be very different [2]. In order
to from oligo- or polysaccharides, monosaccharide units assemble through glysosidic
linkage, in a manner very similar to the assembly of amino acids into peptides through the
peptidic linkage and assembly of bases into DNA through the phosphodiester linkage:
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Figure 44. Formation of maltose (D-Glcp--(1-4)-D-Glcp-) from two glucose units.
Figure 44 illustrates the formation of a glycosidic bond between two glucose units to
form a maltose molecule. However, the glycosidic bond can involve hydroxyl groups linked
to different carbon atoms, including C6. There are thus 15 different disaccharides of
primary sequence D-Glcp--D-Glcp-. Moreover, as all monosaccharides carry several
hydroxyl groups, polysaccharides are not necessary linear, but can be branched. Figure 45
shows the classical representation adopted to depict polysaccharides structures:
Figure 45. Traditional description of a branched polysaccharide.
Monosaccharide units are from Table 6; p specifies that monosaccharide units are in
their pyrannose form; the numbers are those of the carbon atom which bear the hydroxyl
group involved in the glycosidic bond; greek letters  and  refer to the orientation of the
hydroxyl group involved in the formation of the glycosidic bond. By convention, when
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unspecified all monosaccharide units are assumed to be in their pyrannose form, and all
glycosidic bonds to originate from the C1 hydroxyl (except for sialic acids, which are linked
to the C2 hydroxyl). These conventions lead to the simplified traditional representation of
polysaccharides:
Figure 46. Simplified traditional description of a branched polysaccharide.
Additionnaly, oligo- or polysaccharides can bear chemical modifications
(comparable to post-translational modifications in proteins), the most common being
phosphorylation, sulfation, methylation, O-acetylation and fatty acylation of hydroxyl
groups, N-acetylation and N-sulfation of amino groups.
2.2. Complexity of the sugar code
As shown below, monosaccharides exist in a number of isomeric forms, based on
pyranose or furanose forms, configuration L or D and orientation of hydroxyl group  and
. Based on this, the number of different linear n-oligosaccharides would be [3]:
En  2rn  2an  L L +1( )n
where En represents the number of permutations form the primary sequence; based
on 20 common monosaccharides, E2=400. The term 22r accounts for ring size (pyranose or
furanose) and would be 4. The term 22a accounts for anomeric form and would be 4. The
last term accounts for possible linkage positions (L being the number of available hydroxyl
groups, e.g. 5 for hexoses, 4 for pentoses). For a dissachharide it would be of the order of 12
(15 for hexoses and 10 for pentoses). There are thus a total number of approximately 76800
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distincts disaccharides. Even with only D-monosaccharides, as found in the living world,
this number would be 19200, compared to 16 dinucleotides and 400 dipeptides.
Similarly there are 768000 distinct linear trisaccharides (not taking into account
anomerism); if one considers the case of a trisaccharide chain attached to an aglycon
molecule, additional branched isomers must be considered, producing a number of
additional isomers (L branching positions for the aglycon molecule, and then L-1 and L-2
respectively for the two branching monosaccharides):
En  2rn  2an  L  L L 1( )2 
L 1( ) L  2( )
2
For a branched trisaccharide, it would add an additional 9922500 possibilities (not
taking anomerism into account), for a total (linear plus branched) close to 107 different
molecules, compared to 64 trinucleotides and 8000 tripeptides.
2.3. Glycopeptides and glycoproteins
Polysaccharide (glycan) chains are linked to proteins via asparagines (Asn/N) on
consensus sequences NX-S/T; these are N-glycans. N-glycans are divided into three
subclasses:
1. complex type containing GalNAc, GlcNAc, Man, Gal and Neu5Ac residues
2. high mannose type containing GlcNAc and a high number of Man
3. hybrid type containing both complex and high mannose types strctures.
N-glycosylation has been widely studied and biosynthesis pathway are reasonnably
well understood (see below).
Glycan chains can also be linked to proteins through linkage to serine or threonine
residues; these are O-glycans. No consensus sequence has been found for O-glycosylation.
The modification of serine or threonine residues occurs by addition of a GalNAc residue.
Eight core structures have been identified, that are presented in Table 7:
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core 1 core 5
core 2
core 6
core 3 core 7
core 4
core 8
Table 7. The eight core structures in O-glycosylation.
2.4. Glycolipids
Glycolipids are glycoconjugates that comprise one or more saccharide unit
glycosidically linked to a hydrophobic moiety such as acylglycerol, ceramide or prenyl
phosphate. According to the type of lipid moiety linked to the glycan chain, glycolipids are
classified as:
a. glycoglycerolipids: glycolipids containing one or more glycerol residue :
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Figure 47. Typical structure of a glycerolipid.
b. glycophosphatidylinositols (GPI): oligosaccharides glycosidically linked to the
inositol moiety (including those bearing different modifications such as O-acyl, O-
alkyl… on their glycerol or inositol residues). While the diversity of GPIs is only
being unravelled, many appear to share a common “core” (see Figure 48).
Figure 48. Typical glycophosphatidylinositol (GPI).
GPIs covalently attached to peptides or proteins (usually through the C-
terminus via an amide linkage) are called GPI anchors.
c. glycosphingolipids (GSL) are carbohydrate-containing derivatives of a sphingoid or
ceramide. The most prominent lipid anchor in higher organisms is a ceramide,
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which consists of sphingosine substituted at its NH2 group by fatty acids of various
lengths. There are two types of GSL: neutral, comprising neutral sugar moieties, and
acidic comprising groups such as sialic acids, uronic acids… Syalilated GSL called
gangliosides carry sialic acid linked to C3 or C6 of Gal or GalNAc of the core
oligosaccharide.
Figure 49. Simple glycosphingolipid Gal-Cer. Monosaccharide composition of major
ganglioside species are shown on the right.
The ceramide moiety potentially bears a certain heterogeneity, that is clarified by the
indication (d18:1/18:0), which indicates the number of carbon atoms in each branch of the
ceramide as well as the number of unsaturated bonds. Nomenclature of glycolipids has been
recently published by the Union for Pure and Applied Chemistry [4].
3. Physiology and biomedical aspects
Glycoconjugates are ubiquitous through the living world, but tend to be more
complex and more abundant in higher organisms. Glycans definitively play a role in cell
structure, especially when attached to matrix molecules such as collagen and proteoglycans.
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They may also have a general protective role against proteolysis, as is well known for
immunoglobulins. Protein glycosylation can also induce an on/off effect, such as for the -
human chorionic gonadotrophin (HCG), which is unable to activate adenylate cyclase
when deglycosylated [5], or fine tuning of an enzymatic function or receptor affinity.
Glycans can also act as low affinity binders in the extracellular domain:
glycosaminoglycans bind chemokines on the cell surface and facilitate the formation of
chemokine gradients that direct cell migration in inflammation [6].
Protein glycosylation also plays a recognition role, such as in protein clearance from
plasma [7], in cell-cell and cell-matrix interactions: for example the glycosylation of
selectin ligands play a crucial role in the regulation of critical interactions among blood
cells [8, 9]. As key elements that take part in cell-cell communication, glycans are also
recognised as key diagnostic and therapeutic targets in cancer [10]. These ubiquitous and
versatile roles of glycans in most physiological processes imply that they indeed take part in
many physiological disorders and diseases.
3.1. Congenital disorders of glycosylation (CDGs)
One class of diseases that is directly linked to glycosylation alterations are
congenital disorders of glycosylation (CDGs), formerly named carbohydrate-deficient
glycoprotein syndromes. CDGs are inherited disorders affecting the assembly or processing
of glycans on glycoconjugates. One difficulty in the diagnosis of CDGS is that their clinical
spectrum is very variable, ranging from strabismus or ataxia to lethal multisystemic
disorders such as cardiomyopathy, nephritic syndromes, hepatic fibrosis…, statomotor and
mental retardation being very frequent. They can be considered as orphan diseases as only a
few hundreds patients are affected worldwide, and little research is done: the first molecular
description of a disorder in the biosynthesis of N-glycans has been reported in 1995 only
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[11]. Molecular diagnosis is mainly based on the isoelectric focusing pattern of serum
transferrin: however, this diagnostic procedure is only indirect, and not all CDGs result in
alterations of transferrin [12].
Most types of CDGs discovered so far relate to defects in the N-glycosylation
pathway of glycoproteins. But it should be pointed out that N-glycosylation is relatively
well-known, whereas little is known about the O-glycosylation biosynthetic pathway;
moreover, 20% of diagnosed CDGs have not received molecular explanation yet. It is thus
highly probable that new types of CDGs will be identified in the years to come.
3.2. N-linked glycoproteins
Protein translation occurs on ribosomes either in the cytoplasm or on the
endoplasmic reticulum (ER). Upon the start of translation, the N-terminal part of the
synthesised protein is translocated within the ER. The building of an N-linked glycan
structure onto asparagines residues start with the synthesis of a dolichol-saccharide
precursor in the ER, which is brought in the vicinity of the protein and the saccharide is
enzymatically transferred from its dolichol anchor to an asparagine residue. A great number
of biosynthesis steps then build the glycan chain on this first saccharide. The protein is then
transferred to the Golgi by vesicle transport where further carbohydrate heterogeneity is
created by a whole enzymatic apparatus. An overview of this biosynthetic pathway is
shown in Figure 50.
Figure 50. (next page) Scheme of the biosynthetic pathway of N-glycosylation. Reprinted
with permission from [12].
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This pathway involves tens of enzymes (most of then are protein complexes); any
enzymatic alteration (lack of activity, hyperactivity, wrong activity) can lead to the
production of misglycosylated proteins that will not be able to assume their physiological
functions. Documented CDGs are indicated by red crosses along the biosynthetic pathway
in Figure 50.
3.3. O-linked glycoproteins
Whereas N-glycosylation occurs cotranslationally in the ER and further in the Golgi,
O -glycosylation occurs posttranslationally and occurs downstream of the protein
production. In the most common type of O-glycosylation (mucin-type-O-glycosylation), an
N-acetylgalactosamine (GalNAc) is attached to Ser/Thr of the protein [13]. Alternatively,
O-GlcNAc addition on Ser/Thr , direct glucosylation, fucosylation and galactosylation, and
O-mannosylation also exist [12, 14, 15].
Many glycan processing enzymes are specific to O-glycosylation, but there are also
some documented overlapping between N- and O-glycosylation biosynthetic pathways.
3.4. Schindler disease
Schindler or Kanzaki disease is defined as an -N-acetylgalactosaminidase (-
NAGA) deficiency [16], a genetic autosomal recessive trait inherited metabolic disorder,
characterised by deficient activity of the lysosomal enzyme -NAGA and consequent
abnormal urinary excretion of glycoconjugates [17]. A deficiency of the activity of -
NAGA should theoretically result in the accumulation of undegraded glycoconjugates
terminating with the GalNAc residue. However, major urinary excretion products have been
found to be sialylated glycosylated amino acids including NeuAc2-3NeuAc1-
3[NeuAc1-2]GalNAc1-O-Ser/Thr and NeuAc2-3Gal1-3GalNAc1-O-Ser/Thr [18].
Microfluidic front-end technologies for protein electrospray mass spectrometry
141
Therefore the assessment of urinary glycopeptides present in both healthy individuals and
patients suffering from Schindler disease is of major importance for  a better understanding
of the disease mechanism.
3.5. Glycans and cancer
Glycobiologists have known for a long time that the structures of glycans that
decorate eukaryotic cell surfaces, change with the onset of cancer [19]. Changes in
glycosylation include under-, over-, and neoexpression of glycans. Most often these
modifications are due to changes in expression levels of glycosyltransferases in the Golgi
[10], which both affects N- and O-glycoproteins. Another common feature is the over- or
altered expression of glycolipids, in particular of gangliosides. Gangliosides are sialic acid
containing glycosphingolipids (see paragraph 2.4 above), present in the cell membrane of
all vertebrates and especially in the cells of the nervous system. Changes in their
composition and content have been observed during physiological growth and
differentiation as well as in neoplastic cell transformation. A decrease in the regular
ganglioside profile and an increase in the structures detected only in small amounts in
normal brain tissue have been shown in primary brain tumours [20, 21]. This features
demonstrates the direct correlation between ganglioside composition and histological type
and grade of the tumours and that changes in ganglioside expression may serve as
biochemical markers in early histopathological diagnosis, grading and prognosis of
tumours. Additionally, for tumour treatment, one strategy may be to use ligands that
specifically bind the invading cells for which gangliosides are a potential group of tumour-
specific targets.
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4. Oligosaccharides mass spectrometry
This section is mainly based on the insightful review by Zaia et al [22]. It aims to
explain the general principles of oligosaccharide mass spectrometry as well as its
specificities compared to peptide and protein mass spectrometry.
4.1. Ionisation of carbohydrates
Carbohydrates have been studied by both electrospray and matrix-assisted laser
desorption/ionisation mass spectrometry. Electrospray ionisation usually results in much
less intense signals than that obtained form peptide solutions of the same concentration. The
main reason for this low sensitivity is the hydrophilic nature of oligosaccharides. It is now
well-established that hydrophobicity of analytes play a crucial role in determining their
spectrum intensity [23, 24]. There can easily be one or two orders of magnitude differences
in the mass spectrum due to differences in hydrophobicity. This has led to derivatisation
strategies to decrease oligosaccharides hydrophilicity, e.g. through permethylation or
peracetylation. Derivatisation strategies will not be described herein because experiments
described below concerns only non-derivatised oligosaccharides. For more details, the
reader is referred to references [22, 25-27].
Besides derivatisation, nanoelectrospray (nESI) has received particular attention for
the analysis of oligosaccharides. Nanoelectrospray produces much smaller charged droplets
that electrospray at high flow rates [28]: in ESI, typical droplet size is about 1 μm, whereas
in nESI, primary droplets have diameters of the order of 100 nm. This thus lead to an
increase of surface-to-volume ratios typically ten times higher. The influence of surface
affinity in analyte charging is thus believed to be less critical [29]. Figure 51 shows ESI
mass spectra of maltopentaose and bovine insulin at equimolar concentration in microESI
and nanospray. In the microESI spectrum (Figure 51a), maltopentaose appears as a sodiated
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peak represented only 5% of the insulin base beak, whereas in nanospray, maltopentaose
and insulin give peaks of comparable intensity.
Figure 51. ESI mixture analysis of maltopentaose and insulin (both 510-6 M) with
conventional forced-flow (“micro”) (a) and nanospray (b). The averaged absolute
intensities (counts) for the base peaks are indicated. Reprinted with permission from [30].
On the other hand, oligosaccharides have also been analysed by matrix assisted laser
desorption/ionisation mass spectrometry (MALDI-MS). Whereas MALDI-MS appears to be
well-suited for heterogeneous mixtures (such as glycans released from glycoproteins) due to
much less critical competition for ionisation between analytes (known as “ion suppression”
in ESI), it suffers from a major drawback: more energy is transferred to analyte molecules
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compared to ESI, which results in fragmentation of labile moieties such as sialic acids [29].
One general way to limit energy deposition during ionisation processes is to use
atmospheric pressure ionisation sources: droplets and desolvated ions are then collisionally
cooled by the ambient gas. But atmospheric MALDI (AP-MALDI) sources have been
introduced only recently [31-33] and only limited work has been done for AP-MALDI
analysis of oligosaccharides to date [34].
4.2. Nomenclature for fragmentation of glycoconjugates
The nomenclature for fragmentation of glycoconjugates is relatively similar to that
for peptides and has been established by Domon and Costello in 1988 [35]. Fragment ions
that contain a non-reducing terminus are labelled with upper case letter from the beginning
of the alphabet (A, B, C) and those that contain the reducing end of the oligosaccharide or
the aglycon are labelled with letters from the end of the alphabet (X, Y, Z). Subscripts
indicate the cleaved ions. Additionally, A and X ions are produced by cleavage across the
glycosidic ring, and are labelled by assigning each ring bond a number from the ring
oxygen atom and counting clockwise, as shown in Figure 52.
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Figure 52. Nomenclature for glycoconjugate product ions generated by tandem MS. (please
note that for the ease of representation, the angles of the glycosidic bond were not
respected).
4.3. Challenges of oligosaccharide mass spectrometry
Whereas mass spectrometry is the most powerful technique applied to date for the
elucidation of oligosaccharide structures, it still does not allow easy determination of
oligosaccharide sequence; this is explained by the isomeric nature of monosaccharide units,
as shown in Table 8:
Compound Monoisotopic mass Average mass
Neu5Ac 308.0987 308.26247
Glc 180.06339 180.15588
Gal 180.06339 180.15588
Man 180.06339 180.15588
GlcNAc 221.08994 221.2078
GalNAc 221.08994 221.2078
Fuc 164.06847 164.15648
Xyl 150.05282 150.1299
GlcA 193.03538 193.13201
IdA 193.03538 193.13201
Table 8. Monoisotopic and average masses of monosaccharides listed in Table 6.
Mass measurement alone does not allow discrimination between Glc, Gal and Man,
or between GlcNAc and GalNAc, for example. Collision-induced-dissociation (CID)
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usually results in preferential cleavage of glycosidic bonds, leading to profusion of B and Y
ions. To a less extent, ring-cleavage product ions can also be produced, but tend to
disappear for larger ions (due to conformational cooling that can occur preferentially to ring
cleavage, which implies the cleavage of two covalent bonds); this effect can be seen as
similar to the difference in CID spectra of proteins compared to peptides. But at the same
time, product ions coming from glycosidic bond cleavage can only give sequence
information, but no structural information, as it does not allow the discrimination between
isomers (such as the different hexoses or hexosamines). Only ring-cleavage product ions
provide true structural information, such as isomer discrimination or branching
information).
5. Q-TOF analysis of O-glycopeptides and gangliosides
5.1. Material and methods
Chemicals
Analytical grade methanol was obtained from Merck (Darmstadt, Germany) and
used without further purification. Distilled and deionised water (Mili-Q water systems
Millipore, Bedford, MA, USA) was used for the preparation of the sample solutions.
Sample solutions were dried in a SpeedVac SPD 111V system from Savant (Düsseldorf,
Germany) and centrifuged in an Eppendorf 5415 C centrifuge (Hamburg, Germany).
Biological samples
Mixture of O-glycosylated amino-acids and peptides from normal human urine.
 The complex mixture of O-glycosylated amino-acids and peptides investigated in
this work was obtained and partially purified previously from urine of a healthy subject.
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The extraction, separation and purification procedure was described by us previously [17,
36]. The sample is denoted Ty. Stock solutions of the Ty mixture at 1 mg/ml were prepared
by dissolving the dried material in 100% MeOH and freezing it at -200C. Dilution of the
stock solutions in pure MeOH yielded the working aliquots at the concentration of 5.0 and
1.25 pmol/ml calculated for an average molecular weight of 2000 Da.
GT1 ganglioside fraction from normal adult cerebrum
Normal adult (45 years of age) human cerebrum, without pathological signs
according to morphoanatomical and histopathological examination was obtained from the
Department of Forensic Medicine, Faculty of Medicine, University of Zagreb, Croatia.
The brain tissue was weighed and stored at -20 °C until the extraction procedure.
The native fraction of GT1 gangliosides was extracted, isolated and purified as described in
detail elsewhere [37]. The ganglioside sample, denoted further GT1, was dried in Speed
Vac SPD 111V system (Savant, Düsseldorf, Germany). For microchip-ESI MS analysis, the
stock solution of the sample at approximately 1 mg/ml was prepared by dissolving the dried
material in methanol to be stored at–200°C. Dilution of the stock solution in 100%
methanol yielded the working aliquots at the concentration of approximately 5 pmol/ml of
ganglioside extract.
Mass spectrometry
Mass spectrometry was performed on an orthogonal hybrid quadrupole time-of-
flight mass spectrometer (QTOF™ Micromass, Manchester, U.K.) in Micromass Z-spray
geometry. QTOF mass spectrometer is interfaced to a PC computer running the MassLynx
software under Windows N.T. system to control the instrument, acquire and process MS
data. Nitrogen was used as desolvation gas and the source block temperature was kept at
800°C. The sampling cone potential and voltage applied on the microsprayer were adjusted
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to provide an optimal ionization, minimal in-source fragmentation and a high and sustained
electrospray signal.
Tandem mass spectrometry was performed by collision-induced dissociation (CID)
at low energies using Ar as a collision gas. In order to obtain a maximum coverage of
sequence ions, the collision energy was kept at 40 eV for glycopeptide sequencing and
adjusted during the ongoing experiment from 40 to 70 eV for sequencing of GT1 species.
All mass spectra were acquired in the negative ion mode. For mapping and
sequencing of glycoconjugates, the negative ion detection was shown to be advantageous in
comparison with the positive ion mode [22, 38]. In particular, the assignment of already
known or previously unknown components in biological mixtures is easier due to a lower
degree of heterogeneity caused by cation attachment to molecular and/or fragment ions [22,
37-40]. After acquisition, the spectra were calibrated using sodium iodide as a calibrant.
Microchip system
The microchip fabrication has been described previously [41, 42]. Basically, a
photoresist is patterned on a 75 μm thick, copper-coated polyimide foil through a printed
slide acting as a mask. Photoresist is then developed, and chemical etching is then used to
remove the deprotected copper where microchannels are to be patterned. Polyimide is
plasma-etched to the desired depth. The final microchannels are 120 μm wide, 45 μm deep
(nearly “half moon” cross section), with gold-coated microelectrodes placed at the bottom
of the microchannel. A 35 μm polyethylene/ polyethylene terephthalate is laminated to
close the channels. Finally, one end of each channel is manually cut in a tip shape, so that
the outlet of the microchannel is located on the edge of the chip, as described by Gobry et al
[43]. For sample dispensing, a reservoir is pasted over the inlet of the microchannel, or the
chip is sandwiched in a home-made chip holder with an integrated reservoir.
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The whole chip/reservoir assembly was mounted to the QTOF MS. In order to
realise the electrical contact to the ESI power supply, the ESI QTOF source was removed
and the chip system was directly connected to the ESI high voltage plate, which is a fixed
part of QTOF conventional Micromass ESI source. Exchange between the original source
and chip system interface did not claim for any definitive dismantling or special mechanical
modifications to either of the original assembly and no further modifications on the
TOF/MS analyzer were necessary. The position of chip emitter was adjusted in the vicinity
of the entrance hole of the sampling cone by the source assembly, which can be
manipulated in x, y and z direction via micrometer screws. The microsprayer tip was placed
at a distance less than 5 mm, although fine positioning of the microsprayer tip turned out
not to be a critical parameter.
The electrical contact was ensured by a conductive wire with one terminal
connected to the chip electrode and the other fixed on the ESI high voltage plate. The spray
could be initiated at values of 2-3 kV, in the negative ion mode, applied to the nanoESI
plate and 80-100 V applied to the sampling cone without the need of nebuliser gas. Figure
53 shows the electrospray generated from the microfabricated microsprayer.
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Figure 53. Electrospray generated from the microfabricated microsprayer in the Z-spray
source of the QTOF. The sampling cone is visible on the left, whereas the counter electrode
is positioned in front of the chip (top of the picture, not visible).
The chip microchannel was flushed with methanol between two consecutive
experiments with the same sample. For all experiments, desolvation at 800°C under drying
gas was effective, so that the chip unit could be left connected to the mass spectrometer
during the channel rinse.
For each sample a fresh chip was used thus any contamination was prevented. The
flow rate generated under the employed source and solution parameters was about 200
nl/min [43, 44].
5.2. Results and discussion
Determination of O-GalNAc-Ser/Thr expression in normal human urine
In human urine, carbohydrates are catabolic products excreted as either
oligosaccharides or glycopeptides and their concentration, amount and structure is known to
Microfluidic front-end technologies for protein electrospray mass spectrometry
151
vary under different physiological and/or pathological conditions. For this reason, screening
and identification of glycopeptide expression in human urine is of major biological
importance.
Ty mixture of O-GalNAc glycosylated amino acids and peptides extracted from
normal human urine was dissolved in pure methanol to a concentration of 5 pmol/μl. An
aliquot of 10 μ l was dispensed into a reservoir pasted over the inlet of the chip
microchannel. The negative ion mode electrospray process was initiated at 2.8 kV applied
to the ESI high voltage plate and 100 V potential of the sampling cone. Under these well-
defined conditions a constant and stable spray accompanied by a high intensity of the total
ion current was generated. In Figure 54a, the (-)chipESI/QTOF MS1 of the Ty sample at 5
pmol/μl concentration is presented.
The signal was acquired over 20 scans (40 seconds) which at the flow rate of about
200 nl/min is equivalent to a sample consumption of 0.66 pmol. The spectrum combined
over 20 scans exhibits a high signal/noise ratio and a number of 26 different saccharide
components. Fifteen species detected as singly and/or doubly charged ions are expressing
O-GalNAc-Ser/Thr core-motif extended by either sialylation or fucosylation. The mixture is
dominated by Ser- and Thr- linked disialo saccharides with chain lengths ranging from
tetra- to octasaccharide. The monosialylated glycopeptides are also well represented in the
spectrum in Figure 54a, being detected as singly charged ions at m / z 760.12,
NeuAcHexHexNAc-Ser, and 774.12, NeuAcHexHexNAc-Thr. Mono- and disialylated free
oligosaccharides are observed as singly charged ions at m/z 470.03 corresponding to
disaccharide NeuAcHex, m/z 673.12 assigned to NeuAcHexHexNAc trisaccharide and m/z
964.16 assigned to NeuAc2HexHexNAc tetrasaccharide. The tetrasaccharide is observed
also as a doubly charged ion at m/z 481.09.
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Figure 54. (-) Microchip ESI QTOF MS of the Ty mixture of O-glycosylated amino acids
and peptides from human urine. ESI voltage 2.8 kV; Sampling cone potential 100V; Signal
acquisition 20 scans. Solvent : MeOH; Average sample concentration: a) 5 pmol/μl; b) 1.25
pmol/μl.
Interestingly, two new structures, not detectable before by any MS-related methods
are visible as doubly charged ions at m/z 1069.19 and 1076.20. The species could originate
from glycopeptides with extended and further modified chains.
In order to test the limit of microchip sensitivity for glycoconjugate detection, Ty
solution was diluted in pure methanol yielding the aliquot at 1.25 pmol/μl concentration. In
Fig. 1b, the (-) microchip ESI/QTOF MS1 of the Ty sample at 1.25 pmol/μl concentration is
Microfluidic front-end technologies for protein electrospray mass spectrometry
153
presented. Setting the same source parameters, the signal was acquired over 20 scans, which
is equivalent to 0.16 pmol sample consumption for this experiment. Even under these
restrictive concentration conditions, a fair signal/noise ratio and 13 different components in
the mixture could be identified.
In Table 9 the assignment of the major species present in Ty sample and detected by
microchip ESI/QTOF MS1 is given.
m/z
(monoisotopic)
Charge
state
Putative Structure 5 pmol/μl 1.25 pmol/μl
470.05 1- NeuAcHex + +
481.11 2- NeuAc2HexHexNAc + +
525.08 2- NeuAc2HexHexNAc-Ser + +
532.08 2- NeuAc2HexHexNAc-Thr + +
543.10 2- NeuAc2HexHexNAc-Thr (Na) + +
571.62 2- NeuAc2HexHexNAc-Thr-Pro -H2O + +
580.62 2- NeuAc2HexHexNAc-Thr-Pro + +
673.12 1- NeuAcHexHexNAc + +
707.61 2- NeuAc2Hex2HexNAc2-Ser + +
714.61 2- NeuAc2Hex2HexNAc2-Thr + +
760.12 1- NeuAcHexHexNAc-Ser + +
774.12 1- NeuAcHexHexNAc-Thr + +
853.16 1- NeuAcHexHexNAc-Thr-Pro -H2O + +
871.19 1- NeuAcHexHexNAc-Thr-Pro + +
890.14 2- NeuAc2Hex3HexNAc3-Ser + +
897.17 2- NeuAc2Hex3HexNAc3-Thr + +
912.64 2- NeuAc2Hex2HexNAc4-Ser -H2O (Na) +
919.69 2- NeuAc2Hex2HexNAc4-Thr -H2O (Na) +
923.65 2- NeuAc2Hex2HexNAc4-Ser -H2O (2Na) +
930.67 2- NeuAc2Hex2HexNAc4-Thr -H2O (2Na) +
964.16 1- NeuAc2HexHexNAc +
1051.18 1- NeuAc2HexHexNAc-Ser + +
1065.19 1- NeuAc2HexHexNAc-Thr + +
1069.19 2- n.a. +
1076.20 2- n.a. +
1087.19 2- n.a. + +
1144.19 1- NeuAc2HexHexNAc-Thr-Pro -H2O +
Table 9. Compositional mapping of the purified native Ty mixture of glycopeptides from
normal human urine as detected by (-) microchip-ESI-QTOF MS. +: ions detected at the
given concentration. n.a.: not assigned.
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An interesting feature of the spectra in Figure 54 is that at 100 V cone potential, the
charge distribution is not shifted towards lower values as observed in the capillary-based
ESI QTOF MS experiments, the intensity of the signals corresponding to doubly charged
ions being the highest ones. Moreover, the advantage of the microchip ESI MS regarding
the minimization of the in-source decay is clearly illustrated in Figure 54 where the in-
source fragmentation of molecular ions is not observed at such a high value of the sampling
cone potential.
To investigate the possibility of performing rapid and accurate glycopeptide
sequencing by MS/MS using the polymer chip for sample infusion, the doubly charged ion
at m/z 532.08, assigned according to the m/z value to the already known structure of
NeuAc2HexHexNAc-Thr, was isolated and submitted to low-energy CID (-) microchip
ESI-QTOF MS/MS. Collision energy, collision gas pressure and precursor ion isolation
parameters were carefully adjusted to provide the full set of structural information upon the
molecule. The product ion spectrum of the doubly charged ion at m/z 532.08 is depicted in
Figure 55. The spectrum was obtained after 30 scans (1min) of signal acquisition, resulting
in a sample consumption of 1.23 pmols.
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Figure 55. (-) Microchip ESI QTOF MS/MS of the NeuAc2HexHexNAc-Ser doubly charged
ion at m/z 532.08. ESI voltage 2.8 kV; Sampling cone potential 100V; Solvent : MeOH;
Average sample concentration 5 pmol/μl; Collision energy 40 eV; Signal acquisition 30
scans; Sample consumption 1.23 pmols. The nomenclature for assignment of fragment ions
is according to published recommendations by Domon and Costello [35].
The product ion spectrum exhibits a high signal/noise ratio and reveals a significant
number of fragment ions fingerprint for detailed structural elucidation of the molecule. The
abundant fragment ion detected as a singly charged ion at m/z 483.07, assigned to Hex-
HexNAc-Thr, corresponds to the loss of both sialic acid moieties from the precursor ion.
The stripping of only one sialic acid moiety is indicated by the doubly charged ion at m/z
386.56 and the singly charged at m/z 774.13 along with the ions obtained by further neutral
loss of H2O at m/z 756.10 and of CO2 at m/z 730.13. The trisaccharide ion C3/B1 at m/z
673.06 is assigned to NeuAc-Hex-HexNAc. Of particular interest for the localization of
sialic acid residue are the singly charged ions at m/z 470.05, assigned to NeuAc-Hex (C2)
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and at m/z 493.07, corresponding to NeuAc-HexNAc (C3/C2). These ions indicating the
attachment of the NeuAc moiety represent valuable diagnostic elements for the sialylation
pattern of the core 1 O-GalNAc mucine molecules. In addition, the ion generated only by
the glycosidic-amino acid bond cleavage, with retention of sialic acid entities, is evidenced
by the doubly charged ion at m/z 481.60, assigned to (NeuAc2)Hex-HexNAc (C3). In the
spectrum in Figure 55, two relevant ring cleavage ions at m/z 350.04 and at m/z 306.08
corresponding to 0,4A2 and 
0,4A2-CO2 are detected. According to our previous studies [45, 46]
these cleavages are diagnostic for the NeuAc2-6 linkage.
Characterisation of GT1 ganglioside fraction from normal adult human cerebrum
Gangliosides are sialylated glycosphingolipids (GSLs) consisting of mono- to poly
sialylated oligosaccharide chains of variable length attached to the ceramide portion (see
page 134). For analysis of complex ganglioside mixtures from biological sources by MS
methods, either with ESI or MALDI, specific conditions related to ionisation process and a
reliable assessment of the heterogeneity in composition, followed by identification of the
molecule architecture, are required.
Optimization of a procedure for capillary-based (-)nanoESI-QTOF MS and tandem
MS for characterization of native ganglioside mixture from brain tissues was recently
reported [37, 47, 48]. In these studies, requirements for elevated values of ionisation
parameters and an extended time for signal acquisition implying relatively high sample
consumption for identification and structural elucidation were defined.
To test a feasibility and advantages of the microchip ESI-QTOF MS analysis
concerning information that could be provided by both MS and MS/MS, as well as to define
corresponding appropriate conditions for the GSL molecular class detection and structural
characterization, a rather structurally complex polysialylated ganglioside fraction, GT1, was
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chosen as the test sample. The analysed GT1 ganglioside fraction, showing migration
properties of GT1b species in high performance thin-layer chromatography (HPTLC), was
isolated from the total native ganglioside mixture purified from adult human cerebrum.
For (-) microchip ESI QTOF MS analysis, GT1 sample was dissolved in pure
MeOH to a concentration of 5 pmol/μ l and an aliquot of 10 μl was loaded into the
microchip reservoir. To optimise the ionic current value, the (-)ESI voltage and cone
potential were increased from zero following a ramping procedure. The maximum current
value was obtained at 3kV ESI and 100 V applied on the sampling cone. In Figure 56a the
total ion current (TIC) of GT1 acquired for 6 min is presented.
Figure 56. (-) Microchip ESI QTOF TIC of the GT1 ganglioside fraction from normal adult
human brain. Maximal ionic current at 3 kV ESI voltage and 100 V sampling cone
potential. Solvent : MeOH; Average sample concentration 5 pmol/μl; a) MS mode; b)
MS/MS mode for the triply charged ion at m/z 717.50.
The TIC profile indicates a sustained spray varying only by ESI source parameter
variation, as well as an efficient ionisation at 3kV ESI and 100 V sampling cone voltages,
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proved by the high intensity of ionic current. Starting at 1.5 minute, the signal was acquired
for 4 minutes under 3kV and 100 V, to give a constant ESI signal documented by the flat
region of TIC. By combining all TIC scans of constant current intensity, a spectrum of high
signal/noise was obtained (Figure 57) however, a fair signal/noise ratio was visible already
after 60 scans (30 seconds) of acquisition.
Figure 57. (-) Microchip ESI QTOF MS of the GT1 fraction derived by combining the TIC
MS scans at 3kV ESI voltage and 100 V sampling cone potential. a) m/z range: (650-1175);
b) zoom out of the m/z range: (1030-1125).
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A reproducible compositional mapping of molecular components in the GT1
fraction mixture was obtained from both sets of formed molecular ions, the triply and the
doubly charged related to gangliosides containing a number of lipid variants (Table 10).
The enlarged area of the spectrum (m/z range 1030-1125), containing a rich pattern of
doubly charged molecular ions all attributed to GT1 species, is presented in Figure 57b. In
particular, each specific GT1 species is characterized by exclusively one triply charged [M-
3H+]3- ion, while the corresponding doubly charged [M-2H+]2- ion is mostly accompanied by
the same charge state [M+Na+-3H+]2- and/or [M-2H+]2--H2O ions.
m/z
(monoisotopic)
Type of Detected
Molecular Ion
Putative
Structure
708.18
1062.69
1073.69
1053.70
[M-3H+]3-
[M-2H+]2-
[M+Na+-3H+]2-
[M+2H+]2--H2O
GT1 (d18:1/18:0)
712.85
1070.19
1081.18
[M-3H+]3-
[M-2H+]2-
[M+Na+-3H+]2-
GT1 (d18:1/19:0)
717.50
1076.70
1087.69
1067.69
[M-3H]3-
[M-2H]2-
[M+Na-3H]2-
[M+2H+]2--H2O
GT1 (d18:1/20:0)
1094.20 L [M+Na+-3H+]2- GT1 (d18:1/21:1)
722.18
1084.20
1095.20
[M-3H+]3-
[M-2H]2-
[M+Na+-3H+]2-
GT1 (d18:1/21:0)
726.85 [M-3H+]3- GT1 (d18:1/22:0)
1108.20L [M+Na+-3H+]2- GT1 (d18:1/23:1)
1109.21 L [M+Na+-3H+]2- GT1 (d18:1/23:0)
Table 10. Compositional mapping of the purified native GT1 ganglioside fraction
(exhibiting HPTLC migration properties of the GT1b species) separated from total
ganglioside mixture isolated from adult human brain tissue as detected by (-) microchip-
ESI-QTOF MS. d=dihydroxy sphingoid base. L low intensity ions.
The presence of three minor, trace abundant, GT1 molecular species is documented
only by very low abundant ions at m/z 1094.20, 1108.20 and 1109.21, which can be
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assigned by calculation to GT1 (d18:1/21:1), GT1 (d18:1/23:1) and GT1 (d18:1/23:0),
respectively.
As obvious from the spectrum pattern, only a low level of in-source fragmentation
occurs during the MS ionization process, according to the ions assigned to disialylated
product ions resulting from the cleavage of one sialic acid residue from the intact
trisialylated GT1 species. The NeuAc residue linked to the terminal Gal residue as a
monosialo group is known to be more susceptible even to the enzymatic cleavage, such as
that by V. cholerae neuraminidase. The loss of the NeuAc residue(s) bound to the inner Gal
would produce a high extent of the disialo ions along with NeuAc-Gg4Cer (GM1-like)
fragment ions, which are not detectable in the spectrum. A significantly low extent of in-
source induced fragmentation using the chip-based ESI vs. conventional capillary-based ion
source was already observed and documented [49], representing one of the major
advantages of the chip usage in MS analysis.
It is well-known that in the case of ganglioside fragmentation by CID MS/MS, a
long signal acquisition time under variable collision energy is necessary to obtain sufficient
abundance of fragment ions diagnostic for the structure elucidation. This approach though
successfully applied by using capillary-based ESI [37, 47, 48] often encounters difficulties
associated to the spray instability and/or signal interruptions. In case of microchip ESI-
MS/MS the triply charged ion detected at m/z 717.50 could be successfully fragmented. The
TIC profile of the sequencing events given in Figure 56b documents the stability of the
MS/MS signal for each of the collision energy values used for this experiment and the
corresponding dependence of the ionic current on this parameter. The MS/MS product ion
spectrum of the triply charged precursor ion at m/z 717.63, corresponding to the GT1
(d18:1/20:0) species is depicted in Figure 58.
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Figure 58. (-) Microchip ESI QTOF MS/MS of the triply charged ion at m/z 717.50
corresponding to GT1 (d18:1/20:0). ESI voltage 3kV. Sampling cone potential 100 V. The
spectrum is derived by combining the scans corresponding to 40 and 70 eV in the TIC
MS/MS from Figure 56b. The nomenclature for assignment of fragment ions is according to
published recommendations [35].
The spectrum was acquired under variable energy (VE-CID) [50] by combining
scans at collision energy values of 40 and 70 eV. The fragmentation process gave rise to
product ions for reliable assignment of the entire carbohydrate sequence of the GT1b isomer
species, as well as to characterize the type of its ceramide portion. However, certain ions
indicative for positional isomers, particularly those of GT1a, the GT1c and/or even the
GT1a, in the mixture with GT1b, are present as minor components. The ion assignment in
the shown spectrum defines the GT1b product ions as represented in the accompanied
fragmentation scheme (Figure 59).
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Figure 59. Structure and the corresponding fragmentation scheme of the GT1b species. The
product ions detected from the spectrum depicted in Figure 58 are assigned.
The triply charged, still high abundant precursor ion is clearly detectable in the
spectrum. As a general characteristic, a predominance of the singly over the doubly and
triply charged fragment ions can be pointed out. Also, no sodiated counterparts are
observed. The complete sequence of the GT1b is deducible from the ions arising from the
non-reducing end of the molecule where dominating Y type ions are accompanied by Z and
ring cleavage X type ions appearing at lower abundance, as deduced  from the
corresponding fragmentation scheme (Figure 59). The d18:1/18:0 type of ceramide is
represented by both Y0 ion and a minor Z0 at m/z 592.50 and 574.55, respectively. The Glc-
Cer sequence is also shown by Y0 and Z0 counterparts at m/z 754.49 and 736.55,
respectively. The Y2/B2 ion at m/z 916.55 gives rise to the Gal-Glc-Cer sequence which
might originate from either GT1a or GT1b isomer after the respective desialylation of either
NeuAc or NeuAc2 residue from the inner Gal residue, or might hypothetically originate
from an isomer containing the non-substituted inner Gal (potential GT1d isomer). The 2,4X2
ion resulting from the ring cleavage at the GalNAc residue corresponds to the inner Gal
disialylated structure, GalNAc-(NeuAc2)Gal-Glc-Cer, consistent with the GT1b isomer. The
disialylation at the inner Gal residue is finally confirmed by the doubly charged Y2 ion at
m/z 748.80, detected at lower abundance. The highly abundant doubly charged signal at m/z
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931.39 correspondingly to GT1b isomer, can be attributed to both Y4 and Y3 ions giving
rise to the presence of disialylated Gg4Cer sequence; that ion, however, do not indicate the
attachment sites of sialic acid residues at the neutral Gg4 core. Except for the Y2 and the
2,4X2 specific for the GT1b isomer, all ions could also arise also from other isomers, such as
GT1, GT1a, GT1c or even, yet not reliably proven to exist, GT1d isomer. The GT1
corresponding sequence was finally corroborated by the triply charged signal at m/z 643.64
consistent with 0,2 type ring cleavage at one of the terminal sialic acid residues which, in
the case of GT1b species, can be formed from both 0,2X4 - 2H
+ and 0,2X3 - 2H
+ ion.
Further support and deeper insight into the detailed structural composition of the
chosen molecular ion is provided by a set of ions formed from the reducing end. In
particular, informative C and B type ions are present and observed to be similarly favoured
under the defined conditions. Structurally significant and/or considerably abundant A type
ring cleavage ions were not found. The B type ion with the highest intensity at m/z 290.08,
attributable to the both B1 and B1 linkage cleavages, and the accompanied C type
counterpart ion, specifying the both C1 and C1 cleavages, characterise the cleaved
monosialo residue. The presence of the disialo group is evidenced by the abundant B2 ion
at m/z 581.13. The C2 ion (m/z 470.12) representing the NeuAc-Gal sequence confirms the
attachment of the monosialo group to the terminal Gal residue, which is consistent with the
GT1b but also the GT1a structural motif. The signal might potentially include the ions
formed from the sialylated inner Gal residue by multiple internal cleavages. The counterpart
signals at m/z 673.15 and 655.21, arising from GT1b as C3 and B3 ions, respectively,
represent both NeuAc-Gal-GalNAc and Gal-GalNAc-NeuAc sequences, and could
therefore arise from any of GT1 isoform. The signal at m/z 364.09 corresponding to the Gal-
GalNAc sequence, assigned to the GT1b internal cleavage B3/B1 ion, is however more
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characteristic for the GT1c isomer (the B2 ion) bearing the non-substituted terminal Gal-
GalNAc residue. The GT1c isoform is further supported by the structure-specific ion at m/z
966.39 assigned to 2,4X2 ring cleavage ion containing the three sialo structural motif.
Finally, the prominent ion at m/z 493.10 attributed to the B type NeuAc-GalNAc- ion can
arise exclusively from the GT1 isoforms (potentially GT1a and/or GT1b), characterised
by the sialylation of the GalNAc residue. This ion strongly supports the hypothesised
presence of at least one GT1 isoform in the purified GT1 mixture from human brain,
containing the GT1b isomer as the major component.
6. FT-ICR analysis of O-glycopeptides
6.1. Material and methods
Chemicals
Analytical-grade methanol was purchased from AppliChem (Darmstadt, Germany)
and used without further purification. Aqueous sample solutions were dried in a SpeedVac
SPD 111V system from Savant (Düsseldorf, Germany). Prior to chip MS analysis the
sample/methanol (MeOH) solutions were centrifuged for one hour in an Eppendorf 5415 C
centrifuge (Eppendorf, Hamburg, Germany).
Biological samples
The first sample investigated in this work is a fraction of O-glycopeptides extracted
from urine of healthy individual. The sample is further denoted Ty2. The second sample is a
fraction of O-glycopeptides, obtained from urine of the child G.P. suffering from Schindler
disease type I, the form of the disease with infantile onset [17, 36]. This mixture is further
denoted Gy2. The patient and healthy control subject were age-matched and the samples
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were prepared identically. The preparation procedure is in detail described elsewhere [51,
52]. Briefly, for isolation of components, the urine has been filtered, submitted to gel
filtration chromatography on Biogel P2, fractionated and desalted by gel filtration
chromatography performed on Fractogel TSK HW 50 in 0.01 M pyridinium acetate pH 5.4
as eluting buffer.
Stock sample/methanol (MeOH) solutions of 1μg/μl have been prepared and stored
at -70°C. The working aliquots of 20, 12, 7 and 6 pmol/μl (calculated for 2500 Da average
molecular mass) were prepared by drying the stock solution and further dissolved in
methanol to the appropriate concentration.
Microchip system
Microchips used in this section are exactly the same as those described above (see
the paragraph “Microchip system” on page 148). For sample loading, the chip was
sandwiched in a home-made chip holder with an integrated reservoir (Figure 60). The chip
was positioned into the holder with the microchannel in contact with the reservoir and the
front part extruding a few mm. The chip was grounded via a conductive wire connected to
the terminal electrode.
Figure 60. Schematic of the polymer chip holder with integrated reservoir. 1. Polymer chip;
2. Sandwich chip holder; 3. Sample reservoir; 4. Conductive wire.
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 Between sample analysis, the chip has been flushed with 100 μl methanol to
prevent any cross-contamination or carry-over processes. A subsequent (-)chipESI/FT-ICR
MS analysis of fresh methanol solution, after flushing the chip, indicated no cross-
contamination and/or carry-over processes. Moreover, no retention of the sample species on
the inner channel walls was observed. The integrated reservoir of the sandwiched polymer
chip turned out to prevent the fast evaporation of the sample solution during the MS
experiments and allowed recovering of the unused sample/solution.
Mass spectrometry
Measurements were performed on a Bruker Apex II Fourier Transform Ion
Cyclotron Resonance mass spectrometer (FT-ICR MS) (Bruker Daltonik, Bremen,
Germany) equipped with a 9.4 T superconducting actively shielded magnet (Magnex
Scientific Ltd., Oxford, UK) and a Bruker Apex II Apollo ESI ion source. The chip was
coupled to the Bruker Apex II ion source by an in-laboratory constructed mounting system.
The interface consists of a metal plate mounted to the Apollo ion source by two 90°
brackets. The plate and the 90° brackets featured two slots for the screws, thus providing x-
and z-axis movement and some y-axis variability. The chip holder was attached to the metal
plate and carefully positioned toward the entrance orifice of the Apex II capillary. Mounting
of the chip interface system did not claim for any definitive dismantling or irreversible
mechanical modifications to either of the original Appolo source components. Moreover,
the exchange between the original source and chip interface is quick and simple.
 The Apex II metal-coated glass capillary was kept in the range of 1500 – 2500 V
while the chip was grounded. The capillary exit voltage was set to –79 V to reduce the in-
source ion decomposition to a minimum. The generated ions were accumulated for 0.05 to
0.3 s in the hexapole located after the second skimmer of the ion source and then transferred
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into the ion cyclotron resonance cell. The ions were trapped by standard trapping
procedures.
All mass spectra were externally calibrated and acquired in the broad band mode
with 1 Mpoints/scan. The calculation of the theoretical masses displayed in Table 11 and
Table 12 was carried out by using the values for atomic weights taken from De Laeter et al.
[53] and including the electron mass (cf. Mamer et al. [54]).
6.2. Results and discussion
The polymer chip was assembled into the sandwich chip holder and fixed onto the
in-laboratory constructed mounting system. The mounting system was conceived and
designed to provide a robust and viable interfacing of the polymer chip to the FT-ICR MS.
The positioning/alignment of the polymer chip on the x-, y- and z- axis turned out to be a
crucial step in the initiation and long-term maintaining of the electrospray, in particular with
respect to the direct-spray configuration of the Bruker Apex II instrument.
Ty2 mixture of O-GalNAc glycosylated sialylated peptides was dissolved to a
concentration of approximately 7 pmol/μl in methanol and 20 μ l of sample/methanol
solution were loaded into the incorporated reservoir. The negative ion mode electrospray
process could be initiated at 1500 V applied to the Apex II capillary and –79 V potential of
the capillary exit. Under these well-defined conditions a constant and stable spray
accompanied by a high ionic intensity was generated. The signal was acquired over 155
scans at a flow rate of about 200 nl/min. The resulted spectrum is depicted in Figure 61.
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Figure 61. (-)ChipESI/FT-ICR MS of the Ty2 mixture of O-glycosylated peptides from urine
of healthy individual. Sample concentration: 7 pmol/μl in methanol. Number of scans: 155.
 The spectrum shows a high heterogeneity of the mixture regarding the number of
species and structural variety, represented in the spectrum by a large number of singly and
doubly charged ions of high signal-to-noise ratio. The most abundant species assigned in
Ty2 mixture are disialylated saccharides linked to Ser and Thr. The Ser- linked saccharides
are documented by the singly charged ion at m/z 1051.349 and its corresponding doubly
charged ion at m/z 525.173 assigned to Neu5Ac2HexHexNAc-Ser. The doubly charged ion
at m/z 707.738 is assigned to Neu5Ac2Hex2HexNAc2-Ser and the doubly charged ion at
m/z 890.302 to Neu5Ac2Hex3HexNAc3-Ser, while the Ser- linked monosialylated
trisaccharide is visible as a singly charged ion at m/z 760.258. Their homologous Thr-
linked structures are detected at m/z values shifted by the corresponding difference between
Ser and Thr, according to their respective charge states. Two free oligosaccharides are
evidenced as singly charged ions at m/z 673.227 corresponding to Neu5AcHexHexNAc and
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at m/z 964.319 attributed to Neu5Ac2HexHexNAc, respectively. An interesting aspect
arising from the spectrum in Figure 61 is the presence of a number of dehydrated sialylated
glycopeptides, which could originate either from an in-source neutral loss of water or as
already metabolically generated components present in the mixture. For instance, the
dehydrated Neu5Ac2Hex2HexNAc2-Ser is detected as a doubly charged ion at m/z
698.733, Neu5Ac2HexHexNAc-Thr as a singly charged ion at m/z  1047.355,
Neu5Ac2HexHexNAc-Thr-Pro as a singly charged ion at m / z 1144.416 and
Neu5AcHexHexNAc-Thr-Pro as a singly charged ion at m/z 853.315. It should be pointed
out, that the abundance of the disialylated saccharides is higher than that of the
monosialylated species. This aspect demonstrates the feasibility of the optimized (-)
chipESI/FT-ICR MS approach to exhibit only a very low degree of in-source decay related
to the labile sialic acid moiety, therefore to consequently fulfil expectations defined as
essential for detection of intact sialylated glycoconjugates. All ions detected and assigned in
the Ty2 mixture under the assumption of a mass accuracy below 10 ppm are listed in Table
11.
m/z
Exp. Theor.
Charge
state
Proposed structure
525.173 527.175 2 Neu5Ac2HexHexNAc-Ser
532.181 532.183 2 Neu5Ac2HexHexNAc-Thr
673.227 673.230 1 Neu5AcHexHexNAc
698.733 698.736 2 Neu5Ac2Hex2HexNAc2-Ser-H2O
707.738 707.741 2 Neu5Ac2Hex2HexNAc2-Ser
714.744 714.749 2 Neu5Ac2Hex2HexNAc2-Thr
760.258 760.262 1 Neu5AcHexHexNAc-Ser
774.278 774.278 1 Neu5AcHexHexNAc-Thr
853.315 853.320 1 Neu5AcHexHexNAc-Thr-Pro-H2O
871.325 871.331 1 Neu5AcHexHexNAc-Thr-Pro
890.302 890.307 2 Neu5Ac2Hex3HexNAc3-Ser
964.319 964.326 1 Neu5Ac2HexHexNAc
1047.355 1047.363 1 Neu5Ac2HexHexNAc-Thr-H2O
1051.349 1051.358 1 Neu5Ac2HexHexNAc-Ser
1065.365 1065.374 1 Neu5Ac2HexHexNAc-Thr
1087.348 1087.356 1 Neu5Ac2HexHexNAc-Thr (Na)
1139.401 1139.410 1 Neu5AcHex2HexNAc2-Thr
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1144.405 1144.416 1 Neu5Ac2HexHexNAc-Thr-Pro-H2O
1162.415 1162.426 1 Neu5Ac2HexHexNAc-Thr-Pro
1416.475 1416.490 1 Neu5Ac2Hex2HexNAc2-Ser
Table 11. Assignment of the ions detecterd in the Ty2 mixture by microchip ESI-FT-ICR-MS
in the negative ion mode.
The advantage of the (-) chipESI/FT-ICR MS approach to combine an efficient
ionization and ultrahigh resolution and mass accuracy of detection is clearly highlighted
here by the high number, 20, of ionic species (Table 11) unambiguously assigned within an
average mass accuracy of 5.89 ppm.
An extensive study regarding the sensitivity and concurrently an efficient production
of structural data has been carried out by (-)chipESI/FT-ICR MS on the Gy2 mixture of
glycopeptides.  For comparative studies exploring the limits of sensitivity exhibited by the
novel (-)chipESI/FT-ICR MS method, at which the level of mixture complexity can still be
reliably assessed, the Gy2 mixture has been screened at different sample solution
concentrations. Thus, the (-)chipESI/FT-ICR MS experiments carried out on the Gy2
mixture at approximately 20 pmol/μl in methanol gave raise to the spectrum in Figure 62.
By applying the same optimised conditions for ionisation/detection by (-)chip/ESI-FT-ICR
MS a highly stable and constant spray as well as a high signal-to-noise ratio was obtained
after 50 scans signal recording (Figure 62). A number of 27 ionic species could be
unambiguously identified and assigned within an average mass accuracy of 5.41 ppm.
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Figure 62. (-)chipESI-FT-ICR-MS of the Gy2 mixture of O-glycosylated peptides from urine
of a patient diagnosed with Schindler disease. Sample concentration: 20 pmol/μl in
methanol. Number of scans: 50.
In comparison with the spectrum of the Ty2 mixture, a higher content of
pentasaccharides is present as evidenced by the doubly charged ion at m/z 562.193 and
accordingly by a singly charged ion at m/z  1125.386 corresponding to
Neu5AcHex2HexNAc2-Ser. The doubly charged ion at m/z 569.199, along with the singly
charged one at m / z 1139.401 are assigned to a homologue structure of
Neu5AcHex2HexNAc2-Thr. Additionally, the hexasaccharides linked to Ser and Thr
bearing two sialic acid moieties are visible here in a higher abundance than in Ty2, as
doubly charged ions at m/z 707.738 and 714.746 and as singly charged ions at m/z 1416.479
and 1430.493, respectively. A nonasaccharide bearing three sialic acid moieties is detected
at a fair abundance as a doubly charged ion at m/z 1058.354 and assigned to a sodiated
dehydrated Neu5Ac3Hex2HexNAc4-Ser with a mass accuracy of 4.6 ppm. The ions
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identified in the Gy2 mixture and assigned with a mass accuracy below 10 ppm are listed in
Table 12.
m/z
Exp. Theor.
Charge
state
Proposed structure
525.173 527.175 2 Neu5Ac2HexHexNAc-Ser
532.181 532.183 2 Neu5Ac2HexHexNAc-Thr
562.192 562.193 2 Neu5AcHex2HexNAc2-Ser
569.199 569.201 2 Neu5AcHex2HexNAc2-Thr
571.702 571.704 2 Neu5Ac2HexHexNAc-Thr-Pro-H2O
673.228 673.230 1 Neu5AcHexHexNAc
698.733 698.736 2 Neu5Ac2Hex2HexNAc2-Ser-H2O
707.738 707.741 2 Neu5Ac2Hex2HexNAc2-Ser
714.746 714.749 2 Neu5Ac2Hex2HexNAc2-Thr
760.258 760.262 1 Neu5AcHexHexNAc-Ser
774.273 774.278 1 Neu5AcHexHexNAc-Thr
853.315 853.320 1 Neu5AcHexHexNAc-Thr-Pro-H2O
871.325 871.331 1 Neu5AcHexHexNAc-Thr-Pro
890.302 890.307 2 Neu5Ac2Hex3HexNAc3-Ser
897.309 897.315 2 Neu5Ac2Hex3HexNAc3-Thr
964.320 964.326 1 Neu5Ac2HexHexNAc
1033.339 1033.347 1 Neu5Ac2HexHexNAc-Ser-H2O
1047.358 1047.363 1 Neu5Ac2HexHexNAc-Thr-H2O
1051.351 1051.358 1 Neu5Ac2HexHexNAc-Ser
1058.351 1058.354 2 Neu5Ac3Hex2HexNAc4-Ser-H2O (Na)
1065.364 1065.374 1 Neu5Ac2HexHexNAc-Thr
1125.386 1125.395 1 Neu5AcHex2HexNAc2-Ser
1139.401 1139.410 1 Neu5AcHex2HexNAc2-Thr
1144.407 1144.416 1 Neu5Ac2HexHexNAc-Thr-Pro-H2O
1162.417 1162.426 1 Neu5Ac2HexHexNAc-Thr-Pro
1416.479 1416.490 1 Neu5Ac2Hex2HexNAc2-Ser
1430.493 1430.506 1 Neu5Ac2Hex2HexNAc2-Thr
Table 12. Assignment of the ions detected in the Gy2 mixture by microchip ESI-FT-ICR-MS
in the negative ion mode.
Even though, under the optimised conditions for glycopeptide ion formation and
detection, a fair coverage of ionic species assignment could be achieved. A large number of
structures represented in the spectrum by doubly and singly charged ions at lower
abundance could be assigned only at a mass accuracy above 10 ppm. This aspect can be
rationalised by two main factors: a) space charge effects, which can occur for high
number/type of ions present in narrow m/z ranges [55-57] and b) overlapping of formally
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isobaric structures which can be frequently encountered when dealing with highly complex
carbohydrate mixture originating from biological sources [39].
Further, the Gy2 mixture was stepwise diluted in methanol down to a concentration
of 3 pmol/μl and subjected to (-)chipESI/FT-ICR MS investigation. The (-)chipESI/FT-ICR
MS of the Gy2 mixture at 12 and 6 pmol/μl are depicted in Figure 63.
Figure 63. (-)ChipESI FT-ICR-MS of the Gy2 mixture of O-glycosylated peptides from
urine of a patient diagnosed with Schindler disease. (a) sample concentration: 12 pmol/μl.
Number of scans: 50. (b) sample concentration: 6 pmol/μl. Number of scans: 100.
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Under these sample dilution conditions a good coverage of glycopeptide ion species
at a fair signal-to-noise ratio to render structural data could still be obtained. No significant
difference with respect to ionic species detection is observed between the spectra in Figure
63a) and b), thereby demonstrating the potential of the novel (-)chipESI/FT-ICR MS to
exhibit high sensitivity along with high mass accuracy and resolution of detection.
Moreover, the long-lasting and constant spray generated from the polymer chip enabled the
MS signal acquisition for an extended time period, resulting in a high signal-to-noise ratio.
This aspect is more clearly illustrated by the spectrum in Figure 63b) where 100 scans were
acquired using a sample concentration of 6 pmol/μl and a flow rate of approximately 200
nl/min. A significant peculiarity of the polymer microchip coupled to FT-ICR MS is the
capability to exhibit a spray of high stability over a long time frame of signal acquisition
using biological samples. In the case of capillary based nanospray analysis of similarly
prepared glycopeptide fractions [18] using in-house pulled glass capillaries, besides the
poor reproducibility of the sprayer shape, often blockages of the tip inducing signal
interruption were noticed. A visual inspection showed clogging of the tip by salt deposition.
The polymer chip turned out to be more tolerant to salt deposition and insoluble impurities
inevitably present in biological samples after laborious preparation stages. During the entire
analysis time, the microchip did not get blocked by any salt crystals or impurities. This can
be most probably attributed to the microsprayer dimensions and higher flow rate exhibited
by the polymer chip.
7. Conclusion
The primary goal of this study was to assess the potential of microfabricated
polymer microsprayers for the analysis of carbohydrates. The requirements were: a spray
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stable enough to acquire signals over tens of spectra and perform tandem mass
spectrometry, a sensitivity comparable to other spraying techniques, and limited in-source
fragmentation of labile moieties such as sialic acids. First, the coupling of the polymer
microsprayers was readily obtained on the Z-spray source of the QoTOF-MS (Micromass,
Manchester, UK), and good spray stability was obtained under gravity flow, as shown in
Figure 56. The coupling of the microfabricated microsprayer was more difficult with the
Appolo source of the FT-ICR-MS (Bruker Daltonics, Bremen, Germany); this is probably
due to the direct in-line configuration of the source. In particular, the positioning of the
microchip with respect to the heated capillary inlet appeared to be critical. However, the
LCQ Duo (Thermo Electron, San Jose, CA, USA) used in our laboratory employs the same
kind of configuration without the same difficulties. Nevertheless, once the electrospray was
started, it could be maintained as long as solution was provided to the microchip reservoir.
The concentrations used in this study and in others from the group of Jasna Peter-
Katalinic on comparable samples are reported below in Table 13:
Electrospray
technique
Sample Concentration
(pmol/μl)
Instrument Reference
Polymer
microchip
Ty (glycopeptides
from healthy
urine)
1.5-5 QTOF [58]
Polymer
microchip
Ty2
(glycopeptides
from healthy
urine)
7 FT-ICR [59]
Polymer
microchip
Gy2
(glycopeptides
from urine of a
Schindler patient)
6-20 FT-ICR [59]
Advion ESI-Chip Q5 fraction of
urine from
Schindler patient
1-7 FT-ICR [60]
Advion ESI-Chip Ty (glycopeptides
from healthy
urine)
5 FT-ICR [60]
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Glass nanospray BPY1
(glycopeptides of
urine from
Schindler patient)
5 FT-ICR [18]
Advion ESI-Chip BQ5
(glycopeptides of
urine from
Schindler patient)
5 QTOF [46]
Polymer
microchip
GT1 (gangliosides
from brain)
5 QTOF [58]
Advion ESI-Chip Gangliosides from
human brain
2-15 QTOF [49]
Glass nanospray gangliosides 0.6-20 QTOF [61]
Table 13. Concentrations used in this study and others from the group of Pr Peter-
Katalinic.
As shown above, the concentrations of glycopeptides and gangliosides analysed
from the microfabricated microsprayers are fully comparable to those from Advion ESI-
Chips (i.d. of 9 μm) and pulled glass nanospray capillaries, which are known as the most
sensitive electrospray techniques to date [29, 30, 62]. Unfortunately no side-by-side
comparison (same sample, same instrument) could be done, but these results are in
agreement with the results reported in Chapter 3 and in [63]. This result is in contradiction
with the current know-how in electrospray: the microfabricated microsprayer has large
dimensions (120 μm wide, 45 μm deep in a half-moon shape), which is supposed to lead to
a worst sensitivity. Moreover, as shown in Figure 53, the electrospray generated from the
microchip consists in a large cone generated relatively far from mass spectrometer inlet
(typically 5-10 mm), whereas pulled capillary nanosprays are used with distances of 1-5
mm); consequently, the sampling of the electrospray jet is believed to be much better in the
case of close spraying with nanosprays than with far-spraying microsprays [29]. No clear
explanation could be provided so far for these comparable sensitivities obtained with
microchips and nanosprays. One possible hypothesis is that the shape of the microchannel
outlet or nozzle influence the size of droplet formed: in two independent studies [64, 65], a
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triangular nozzle (possibly with concave walls) has been found to be an optimal nozzle
cross section in terms of minimisation of droplet size; whereas these two studies were
performed for hydrodynamic spraying, it is probable that the same effect applies for
electrospray. The whole rationale is that particular shapes maximise the pressure applied on
the droplet emitting zone by the flow rate at constant typical dimension (triangle edge
versus circle diameter).
Moreover, it is usually admitted that ionisation is more gentle when nanosprays are
used together with low ionisation potential, which is crucial for the analysis of fragile
molecules such as oligosaccharides or intact protein complexes [30, 66]. Here, the use of
microfabricated microsprayers with relatively high ionisation potential was found to result
in qualitatively less in-source fragmentation of glycans (usually identified from the
presence of high intensity sialic acid ions in the spectra) (Alina Zamfir, personal
communication). Though somehow contrary to the commonly admitted know-how in
electrospray ionisation, this feature has been also identified independently by the group of
Alain Van Dorsselaer in the study of intact protein complexes (roundtable “Non-covalent
complexes”, 21ème Journées Françaises de Spectrométrie de Masse, Strasbourg, September
14-17, 2004): nanospray cannot be used in routine for the analysis of protein non-covalent
complexes because it often leads to disruption of the complex, whereas microspray tends to
better preserve the complex. No clear rationale has been provided so far; the only
hypothesis that can be put forward is that microsprays are usually used with further Taylor
cone/ mass spectrometer inlet distances that nanosprays; it is thus possible that when
microsprays are used, ions experience significant collisional cooling with ambient gas
before entering the low pressure compartment of the mass spectrometer. This hypothesis
still has to be tested by measuring ions internal energies [67] by the ion survivor method
[68] and comparing them between micro- and nanosprays.
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Basically, the methodology systematised by Vekey for ions internal energy
measurement is the following (which is an oversimplified description of the process; for
more detailed information, the reader is referred to [67, 68]): well characterised molecules
are electrosprayed; under optimised conditions, they will not fragment along the ion optics
and mass analyser, and their mass spectrum will consist only in their characteristic intact
peaks. Now if one acquisition parameter along the ion optics (e.g. the tube lens offset that
accelerates or slows down ions before they enter the skimmer-octopole region on the
Thermo Electron LCQ Duo) is tuned so that fragmentation occurs, the extent of
fragmentation can be measured from the mass spectra to build a breakdown curve, such as
the one below:
Figure 64. Typical breakdown curve, showing the disappearance of the parent ion and the
appearance of two fragments as the tube lens offset increases.
In parallel, molecular kinetic calculation (such as RRKM theory) allows to calculate
at which energy different bounds in the parent ion fragment, giving rise to fragments 1 and
2. In a third stage, the mass spectrometric experiment (here the tuning of the tube lens
offset) is modelled in order to calculate how much energy is brought to the gas phase ions
during the experiment. The difference between the energy brought (in the case here) by tube
lens acceleration at breakdown values and the energy necessary to produce the breakdown
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of the parent ion and appearance of the fragments is the internal energy that was carried by
gas phase ions before experiencing tube lens acceleration. Drahos and Vekey have
developed a software called MassKinetics to calculate fragmentation energies of ions, and
how much energy is brought to gas phase ions by a given mass spectrometric experiment
[68]. This methodology has been applied by e.g. Gabelica et al to study the influence of
various instrumental parameters on electrosprayed ions energy [69]:
Figure 65. Effect of source temperature and cone voltage on internal energy distributions
(left), and of source pressure on internal energy distributions (right). Reprinted with
permission from [69].
By following the same approach, it may be possible to compare internal energies of
ions generated from a microfabricated microsprayer with those generated by pulled
capillary nanospray. A lower internal energy with microfabricated microsprayers would
prove that ionisation is softer with microfabricated microsprayers, and would be in line with
the observation that oligosacchararides are less fragmented with the microchip compared to
comparable techniques.
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Chapter 5. On-chip solid-phase extraction
1. Effects of salts on electrospray ionisation
It has been known since the earliest days of electrospray ionisation that the presence
of salts is detrimental in terms of sensitivity and mass resolving power. Tang and Kebarle
were among the first to study this issue [1]; they established an empirical law which shows
that the electrospray current depends on electrolyte concentration in the bulk solution as:
IES = A m0 E[ ]( )n (1)
where m0 is the limiting molar conductivity, [E] the cation concentration and n a
constant close to 0.22 (independent on the electrolyte nature). Furthermore, they observed
that the analyte A+ intensity in the mass spectrum varies with the electrolyte concentration
as:
I(A+ ) = Pf
kA A
+ 
kA A
+  + kE E+ 
IES (2)
where P is a sample factor related to the instrument used, f is the fraction of ions
converted into the gas phase, [A+] and [E+] are analyte and cation supporting electrolyte
concentrations, kA and kE are rate constants expressing the rate of transfer of analyte and
electrolyte ions to the gas phase. Unfortunately, equation (2) did not fit measured analyte
intensities over a wide concentration range: a good fit was obtained in the low concentration
range of [A+] (<10-5 M) with the assumption that kA/kE=1, but deviated from experimental
results above 10-5 M.
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In further studies [2, 3], Tang and Kebarle showed that at low concentration kA/kE
relates directly to relative surface activities of A+ and E+, whereas at high analyte
concentrations, kA/kE expresses the relative surface activities and relative ion evaporation
rates, provided that the ion evaporation model of Iribarne holds true [4]. However, they
were unable to introduce a unified model that accounts for both concentration regions.
1.1. The partition model
More recently, Enke introduced a model for matrix and analyte effects in
electrospray ionisation, based on the hypothesis that ion intensities in a mass spectrum
directly relates to ion abundances on electrosprayed droplets surfaces [5]. Basically, an
electrospray droplet is formed with an excess charge Q that is the net difference between
anions and cations. In positive ion mode (Q>0), cations partition between the bulk droplet,
in which they ion-pair with anions, and the surface of the droplet. One clear limitation of
Enke’s approach is that this partition is postulated a priori, and is only validated by
consistency with experimental results (see below). It is thus important to investigate how
ions distribute in charge droplets.
Gouy-Chapman in electrospray droplets
Following the approach of Myland and Oldham [6], let consider an electrospray
droplet containing cations of charge number z+ and anions of charge number z-, bearing a
total charge Q and having a radius R. The electric field inside a droplet at distance r from its
centre (taken as a potential origin) is given by Gauss’s law:
 d
dr




	 r( ) =
Q r( )
4r2 for 0  r  R (3)
where  is the local electrical potential within the droplet, Q(r) is the charge within a
sphere of radius r, and  is the solution’s permittivity. Let n+(r) and n-(r) be the cation and
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anion  number densities respectively (in m-3), z+ and z- be the cation and anion number of
charge, and q(r) the volumetric charge density (in C.m-3). Then comes:
e z+n+ r( ) + zn r( )  = q r( ) (4)
where e is the elementary charge (1.6 10-19C). According to Boltzmann’s statistics,
n+ r( ) = n0
+ exp z+ e
kBT
 r( )


n r( ) = n0
 exp z e
kBT
 r( )


(5)
where n0
+ and n0
- are cation and anion number densities at r = 0, and Qe/kBT the
Boltzmann factor (38.9215 V-1 at 298K). Contrary to the classical Gouy-Chapman
derivation, where the potential origin is fixed in the bulk neutral solution, far from the
charged planar surface, in order to preserve the generality of the derivation for very small
droplets whose radius is not large compared to the Debye length, it is not postulated here
that  the global charge density is zero at the centre of the droplet. Poisson’s equation in
spherical coordinate writes:
1
r2
d
dr
r2
d
dr



	 =
q r( )
 (6)
Incorporating equation (5) into (6) gives:
d
dr
r2
d
dr




 =
er2
 z
+n0
+ exp z+ e
kBT
 r( )


 + z
n0
 exp z e
kBT
 r( )




	


(7)
This is the Poisson-Boltzmann equation to be solved with the following boundary
conditions:
d
dr




	
r=R
=
Q
4R2 (Gauss’s law at r = R) (8)
d
dr




r=0
= 0
(no potential discontinuity at the centre
of the droplet)
(9)
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Myland and Oldham solved equation (7) numerically, by a finite difference model
[6] for a droplet at the limit of Rayleigh fission, meaning that its radius R and global charge
Q are related by:
Q = 8 0 R3 (10)
Where  is the surface tension of the liquid used. What they found is the cation and
anion distributions within the droplet, as shown in Figure 66:
Figure 66. For a droplet of radius 0.1 μm, the curves show concentration profiles
normalised by the feed concentration of the 1:1 electrolyte solution. The full, dashed and
dotted lines relate to concentrations of 0.02482, 0.06572 and 0.21036 eq.m-3. In all cases,
the upper curve represents the cation and the lower curve the anion. Reprinted from [6]
with permission.
As clearly visible in Figure 66, most cations are close to the droplet surface; it can
be estimated from the graph and other results presented in [6] that 75% of cations are
contained in the 10% outer shell, whereas 95% of anions are contained in the 90% inner
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shell. This outer cation amount is even bigger when (i) the electrolyte concentration
increases and (ii) when the droplet size increases.
Enke’s simple partition model
The calculation of electrolyte distributions shown above now gives a basis for the
two-compartment model adopted by Enke [5], in which cations partition between a bulk
phase in the core of the electrospray droplet where they are neutralised by anions, and a
surface layer, as shown below:
Figure 67. Scheme of the two-compartment model used in the partition model
This model is a macroscopic model (that do not describe physical reality)
comparable to the ones often used in biosensor data analysis, where diffusion processes
toward the surface of the biosensor are fitted by a two-compartment model, such as in [7,
8]. In the case studied here, cations can be analyte ions A+ or supporting electrolyte E+,
whereas anions are counterions X-. At this point, the thickness of the outer shell need not be
defined. Partition of analyte and electrolyte ions between the two compartments can thus be
described by:
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A+X ( )
i
 A+( )
S
+ X ( )
i
KA =
A+ s X  i
A+X  i
(11)
 
E+X ( )
i
 E+( )
S
+ X ( )
i
KE =
E+ s X  i
E+X  i
(12)
Where s subscripts denote surface compartment and i subscripts the interior
compartment of the droplet. The excess charge Q born by the droplet is then :
Q[ ] = A+ s + E+ s (13)
Given that [Q]=IES/F (14) where F is the Faraday constant and  the flow rate, in
typical electrospray conditions with IES = 100 nA and  = 6 μl/min, the excess charge is
approximately 10-5 M. If we assume that the total fraction of analyte and electrolyte present
in the outer compartment is very small (which is contradictory to paragraph “Gouy-
Chapman in electrospray droplets”, see above), then KA and KE reduce to:
KA =
A+ s X  i
CA
KE =
E+ s X  i
CE
(15)
Where CA and CE are the analyte and electrolyte bulk concentrations. If [X
-]i is
eliminated from equations (15):
A+ s =
CAKA
CEKE
E+ s (16)
Which together with equation (13) results in:
A+ s =
CAKA
CAKA + CEKE
Q[ ] (17)
Equation (17) relates the analyte concentration in the outer compartment (which has
been hypothesised to define the mass spectrum intensity) to the excess charge concentration
present in the electrospray droplets. Remarkably, this relation is very similar to equation (2)
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introduced by Tang and Kebarle [1], even though it was derived from very different
principles; Tang and Kebarle used ion evaporation rates whereas the model presented above
uses only equilibrium constants. However, equation (17) suffers from the same limitation as
Tang and Kebarle’s model, which was unable to account for nonlinearity when analyte
intensity in the mass spectrum was plotted versus analyte concentration in the bulk solution.
We shall thus consider a more general model, where no a priori hypothesis is made about
analyte and electrolyte ratios between the two compartments.
Enke’s general partition model
The mass conservation of analyte and electrolyte ions can be written as:
CA = A
+ s + A+X  i
CE = E
+ s + E+X  i
(18)
Then from equation (11) and (12) comes:
KA
KE
=
A+ s CE  E+ s( )
CA  A+ s( ) E+ s
=
A+ s CE Q  A+ s( )
CA  A+ s( ) Q  A+ s( )
(19)
Equation (19) can now be rearranged to reach a quadratic equation in [A+]s:
A+ 
s
2 KA
KE
1

	  A
+ 
s Q[ ]
KA
KE
1

	 + CA
KA
KE
+ CE



	 + CA Q[ ]
KA
KE
= 0 (20)
This equation relates directly [A+]s and CA with use of only the partition equilibrium
constants KA and KE, and the measurable excess charge [Q]. At high values of analyte
concentration CA, equation (20) simplifies into [A
+]s = [Q], which accounts for the
saturation region experimentally observed. At very low values of CA, equation (20)
simplifies into:
A+ 
s = CA
KA / KE
KA / KE 1+ CE / Q[ ]



	 (21)
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Which accounts for the linear region observed experimentally at low analyte
concentration.
From equation (20), one can now plot the analyte concentration in the outer
compartment versus the analyte concentration in the bulk electrosprayed solution, as shown
in Figure 68:
Figure 68. Response function for a singly charged analyte with a singly charged electrolyte.
[Q] = 10-5 equiv/l, CE= 10
-3 M and K=KA/KE=0.01 to 100.
In can be seen from Figure 68 that the mass spectrometric response for a given
analyte is highly dependant on the KA/KE ratio, which means that analyte and electrolyte
ions compete to reach the outer compartment (surface of the droplet): at high KA/KE ratio
(analyte with a much stronger surface affinity that the electrolyte), the analyte intensity is
perfectly linear up to the saturation regime, whereas at low KA/KE ratio (electrolyte with a
much stronger surface affinity that the analyte), the mass spectrometric response is non-
linear. This model was validated by Enke [5] on data from Kebarle and Tang [9], as shown
in Figure 69:
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Figure 69. Fit of equation (20) on data presented by Kebarle and Tang in [9]: electrospray
analysis of heroin hydrochloride (HerH+) and cesium (Cs+) ions in the presence of 10-5 M of
NH4CH3O. Reprinted with permission from [5].
Effect of salt concentration in Enke’s model
The model presented above allows to predict the response for analyte A+ in the
presence of various concentration of salts, based on equation (20):
Figure 70. Calculated response for a singly-charged analyte at various salt concentrations.
(KA/KE=50, [Q]=10
-5 equiv/l)
Chapter 5. On-chip solid-phase extraction
194
The presence of salts is clearly responsible for a loss of sensitivity: for an analyte
concentration of 10-7 M, switching from 10-6 to 10-1 M of salts results in a decreased analyte
intensity by more than two orders of magnitude. However, comparison of this model with
experimental results revealed a more complicated situation [10]:
Figure 71. Effect of tetrapentylammonium (TPA+) and sodium ions concentrations on the
intensity of TPA+ in the mass spectrum. Reprinted from [10] with permission.
In agreement with the model, when CNa
+ < 10-3 M, the TPA+ response is proportional
to CTPA
+ up to 10-5 M. However, for a given TPA+ concentration, the response increases with
increasing CNa
+ up to 10-4 M and then decreases again, which is in contradiction with the
model. In fact, Enke’s partition model assumes that [Q] is independent of analyte and
electrolyte concentrations, which is not true; in particular, [Q] increases with increasing
electrolyte concentration:
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Figure 72. Effect of CTPA
+ and CNa
+ on [Q], which was calculated from eq. (14) using the
measured IES  and  = 8μl/min. Reprinted with permission from [10].
Unfortunately, taking into account this dependency of [Q] on electrolyte
concentration does not explain the effect of increasing electrolyte concentration, and to our
knowledge, no clear explanation on the analyte intensity dependency on electrolyte
concentration was provided to date [10].
But it is worth noting that the partition model accounts at least qualitatively
for the increased sensitivity, dynamic range and better robustness of nanospray ionisation
towards the presence of salts [11]: the total excess charge [Q] is inversely proportional to
the flow rate  (see equation (14)), which means that in classical electrospray conditions
where =6 μL/min and IES=100 nA, [Q]10-5 eq/l whereas in nanospray conditions where
=50 nL/min and unchanged current, [Q]= 10-3 eq/l. The available excess charge is thus
much higher in nanospray compared to classical electrospray, as shown in Figure 73:
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Figure 73. Response curves at different flow rates for an electrolyte concentration of 10-5
M, KA/KE=50, IES= 100 nA.
More interestingly, at low flow rates, the effect of increasing salt concentrations is
less pronounced, as shown in Figure 74:
Figure 74. Effect of salt concentration on analyte response for a flow rate of 50 nl/min,
KA/KE=50, IES= 100 nA.
When comparing Figure 74 to Figure 70 for which =6 μl/min, one can see that the
decrease in analyte response when increasing the electrolyte concentration from 10-6 to 10-1
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M passes from more than two orders of magnitude (for classical electrospray) to less than
half an order of magnitude (for nanospray).
Pros and cons of Enke’s partition model
Enke’s partition model was successful in describing the saturation observed when
increasing analyte concentration (see for example Figure 69); this saturation of analyte
intensity is not due to instrumental limitations, but to intrinsic properties of electrospray
ionisation: the global charge available is indeed limited by the electrospray current itself
(see equation (14)). The model also qualitatively accounts for the decrease of sensitivity
observed with increasing salt concentrations. To date, it has been the most successful
investigation and prediction of mass spectrometric response and has been extended
qualitatively to the competition of several analytes for ionisation [5, 12]. However, the
whole model is based on two strong hypotheses:
1. the intensity of a compound in the mass spectrum is proportional to its concentration
at the surface of electrospray droplets
2. compounds partition between the bulk of electrospray droplets and an outer
compartment.
which physical meaning is not so clear. Hypothesis 1 implies that gas phase ions are
formed solely by ion evaporation from electrospray droplets [2, 13-17], which is thought to
hold true for small compounds [18]. For analytes larger than 3.3 kDa, the charge residue
model [15, 19, 20], which hypothesises that electrospray droplets undergo coulombic
fissions and solvent evaporation till only one analyte molecule be present in the droplet,
prevails. In particular, it better accounts for protein charge states observed in ESI-MS [21-
24]. All experimental validations of Enke’s partition model were conducted with small
inorganic (see Figure 69) or organic ions (see Figure 71). It is highly doubtful that this
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model accounts for mass spectrometric response of large analytes such as polypeptides and
proteins.
Moreover, it is broadly accepted that charged analytes locate at the surface of
electrospray droplets because of electrostatic repulsions, which is at the core of hypothesis
1. However Znamenskiy et al showed by very simple calculations that metastable cases can
occur, in which a potential energy minimum corresponds to charges located at the centre of
the droplet [25]. They even found by molecular dynamics calculation that ions are not
located close to the surface, as shown in Figure 75:
a) b)
Figure 75. Radial distribution of water molecules and ions around the centre of the
nanodroplet. a) the droplet contains 23 hydronium ions b) the droplets contain 21 diglycine
ions and 2 hydronium ions. Reprinted with permission from [25].
Hypothesis 2 states that ions partition between the core of the droplet and an outer
shell. Whereas this may not be true, as shown in the Gouy-Chapman derivation of ion
distribution in charged droplets (see paragraph “Gouy-Chapman in electrospray droplets”
above) the physical meaning of the partition coefficient is not clear. Its first aim is to reflect
differences in compounds surface affinities, which comprises both electrostatic and
solvation effects.
Moreover, the partition model does not take into account droplet evolution through
time (solvent evaporation, droplet fission, ion evaporation). Recently, Cech et al tried to
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refine the partition model by incorporating a simple fissioning process [26]: when solvent
evaporates, the droplet shrinks till its surface reaches 85% of its initial volume and then
fissions. Offspring droplets are then thought to carry 2% of the parent droplet’s mass and 15
% of its charge, as assumed by Gomez et al [27]. The model is thus re-evaluated taking into
account the number of fissions undergone by electrospray droplets. Unfortunately, it does
not account for experimental results any better than the partition model presented above and
in [5, 10].
Finally, none of the above-mentioned approaches take into account the external
electric field, which has a typical value of 106 V.m-1. For the sake of comparison, the
electric field just outside a droplet carrying 100 elementary charges is plotted in Figure 76a:
the “intrinsic” field is generated by the droplet charge itself (calculated by Gauss’ law) and
the external field is the one corresponding to the electrospray voltage. Comparably, the
intrinsic field for droplets at their Rayleigh limit (see equation (10)) is plotted in Figure 76b.
a) b)
Figure 76. Values of the electric field just outside a) droplets carrying 100 elementary
charges, and b) droplets at their Rayleigh limit.
As can be seen from Figure 76, if the number of charges is fixed arbitrarily to 100,
the external electrical field has a non-negligible value for bigger droplets (>200-400 nm in
radius), whereas if one considers droplets at their Rayleigh limit, the intrinsic field is always
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much higher than the external one. It thus appears reasonable to neglect the external electric
field in the study of fissioning droplets.
1.2. Analyte cationisation by salts
The previous section deals with the effect of salts on global response of electrospray
ionisation. However, the presence of salts in the analysed solution can result in another
effect with direct consequences for mass spectrometric analyses: analyte cationisation.
Briefly speaking, analyte ionisation during electrospray is driven first by an in-solution
charging, defined by the analyte pKa:
A + H3O
+  AH+ + H2O (22)
In a second stage, a gas-phase analyte charging can occur, defined by the analyte
proton affinity:
A + H+  AH+ (23)
The proton affinity (PA) is defined as the negative change of enthalpy associated
with the protonation reaction (23).
But gas-phase charging can also occur via “metallization”, for example by sodium
ions:
A + Na+  ANa+ (24)
Which is thus defined by sodium affinity. The direct consequence of metallization is
the appearance of extra peaks in the mass spectrum: besides the [M+nH]n+ distribution,
[M+nNa]n+ and possibly [M+nH+mNa](n+m)+ and [M+nNa-mH](n-m)+ distributions appear,
which is detrimental to the mass spectrometric analyses: it can first decrease sensitivity by
dividing the analyte intensity into several peaks, and complicate mass calculation and
spectrum deconvolution. Figure 77 shows the complexity that can arise from the presence
of salt clusters in the spectrum of a simple cyclic pentapeptide:
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Figure 77. Mass spectrum of a single cyclic pentapeptide in the presence of sodium salts.
Reprinted with permission from [28].
Fortunately, peptides and proteins usually have much higher affinity for protons
than for sodium cations. For example, Feng et al used the Cooks kinetic method [29] to
measure lithium and sodium ion binding energies of amino acids [30]; in this methodology,
complexes of the form P1M
+P2 are formed by electrospray ionisation, and further
dissociated in the instrument, typically by collision activated dissociation. The reactions
undergone by the peptide complexes are thus the following:
The observed intensities can thus be converted into thermodynamic values by:
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I P1M
+( )
I P2M
+( )
=
k1
k2
 K
RTeff lnK = GM 1( )  GM 2( )
(25)
This technique thus allows to calculate differences in binding energies between pairs
of peptides. Using this technique as well as reference experiments, Feng et al found that
proton affinities of dipeptides were in the range of 106 J/mol whereas their sodium affinities
were in the range of 105 J/mol. This factor of 10 in binding energies corresponds to a factor
of 22000 in equilibrium constants, and thus to a much stronger affinity of peptides for
protons than for sodium.
2. State-of-the-art in microfluidic sample clean-up
From the discussion above, it can be clearly understood that sample clean-up prior
to electrospray ionisation is of utmost importance. Sample clean-up comprises desalting, but
also elimination of co-solvents usually encountered in biological sample preparation
protocols, such as solubilisation agents (detergents, urea, thiourea…). Moreover, as
electrospray ionisation most often requires the presence of organic solvents for efficient
analyte desolvation, sample clean-up devices that allow solvent exchange as well are highly
desirable. Microfluidic sample clean-up have been reviewed in references [31-33].
2.1. Sample clean-up by solid-phase extraction
Solid-phase extraction (SPE) refers to processes where analytes of interest are
retained selectively on a stationary phase, while solvents and undesired compounds are
washed out, and retained analytes can therefore be eluted [34]. SPE is particularly
promising in combination with microfluidic devices, because elution volumes can be
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incomparably small. Typical features of solid-phase materials are their retention mechanism
(hydrophobicity, electrostatic interactions, affinity…) and their specific surface area.
With wall derivatisation
One straightforward approach to incorporate a solid-phase in a microfluidic system
is to derivatise microchannel walls with molecular reagents that bear the desired functional
property. The biggest advantage of this approach is the ease of functionalisation, as it is
usually accomplished by flowing reagents through the microchannel to be derivatised.
However, its biggest limitation is that the surface-to-volume ratio of the solid-phase is
defined by microchannel geometry only. Kutter et al have presented a glass microchip
whose walls have been derivatised with octadecyltrimethoxysilane to make a C18 solid
phase [35]. Whereas extraction performances were demonstrated with a fluorescent dye
alone in simple buffers, the only limitation of this approach is the limited specific surface
area that can be reached (from 230 to 781 mm-1, as reported in [36]), compared to other
solid-phase systems (see Table 14 at the end of this section). However for some applications
the high surface-to-volume ratio of a microfluidic system may be sufficient to achieve a
proper SPE with wall derivatisation only.
Based on reverse-phase microparticles
One of the conceptually easiest ways to integrate a solid-phase into a microfluidic
system is to use microbeads; unfortunately, packing a microchannel with microbeads turns
out to be a difficult technical task. First the packing material must be flown and trapped into
the microchannel; Li et al [37] used a first plug of 40 μm C18 beads, to make a filter at the
junction of a large 800 μm wide, 150 μm deep and 22 mm long channel and a small 10 μm
deep, 30 μm wide injection channel. The large channel was then packed with 5 μm C18
beads, resulting in a surface-to-volume ratio around 107 m-1 (estimated from authors’ data
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and Waters’ technical information). This system reached nanomolar sensitivity for leucine-
enkephalin, when coupled to on-chip CE and direct infusion to ESI-MS. The same team
previously reported an elegant methodology to pack microchannels with beads: restriction
microstructures were integrated in the microchannel as shown in the left panel of Figure 78:
Figure 78. A 330 pL microchamber is defined by two weirs in the sample flow path that
retain microparticles but allow solution flow. Left: schematic diagram of the device; the
transverse microparticle filling channel is not shown. Reprinted with permission from [38]
Right: a) image of the chamber at an initial stage of electrokinetic packing and b) after
completion. Reprinted with permission from [39].
Two weirs were microstructured in the flowing path of the sample channel, so that
the gap between the top of the weirs and the cover plate that closes the microchannel is 1
μm; this two weirs define a 330 pL microchamber that can be filled with C18 silica particles
(from 1.5 to 4 μm in diameter), under electroosmotic flow using a transverse channel (not
shown in left panel of Figure 78) [38]. Panel a) shows an early stage of packing, and panel
b) the packing after completion. Moreover, the authors reported a so-called “solvent lock”:
electrokinetic packing is performed in acetonitrile, and when aqueous buffer is applied to
the reverse-phase bed, particles tend to “lock”. With this set-up, authors were able to
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preconcentrate and detect 1 pM solutions of fluorescent molecules after a 3 min loading of
the reverse-phase bed [39]. More recently, Marko-Varga et al [40, 41] used a simplified
“weir approach” to pack a 330 μm wide and 200 μm deep microchannel with a 100-300 nL
reverse-phase bed. This microfluidic device was used to remove salts and urea from
standard peptide mixtures or from in-gel digested proteins prior to deposition on MALDI
targets. 1 nM peptide mixtures (20 fmol) were successfully analyzed as well as various
proteins identified after 2D-GE and in-gel digestion. Despite these few successful uses of
microparticles, packing a microchannel with reverse-phase microbeads remains a difficult
task, because of clogging, back pressure effects, interactions of particles with microchannel
walls… Lettieri et al have recently introduced a new concept for bead handling in
microfluidic systems [42]: when opposing a parabolic pressure driven flow profile with a
flat EOF profile (with a low net flow rate) at converging or diverging channels,
recirculation of microbeads occurs, so that trapping can be performed without any
mechanical restriction, as shown in Figure 79.
Chapter 5. On-chip solid-phase extraction
206
Figure 79. Protein A coated beads (1 μm) circulation at a divergent channel under opposite
EOF and pressure-driven flow. (a), (b) Numerical simulations of vector flow (μm/s-1) with
two different geometries; (b), (c) corresponding experiments. Reprinted from [42] with
permission.
Furthermore, if one of the flows is shut down, microbeads can then be moved to
another part of the microfluidic device (e.g. a detection window). This methodology was
assessed with the capture of fluorescent biotin by streptavidin beads, and washing out of
excess biotin. This work shows a nice example of an innovative solution to trap
microparticles in a microfluidic device. It is thought that many other methodologies will
appear in the future for microparticle handling in microchannels.
Based on monoliths
As discussed above, the two classical ways to integrate solid-phases in
microchannels are (i) wall derivatisation, which leads to limited surface-to-volume ratios
and makes compulsory the use of small channels or (ii) bead packing, which usually leads
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to back-pressure and clogging problems. An elegant and innovative solid-phase integration
has been pioneered by Frechet’s group: monolithic materials are polymerised directly in the
microchannel, after the channel has been filled with the monomers mixture. Polymerisation
is then induced whether by temperature or by UV light. The choice of monomers allows the
design of the desired surface chemistry (polarity, hydrophobicity, charge, reactive groups
for grafting antibodies or proteins) and the experimental condition (mainly the composition
of the porogenic solvent) allows the control of pore size. For example Yu et al have tested
the use of photopolymerisable monoliths based on methacrylate derivatives [43, 44]:
ethylene methacrylate (EDMA), 2-hydroxyethyl methacrylate (HEMA), butyl methacrylate
(BMA), 3-(trimethoxysilyl)propyl methacrylate, glycidyl methacrylate (GMA), were used
to produce monoliths with different surface properties. Whether ion exchange or
hydrophobic solid-phases were incorporated into glass microchips, with a mean pore size of
19 μm to allow flow-through experiments, and tested as SPE sorbents with a model peptide
and Green Fluorescent Protein. Both analytes underwent a preconcentration of 1000 when
adsorbed on a 7-mm-long bed (100 μm wide, 40 μm deep) with a surface-to-volume ratio of
106 to 107 m-1 (estimated from authors’ data) and eluted with a variety of salts or
acetonitrile/water mixtures respectively. These simple proofs of principle exemplify the
ease of integration of porous monoliths in microfluidic devices as well as the versatility of
surface properties that can be tailored.
Solid phase type Specific surface-to-volume ratio From ref.
Wall derivatisation 781 mm-1 [36]
Microparticles 107 m-1 [38, 39]
Monoliths 107 m-1 [43, 44]
Table 14. Comparison of surface-to-volume ratios obtained with different solid-phase
preparation strategies.
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2.2. Filtration and microdialysis
Dialysis systems have been incorporated into microfluidic devices by several teams,
most of time for direct coupling with ESI-MS. The simplest device consists in two
microchannels placed face-to-face and sandwiching a dialysis polymeric membrane.
Sample is then flown through the membrane to exclude high-molecular weight compounds
as in [45], or counter flown  against a dialysis buffer, so that salts and low molecular weight
compounds are expelled [46], as shown in Figure 80.
Figure 80. The two schemes introduced for sample filtration (left) or microdialysis (right)
Xiang et al [47] developed a dual dialysis miniaturised system: the device embeds
one high- and one low molecular-weight-cut-off membrane, and the sample is sequentially
counter flown against both of them before being injected into ESI-MS, which allowed the
analysis of a whole E. Coli lysate prepared in 6.8 M urea. Jiang et al [48] proposed a
somewhat more refined dialysis and filtration microdevice: in a first stage, a mixture of
aflatoxin antibody and aflatoxin is flown against a dialysis buffer at a PVDF membrane
interface, so that all unbound aflatoxin is expelled; the complexes are then flown against dry
air to be concentrated, and enter a second dialysis device, where they are dissociated; the
eluted aflatoxins can then be analyzed by ESI-MS. The use of microfluidic dialysis allowed
a gain in sensitivity of two orders of magnitude in the detection of aflatoxins, thanks to
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limited dilution during dialysis, post-dialysis concentration and limited loss of sample
through integration of all steps.
2.3. Liquid-liquid extraction
Liquid-liquid extraction is a well-established procedure for sample preparation in
bioanalytics [49], due to its robustness and specificity; in the recent years, it has regained
interest due to its potential for high-throughput [50]. Many protocols have been developed,
whether based on aqueous two-phase systems (often salt / detergents systems) or aqueous /
organic solvent multiphase systems. This can be applied to enrichment or isolation of
subclasses of proteins or isolation of single proteins directly from biological matrices [51].
At the same time, microfluidic systems are operated under laminar flow (low
Reynolds number), which means that two solutions can be flown next to each other within
the same channel without any other mixing than analyte diffusion from one flow to another
[52]. Up to now, multiphase extraction microdevices have been applied only in inorganic
chemistry: Tokeshi et al have performed extraction of complexed cobalt in an aqueous/
toluene dual-flow microchannel. A very stable 2 mm long interfacial zone was established
and the flow was stopped. The extraction was then completed within 60s whereas the
conventional solvent extraction procedure (starting from 10 ml aqueous solution) was ca. 10
min long [53]. Schilling et al presented a more integrated approach for cell lysis, protein
extraction and -galactosidase quantitation [54]: cells-containing solution and lysis buffer
are flown under pressure driven flow in the same channel, so that cell lysis occurs at the
flows interface. Cell debris essentially do not diffuse in the lysis buffer, whereas protein
components partition between the two flows, as shown in Figure 81.
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Figure 81. Design of the microfluidic device for cell lysis, protein extraction and -
galactosidase detection. Reprinted with permission from [54].
The lysis buffer is then flown in another microchannel along with a detection flow
containing a fluorogenic substrate for -galactosidase; fluorescence appears at the flows
interface, so that the enzyme can be quantified. This rather simple device allows the
isolation of intracellular compounds from cell debris, and it is likely that fractionation
properties (range of extracted molecules’ diffusion coefficients) can be adjusted by
changing the flow rates: by increasing flow rates, large molecules will have less time to
diffuse in the lysis flow, so that only low-molecular weight compounds will be extracted.
3. On-chip solid-phase extraction as stand-alone device
As shown above, solid-phase extraction is the most favoured technique for sample
clean-up prior to mass spectrometric analysis, both for microfluidic devices [35, 37-41, 43,
44] and in classical sample preparation protocols, as exemplified by the success of
functionalised pipette tips such as ZipTips™ from Millipore. However, integrating a solid-
Microfluidic front-end technologies for protein electrospray mass spectrometry
211
phase into microchannels turns out to be a difficult technical task: first if a packing
approach is to be used, one needs to integrate a frit into microchannels to retain
microparticles, which is feasible only with photolithographic techniques; then the
assembled microfluidic structure has to be pressure-resistant, so as to cope with back
pressures usually encountered in packing protocols. On the other hand, developing solid-
phase monoliths imposes compatibility of the polymerization solvents with the microchip
material, and grafting the solid-phase onto microchannels walls to avoid any shrinking
effect during polymerization.
3.1. Polymeric membranes as a solid-phase
On the contrary, one can use polymeric membranes for off-line capture of analytes of
interest, and then interface them at the inlet of a microfabricated polymer microspray, as
shown below:
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Figure 82. Scheme of
operation: membranes are
first incubated in the sample to
clean-up (a), then placed at
the bottom of the microspray
reservoir (b); the membrane is
then washed by pumping
deionised water through the
microspray (c), and the elution
solution is then applied,
together with the electrospray
voltage (d).
3.2. Material and methods
This experimental scheme was tested with poly(vinylidene difluoride) (PVDF)
membranes Immobilon P (0.45 μm pore size, 120 μm thick) from Millipore which are
usually employed in electroblotting experiments of proteins after 1D or 2D gel
electrophoresis [55, 56]; they retain compounds primarily through hydrophobic interactions,
and to some extent through electrostatic effects [57]. Model compounds were S-propranolol
hydrochloride from Fluka (Buchs, Switzerland), insulin from bovine pancreas and equine
myoglobin from Sigma (Saint-Louis, MO, USA), and human angiotensin II from Bachem
(Bubendorf, Switzerland). Phosphate buffer saline (PBS) tablets (0.138 M NaCl, 0.0027 M
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KCl, 0.01 M phosphate, pH 7.4) were from Sigma, HPLC grade methanol from Merck
(Darmstaadt, Germany), and acetic acid from Fluka.
Microsprays were produced by DiagnoSwiss SA (Monthey, Switzerland) in
polyimide, with microchannel dimensions of 120 μm wide, 45 μm deep and 1 cm long, and
closed in-house with a polyethylene / polyethylene terephthalate (PE/PET) 35 μm sheet
(Morane, Oxon, UK) using a laminator (Morane, Oxon, UK) set at 130 °C (upper roll), 50
°C (lower roll) and 2 bars. They were cut in a tip shape with scissors, and a reservoir was
pasted over the inlet.
All experiments were done on a LCQ Duo mass spectrometer (Thermo Electron,
San Jose, CA, USA) used in positive ion mode polarity; the electrospray source was
removed, and the microchip positioned in front of the heated capillary inlet as previously
reported [58, 59]. The electrospray voltage was delivered by a platinum electrode plunged
into the microchip reservoir, and was around 2.4 kV. All acquisitions were done in full scan
mode (50  m/z  2000) or MS/MS mode without any averaging. The heated capillary was
kept at 200 °C, and in each experiment, ion optics parameters were optimised on the
compound of interest.
Membranes are first cut in 6 mm diameter pieces, which fit the microchip reservoir
as well as the bottom of flat 96 well microtiter plate wells, and wet with methanol and
rinsed with milliQ water, as recommended by Millipore. They are then incubated in PBS
with 10% methanol (v/v) with the molecule of interest, under shaking at room temperature,
whether for one hour or overnight. The incubation volume is typically 200 μl in a 96 well
plate. In a second step, the membrane is placed within the reservoir over the microchannel
inlet, and rinsed extensively with milliQ water by pumping 250 μl three times through the
microchannel. The membrane is then wet with the spraying solution (MeOH:acetic acid:
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water at 50:1:49%) and placed in front of the MS heated capillary. The high voltage is then
applied by placing a platinum electrode within the reservoir.
3.3. Results
Detection of propranolol from a salty solution
The present desalting scheme has been successfully applied to the detection
of a small drug, propranolol, in PBS + 10% methanol, without any previous treatment of the
sample. The membrane was incubated one hour in a 500 μg/ml propranolol solution, at
room temperature under shaking, and consecutively washed and wet by 50 μl of the
spraying solution (50% methanol : 49% water : 1% acetic acid). Figure 83 shows the
spectrum of propanolol eluting from the membrane, with the single peak at m/z = 260.14
and no contaminant coming from the polymer microchip or the membrane.
Figure 83. MS spectrum of propranolol eluting from the membrane incubated in 500 μg/ml
(1.7 mM) in PBS. Inset: MS/MS spectrum of parent ion m/z 260.14 at 30% collision energy.
The inset in Figure 83 shows the MS/MS spectrum of parent ion m/z = 260.14,
whose peaks are listed in Table 1. MS/MS was acquired at 30% collisional energy.
Microfluidic front-end technologies for protein electrospray mass spectrometry
215
m/z Relative intensity
98.14 9.63
116.24 49.32
132.14 1.86
157.15 23.53
183.16 100
218.02 10.24
242.11 10.29
260.14 22.15
Table 15. m/z list of ions in the MS/MS spectrum of parent ion m/z = 260.14 of the
propranolol MS spectrum
In comparison, Figure 84 shows the spectrum of a 500 μg/ml propranolol solution
sprayed directly from PBS.
Figure 84. MS spectrum obtained from a direct electrospray of 500 μg/ml propanolol in
PBS + 50% methanol (vol:vol).
In order to investigate the effect of the concentration of propranolol in the
incubation solution, membranes were incubated in various concentrations of propranolol,
from 500 μg/ml down to 10 ng/ml (1.7 mM down to 33.8 nM). In order to avoid any
misleading identification of propranolol, the quantitation was made on the main peak of the
MS/MS spectrum of parent ion m/z = 260.14, that is to say m/z = 183.16, which is shown in
Figure 85. There is a clear relationship between the logarithmic concentration and the
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logarithmic intensity of the peak. But even 500 μg/ml is far from the saturation of the
membrane binding capacity for propranolol in this system.
Figure 85. Intensity of the m/z=183.1 main peak of the MS/MS spectrum of propanolol
(parent ion m/z=260.1) at various incubation concentrations (from 10 ng/ml to 500 μg/ml).
Peptide and protein desalting
The procedure described above has also been applied successfully to human
angiotensin II. In particular, the electrospray from a microchannel outlet has been reported
to be very stable through time without the membrane [58]. Electrospray generation through
the membrane does not impend the temporal stability: Figure 4 shows the reconstructed
chromatogram of specific mass m/z=523.8 (main peak of human angiotensin II) in the
solution eluting from a membrane incubated for one hour in 10 μg/ml (9 μM) solution of
angiotensin. The 50 μl of spraying solution added over the membrane in the chip reservoir
could be sprayed during more than half an hour without any problem, which shows that the
presence of the membrane does not impend the physical stability of the spray. Of course
most of the adsorbed angiotensin is released from the membrane within the first five
minutes, due to disruption of hydrophobic interactions between the membrane and
angiotensin molecules by the spraying solution. In principle, the elution duration could be
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adjusted if needed by increasing or decreasing the percentage of methanol in the spraying
solution.
Figure 86. Ion reconstructed “chromatogram” of ion m/z 523.8.
Insulin was also desalted: membranes were incubated for one hour at room
temperature in 200 μl of different concentrations of insulin (from 0.2 to 75 μM) in PBS
+10% methanol. Figure 87 (left) shows the spectrum of insulin eluting from a membrane
incubated in a 10 μM insulin saline solution. The quantitation of insulin eluting from the
membranes was done on the (M+5H)5+ ion (m/z = 1147.5): Figure 87 (right) shows the
logarithmic absolute intensity of the peak versus the logarithmic incubation concentration.
In order to estimate the saturation concentration, an exponential was fitted to the
experimental points. Saturation was estimated as 95% of the plateau value, which gives a
saturation concentration of 40 μM in this system.
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Figure 87. Desalting of insulin. Left: spectrum of insulin eluting from the membrane. Right:
Intensity of peak m/z = 1147.5 versus concentration of insulin in the starting sample.
Furthermore, in order to validate the procedure with larger molecules,
membranes were incubated in a 10 μM myoglobin solution, for one hour, at room
temperature, in 200 μl of PBS + 10% methanol. The membrane was consecutively washed,
put in a microspray, and 50 μl of the spraying solution was put over the membrane. The
resulting spectrum is shown in Figure 7; no salt cluster can be observed nor contaminant
coming from the membrane.
Figure 88. Desalting of myoglobin from a PBS solution. Single spectrum of solution eluting
from the membrane.
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Influence of elution solution composition
In order to gain some insight into the dependency of the solvent composition on
elution behaviour, membranes were incubated in 10 μM of insulin in PBS, placed on the
chip, and washed with milliQ water; different elution solutions were then applied, and the
total ion chromatograms were recorded:
a) b)
c) d)
Figure 89. Total ion current of insulin eluting from the membrane in a) 30% MeOH: 1%
acetic acid: water, b) 40% MeOH: 1% acetic acid: water, c) 60% MeOH: 1% acetic acid:
water, d) 70% MeOH: 1% acetic acid: water
In order to measure the elution rate, total ion chromatograms were fitted to:
TIC = TIC0 + Aexp  t  t0



 (26)
Which gave the elution rate  for each solvent composition:
% of methanol Rate constant  (min-1)
30 8.51±1.60
40 3.06±0.07
60 1.91±0.10
70 0.71±0.04
Table 16. Effect of methanol content on elution behaviour
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4. On-chip solid-phase extraction with infusion
In order to minimise the elution duration by controlling externally the elution
solution flow rate, a capillary connection was added to the solid-phase extraction set-up, as
shown below:
Figure 90. Scheme of on-chip SPE with capillary connection.
4.1. Material and methods
Urea, S-propranolol hydrochloride and cytochrome C from horse heart were
obtained from Fluka (Buchs, Switzerland). Phosphate buffered saline (PBS) tablets (0.138
M NaCl, 0.0027 M KCl, 0.01 M phosphate, pH 7.4), 1,4-dithio D,L-threitol (DTT),
iodoacetamide, CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate),
-lactoglobulin A from bovine milk and insulin from bovine pancreas were from Sigma (St
Louis, USA). Human angiotensin II was from Bachem (Bubendorf, Switzerland). Methanol
(Merck, Darmstadt, Germany) and acetic acid (Fluka) were used without any further
purification. Deionised water (18.2 MW) was produced using a Milli-Q system from
Millipore (Bedford, USA). Proteins were dissolved in deionized water to a 1 mg/ml
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concentration. The PVDF membrane is an Immobilon-P™ membrane from Millipore
(Bedford, USA).
Polyimide microchips were provided by DiagnoSwiss (Monthey, Switzerland).
Their fabrication has been described in detail elsewhere [60, 61]. The microchannel is 120
μm wide, 35 μm deep and 1 cm long. The coupling of the microchip with the mass
spectrometer is quite simple, and has been presented previously [58, 59, 62]: one extremity
of the microchannel is cut in a tip shape, and placed in front of the MS heated capillary. The
spraying voltage (typically between 2 and 2.8 kV) is applied through a microelectrode
embedded within the microchannel, and the position of the chip is adjusted to obtain a
stable spray. The microchip is coupled to a syringe pump (Cole Parmer 74900) thanks to a
home made low dead-volume holder. The PVDF membrane is sandwiched between the inlet
of the microchannel and the fluidic connection, as shown in Figure 90. The mass
spectrometer is a LCQ Duo Ion Trap (Thermo Electron, San Jose, USA). The heated
capillary is kept at 200 °C, and the spray voltage is adjusted in order to have a spray current
between 50 and 200 nA. All spectra are acquired in the positive mode, in full-scan mode.
The membrane is first wet with methanol (0.2 μl/min during 5 min) and then rinsed
with milliQ water (0.2 μl/min during 5 min), as recommended by the membrane supplier.
The sample is then adsorbed on the membrane by pumping the salty solution through the
membrane at 0.2 μl/min to 5 μl/min. When the desired volume is pumped through the
membrane, salts are washed out by pumping water (same duration and flow rate compared
to the retention step). The eluting and spraying solution (50% methanol: 1% acetic acid:
water) is then pumped to elute and spray the retained drugs, peptides and proteins.
-lactoglobulin A was incubated in PBS (pH 7.4) at a concentration of 2.7 μM in the
presence of 8 M urea and 4 mM DTT for 30 minutes at 45 °C. Just before incubation, the
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solution was gently flushed with nitrogen, in order to expel oxygen. Iodoacetamide was
then added to a final concentration of 38 mM, as in a previous study [63]. The solution was
flushed again with nitrogen, and the mixture was incubated at 45 °C in the dark for 30
minutes. DTT and iodoacetamide stock solutions were freshly prepared.
4.2. Results
Sample preconcentration
In order to investigate the preconcentration that can be obtained, propranolol
dissolved in PBS to a concentration of 87 μM was pumped at 0.5 μl/min during 30 minutes.
After washing out of salts with deionised water, the spraying solution was applied at 0.2
μl/min. The position of the chip was optimized and the flow rate was then switched to 0.6
μl/min. Figure 91 shows the elution profile of propranolol. Spectra were acquired in full-
scan mode without any averaging, and the chromatogram of specific ion m/z = 260.3 was
post processed.
Figure 91. Reconstructed chromatogram of propranolol ion.
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It can be observed that approximately 90% of propanolol is eluted within 2 minutes,
which results in a preconcentration ratio of 12.5. The tailing that can be seen on the elution
profile in Figure 91 can be attributed to diffusive phenomena within the membrane, and
desorption of analytes into the reservoir, which represents a dead volume of 5 nL. It can be
noted that the elution behaviour of the analyte depends on the eluant flow rate, on the nature
of the eluant, and on the concentration of organic solvent within the eluant. All three
parameters can be optimised for each analyte of interest. For example to preconcentrate a
very hydrophobic analyte, one can use acetonitrile instead of methanol, optimise the
concentration of acetonitrile in order to recover the maximum amount of analyte from the
membrane, and then increase the eluant flow rate until the sampling rate of the mass
spectrometer becomes the limiting factor.
Desalting of a mixture
A mixture of propranolol (50 μM), insulin (50 μg/ml) and cytochrome C (50 μg/ml)
dissolved in PBS was pumped through the microchip at 0.2 μl/min during 15 minutes. Salts
were then washed out with water, and the eluting and spraying solution was applied at 0.6
μl/min. Figure 92 shows the resulting spectrum: all analytes were recovered and no salt
cluster can be observed. The noise level is comparable with that obtained for salt-free
solutions.
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Figure 92. Desalting of a mixture of propranolol, insulin and cytochrome C dissolved in
PBS.
Desalting in the presence of urea
Urea is used classically as a solubilising agent for hydrophobic proteins [64] or as a
denaturant. A mixture of propanolol (50 μM), insulin (50 μg/ml) and cytochrome C (50
μg/ml) dissolved in PBS in the presence of 7M urea was pumped through the microchip at
0.2 μl/min. The elution step was done at 0.6 μ l/min. Figure 93 shows the resulting
spectrum, recorded without any averaging.
Figure 93. Desalting of a mixture of propranolol, insulin and cytochrome C dissolved in
PBS in the presence of 7M urea.
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Surprisingly, the presence of urea at high concentration does not prevent the
adsorption of analytes on the PVDF membrane and does not add any spectral noise.
Whereas the mechanism of action of urea as a protein denaturant is not fully understood, it
is well established that urea disrupts intra-molecular hydrophobic interactions. But it does
not seem that urea prevents interactions between hydrophobic analytes and the PVDF
membrane.
Interestingly, one can see from Figure 92 and Figure 93 that the cytochrome C peak
distribution is shifted towards lower m/z ratios when incubated in high concentrations of
urea. It is now well established that the peak distribution in ESI mass spectra is strongly
correlated with the folding state of the protein [65-73]: whereas it is not clear yet whether
shifted charge states arise from a shielding of protonation sites in well-packed hydrophobic
cores of folded proteins, or if in unfolded proteins, protonated sites can not be neutralized
by structurally neighbouring oppositely charged sites [23], it is consensual that unfolded
proteins have charge state distributions shifted to lower m/z ratios compared to native
proteins. Here, one can see in Figure 93 that cytochrome C denatured in 7M urea does not
refold during washing out of salts and elution, as shown by the loss of higher peaks
attributed to the native state of the protein compared to Figure 92.
Desalting in the presence of detergents
Detergents are commonly used for hydrophobic proteins solubilisation [64, 74];
though the rationale for selectivity of particular detergents for sub-classes of proteins
solubilisation is not clear, classical detergents (or detergent mixtures) are used in
proteomics. The most commonly used detergents in protein biochemistry are shown in
Figure 94:
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a)
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c)
d)
Figure 94. Commonly used detergents in protein biochemistry: a) CHAPS (zwitterionic) b)
Tween 20 (non ionic) c) Triton X100 (non ionic) d) SDS (anionic)
The on-chip sample clean-up was tested in the presence of CHAPS; detergent
concentrations of 0.1%, 1%, 2% and 4% (w:v) were added to a mixture of 50 μg/ml of
human angiotensin II, 50 μM of propranolol, 50 μg/ml of insulin, and 50 μg/ml of
cytochrome C in PBS. At all concentrations tested, it was impossible to recover any signal
from propranolol, angiotensin and cytochrome C, as shown in Figure 95:
Figure 95. Sample clean up in the presence of CHAPS. Left: 0.1% of CHAPS (w:v) added to
the sample. Right: control experiment with no CHAPS added.
Only insulin and the heme group from cytochrome C are visible in the left spectrum
(peaks at m/z 288, 413, 637, and 1027 are contaminants present in the instrument); the
rationale for this is that these are the most hydrophilic compounds present in the sample
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Chemical tagging of cysteine residues
In order to show the interest of such an integrated desalting step, a specific chemical
tagging of cysteine residues of -lactoglobulin A was done with iodoacetamide. The
scheme of the reaction is shown below:
Figure 96. Alkylation of cysteine by iodoacetamide.
Cysteine alkylation with iodoacetamide is very specific at near-neutral pH (7 to 8.5)
and is a well-known procedure in sample preparation for 2D gel electrophoresis [75, 76] to
prevent formation of disulfides, or acrylamidation during migration within the gel; it has
also been used to increase the information content of peptide mapping experiments [63], or
to undergo quantitative comparison of two proteinaceous samples by the Isotope-Coded-
Affinity-Tag (ICAT) approach [77-79], where iodoacetamide is linked to a biotin to allow
isolation of labelled tryptic digested peptides. Here, the purpose was simply to count the
total number of cysteines in -lactoglobulin A by fully denaturing in 8M urea followed by
DTT reduction and alkylation by iodoacetamide. Figure 97 shows the spectrum of -
lactoglobulin A infused from the microspray at a concentration of 2.7 μM in MeOH 50%:
CH3COOH 1%: water (without any salt) at 200 nL/min. The molecular mass obtained from
the spectrum is 18363.8 ± 6.1 Da.
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Figure 97. Spectrum of -lactoglobulin A infused at 200 nL/min at a concentration of 2.7
μM; full-scale intensity is 2.25. 105 counts.
Figure 98 shows the spectrum of -lactoglobulin A eluting from the membrane after
denaturation, reduction by DTT and alkylation by iodoacetamide; desalting was done by
pumping 50 μl of the incubated sample at 5 μL/min and washing out of salts with the same
volume of water at the same flow rate. The resulting molecular mass is 18650.6 ± 2.9 Da.
The mass shift corresponds exactly to the tagging of 5 cysteine moieties by iodoacetamide
(Dm = 57 Da).
Figure 98. Spectrum of -lactoglobulin A eluting from the PVDF membrane after
denaturation, reduction, and alkylation with iodoacetamide.
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5. Proteomic application of on-chip desalting
The results described in this section were obtained through a collaboration with the
National High Magnetic Field Laboratory in Tallahassee, Florida, USA, thanks to a kind
hosting by Alan Marshall and Mark Emmett, and with the technical assistance of Tukiet
Lam and Logan Mackay.
5.1. Material and methods
Methanol (MeOH) and deionised water were from JT Baker (Phillipsburg, NJ,
USA). Bovine ubiquitin (SwissProt accession number P02248, 76 amino acids, 8565 Da),
horse heart myoglobin (SwissProt accession number P02188, 153 amino acids, 16951 Da),
and formic acid were from Sigma (St. Louis, MO, USA).  Pepsin was from Roche
(Indianapolis, IN, USA). Poly(vinylidene difluoride) (PVDF) membranes were bought from
Millipore (Immobilon P, Millipore, Bedford, MA, USA).
Microchips were kindly provided by DiagnoSwiss SA (Monthey, Switzerland).
Microchip fabrication has been previously described [60, 61]. Copper-coated polyimide
foils are subjected to several steps of chemical and plasma etching, resulting in 120 μm
wide, 45 μm deep and 1 cm long microchannels. 52 μm in diameter gold microelectrodes sit
at the bottom of the microchannel, one of which is used to deliver the electrospray voltage.
The microchips are laminated with a polyethylene/polyethylene terephthalate lamination
foil, and cut into a tip shape, so that the microchannel is opened on the edge of the chip, as
described by Gobry et al [58].
The microchip coupling has been described previously [58, 59]. In the present study,
a homemade microchip holder with low dead-volume connections is used to couple the
microchip to an infusion line.  The sample is delivered by a Harvard Apparatus syringe
pump at a flow rate between 0.25 and 2 μL/min [80]. The electrospray voltage is applied
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directly on the chip through a contact pad connected to the microelectrodes sitting in the
microchannel. Electrospray voltage is 2 kV, and the chip is positioned in front of the heated
capillary inlet so that the spacing between the microchannel outlet and the heated capillary
is 2-5 mm.
The desalting process is the same as presented previously [81] (see section 4).
Basically, a 3 mm diameter piece of PVDF membrane (120 μm thick) is wetted in pure
MeOH and sandwiched between the microchannel inlet and the capillary connection, so that
the only dead volume is the membrane itself. Infusion of a colored solution shows that 1
mm2 of the membrane area is accessible. 10% MeOH (v:v) was added to the sample to wet
the membrane as the sample is loaded at typical flow rates of 10 to 20 μl/min. The sample is
then washed with an equal volume of 0.5% formic acid in water, and eluted with a
methanol:water:formic acid mixture (see below for details) at the same flow rate
All experiments were performed with a homebuilt 9.4 T FT-ICR mass spectrometer
as described elsewhere [82, 83]. Electrospray was generated by applying 2 kV and 350 V to
the gold microelectrode on the microchip and the tube lens, respectively. Desolvation was
assisted by the use of a heated metal capillary operating in constant current mode at 4 A,
and ions were continuously externally accumulated (~1.7 s total accumulation time) in the
front octopole (1.5 MHz at 0.7mV). Bruce-o-pole setting of 1.2 ms at 30 V was used for
improved ion extraction from external accumulation [84]. Ions were then transferred to the
open cylindrical ICR cell where they were trapped, excited and detected. The time-domain
ICR signal (2 Mword) was subjected to baseline zeroing, followed by Hanning apodisation
and one zero-fill before Fourier transformation, magnitude calculation, and frequency to
mass conversion [85, 86] based on external mass calibration. All mass spectra were
acquired by the use of the MIDAS data acquisition system developed in-house [87, 88].
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Myoglobin was subjected to digestion with pepsin: three different mixtures of
myoglobin:pepsin were incubated on ice for two minutes in 20 μL of water acidified with
0.5% formic acid. The ratios of myoglobin to pepsin were 100 pmol:100 pmol, 10 pmol:10
pmol, and 500 fmol:2 pmol. MeOH was then added to 10%, and the solution applied to the
chip.
5.2. Results
Infusion experiments
To demonstrate the ease of coupling of the microchip microelectrospray with the
homebuilt electrospray interface, simple protein solutions were sprayed through the
microspray emitter. A 5 μM solution of ubiquitin was prepared in 50% MeOH: 49.5%
water:0.5 % formic acid, and infused at 1 μL/min. Figure 99 (left) shows a single-scan FT-
ICR mass spectrum of the ubiquitin solution, showing isotopic resolution of the 7+ and 6+
charge states (inserts) at resolving powers of 96500 and 82700. A 5 μM myoglobin solution
was infused in the same way, resulting in the spectrum shown in Figure 99 (right), at a
56400 resolving power for the 18+ charge state (insert).
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Figure 99. Left: FT-ICR single spectrum of 5 μM ubiquitin, with resolution of isotopic
distributions for the 7+ and 6+ charge states (inserts) at resolving power of 96500 and
82700 respectively. Right: single spectrum of 5 μM myoglobin, with resolution of the
isotopic distributions of the 18+ charge state (insert) at a resolving power of 56400.
Desalting of proteins
125 pmol of ubiquitin and 500 pmol of myoglobin were prepared in 20 μL of 1 M
NaCl (resulting in 6.25 and 25 μM respectively). The two solutions were subjected to on-
chip desalting as described above. Single-scan spectra obtained from the solution eluting
from the PVDF membrane are shown in Figure 100, along with magnification of the
isotopic resolution of the 7+ and 6+ charge states of ubiquitin and 18+ charge state of
myoglobin (see inserts).
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Figure 100. Single scan spectra of solutions eluting from the PVDF membrane. Left: 125
pmol of ubiquitin applied to the chip in 1 M NaCl, and Right: 500 pmol of myoglobin
applied to the chip in 1 M NaCl.
The respective resolving powers are 128700 at m/z=1224 and 82700 at m/z=1428 for
the two isotopic distributions of ubiquitin, and 49600 at m/z=942 for the 18+ charge state of
myoglobin.
Desalting of peptides/pepsin digests
Determination of solvent accessibility in proteins and protein complexes by H/D
exchange followed by enzymatic digestion and MS of dozens of the resulting peptides
requires high sequence coverage as well as sufficient redundancy (defined herein as the
number of peptides in which each amino acid is represented) [89]. Figure 101 shows 10 co-
added ESI FT-ICR mass spectra of the peptides eluting from the membrane in 50%
MeOH:49.5% water:0.5% formic acid following peptic digestion of 100 pmol of
myoglobin.
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Figure 101. 10 scans co-added, corresponding to 100 pmoles digested myoglobin eluting
from the chip in 50% MeOH: 49.5% water: 0.5% formic acid.
58 peptides can be identified from this single spectrum, resulting in 98.7% sequence
coverage (only the two N-terminal amino acids are missing), with an average redundancy of
9.1 peptides per amino acid. The average mass accuracy is 9.9 ppm. At lower myoglobin
concentration, digests were eluted from the membrane in 75% MeOH:24.5% water:0.5%
formic acid in order to shorten the elution time and enhance sensitivity. Sequence coverage,
mass accuracy, and redundancy for each of various experimental conditions are given in
Table 17.
Number of
peptide
matches
Sequence
coverage (%)
Average mass
accuracy (ppm)
Redundancy4
(peptide/amino
acid)
100 pmol 58 98.7 9.9 ± 7.7 9.1 ± 4.4
10 pmol
(coadded)
16 96.7 19.0 ± 10.2 3.1 ± 2.0
500 fmol
(coadded)
12 58.2 25.5 ± 11.7 2.1 ± 2.4
Table 17. Evaluation of myoglobin mapping by on-chip desalting of peptic digest.
                                                 
4 Redundancy gives the average number of peptides in which one particular amino
acid is represented.
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For the two lower concentrations (100 pmol and 500 fmol of starting material), the
peptides elute differentially, so that it was necessary to co-add all spectra corresponding to
the total elution period (10 spectra for the 100 pmol digest and 4 spectra for the 500 fmol
digest) to obtain optimal sequence coverage. This difference in elution behaviour can be
explained by the limited binding capacity of the membrane (85 μg/cm2, supplier data, or a
binding capacity of ~100 pmol for the present membrane disk). The 100 pmol digest may
thus be close to the saturation of the membrane, and consequently have a different elution
behaviour. Several membranes can be stacked to increase the binding capacity if necessary,
without a significant increase in back-pressure (data not shown).
However, for the lowest concentration tested here (500 fmol of myoglobin), the
sequence coverage decreases to 60%, which may be satisfactory for protein identification
by peptide mass fingerprinting, but not for protein mapping experiments. The minimal
amount of starting material for this setup can thus be estimated to be between 10 pmol and
500 fmol to obtain good sequence coverage.
6. Conclusion
This chapter presented the integration of a solid-phase extraction step on
microfabricated polymer microsprays. This new sample clean-up process can be used off-
line, when capture membranes are incubated within the sample solutions to clean-up, and
then placed on the microspray for subsequent elution, or directly used as a stop-and-go
microspray with an infusion line. The sample is then pumped through the membrane which
is further washed before application of the elution solution. The main features of this
integrated sample clean-up process are its ease of use and quickness. The complete sample
loading, washing and elution can be completed within 2-5 minutes. The main drawback of
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this in-line process is that elution and spray onset have to be started at the same time in
order to follow the whole elution process, which turns out to be difficult in practice with the
prototype positioning devices used in this study: most of time, the chip positioning has to be
adjusted after the beginning of elution to obtain good spraying performances. One
possibility to circumvent this problem would be whether to develop a robust interface for
reproducible and easy microspray positioning, or to use dual microsprays (as described in
the following chapters): one microchannel would then be used to start the spray with a
typical spraying solution, and the other microchannel would be used as described in this
chapter for the SPE process. In this way, microspray positioning and electrospray onset
could be guaranteed before starting the elution.
Whereas the proof-of-concept described in this chapter was conducted with
PVDF membranes only, the same process can easily be adapted to membranes tailored with
other functions and selectivities, such as antibody-grafted membranes for affinity capture
and enrichment of specific compounds, which would prove useful in diagnostic applications
where no monoclonal antibody is available or where analyte heterogeneity need to be
characterised, even after antibody capture, or in proteomics applications where peptides
need to be quantified after antibody capture [90]. Alternatively, membranes can come from
an upstream process such as electroblotting after gel electrophoresis (even though elution of
electroblotted proteins may prove challenging) or chemical processing [91-93].
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Chapter 6. Whole protein analysis by dual
channel microsprayers
1. Introduction
Electrospray mass spectrometry is mainly used in proteomics for peptide analysis:
when combined with proteolysis, the measurement of peptide masses and partial sequences
by tandem mass spectrometry allow protein identification on a large scale. Whole protein
analysis by electrospray mass spectrometry has been used traditionally for protein
characterisation in various cases, such as for the control of the mass of a recombinant
protein, the investigation of protein interactions after chemical cross-linking… But whole
protein analysis does not allow protein identification, requires purified proteins, and usually
results in poorly localised information along the protein sequence (such as the localisation
of post-translational modifications).
One particular domain into which new breakthroughs have been obtained in the
recent years is the analysis of very large multi-protein complexes: the group of Carol
Robinson has been able to analyse intact ribosome complexes and determine their
components and their stoechiometry [1, 2], characterise antibody-antigen complexes [3] or
molecular chaperone complexes [4-7]. All these results proceed through analysis of gas
phase ions in the range on megadaltons that has been made possible by developments of
dedicated mass analysers.
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Recently, new mass spectrometric procedures (collectively named top-down
proteomics since they proceed from whole proteins) have been developed; basically they all
rely on new high energy dissociation techniques that are able to fragment proteins in the gas
phase, such as optimised collision-induced-dissociation (CID) [8], or electron capture
dissociation (ECD) [9-11]. Basically, proteins are first separated in the liquid phase by
reversed phase liquid chromatography or capillary electrophoresis, and then delivered to the
mass spectrometer by electrospray ionisation. First intact protein masses are measured, and
proteins are isolated in the gas phase, excited so that they fragment and fragment masses are
measured, in which case the isolated protein can be identified by peptide mass
fingerprinting, and its post-translational modifications characterised [12-14]. Top down
proteomics can now be performed directly from bacterial lysates, and provides full
characterisation of proteins up to a few tens of kilodaltons. Further technical developments
in terms of ion accumulation, speed of ion processing in the gas phase, and sensitivity are
necessary to enable the analysis of more complex proteomes. In addition, the range of
molecular weights that are currently accessible to full gas phase fractionation is still limited
to a small portion of proteomes. Nevertheless, top-down proteomics provides an analytical
route alternative to shotgun proteomics. Similarly to 2D-GE combined with MALDI-MS, it
does not necessitate complex database interrogation, as proteins are analysed one (or a few)
at a time.
In this chapter, a new microfabricated microsprayer is introduced, which comprises
two microchannels that have outlets in close proximity, on the edge of the microchip, so
that the solutions contained in the two microchannels mix only within the Taylor cone,
when electrospray is generated. By tuning solvent compositions and flow rates in the two
microchannels, proteins can be sprayed in their native state, or denaturated within the
Taylor cone by organic solvents or acids. Protein unfolding can thus be induced in solution
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and measured from the mass spectrum through the charge state distribution of the protein in
the mass spectrum.
2. Whole protein analysis by ESI-MS
2.1. Of the number of charges carried by a protein in vacuum
Protein analysis by mass spectrometry has been enabled by the development of soft
ionisation sources, namely electrospray ionisation (ESI) and Matrix Assisted Laser
Desorption Ionisation (MALDI) in the late eighties, that allow transfer of intact
biomolecules from the liquid (ESI) or solid (MALDI) phase to the gas phase where they are
separated according to their mass to charge ratio. A typical spectrum of a protein generated
by electrospray mass spectrometry is shown Figure 102:
Figure 102. Electrospray mass spectra of (A) insulin (5730 Da), (B) lysozyme (14300 Da),
(C) -amylase (54700 Da) and (D) conalbumin (76000 Da). Reprinted with permission
from [15].
Spectra display several peaks corresponding to different charge states of the protein;
each peak thus has an m/z ratio of [M+nH]/n where M is the protein molecular weight, H
the mass of a proton, and n the number of charges carried by the protein. The rationale for
the number of charges carried by a protein transferred to vacuum by ESI as well as the
distribution of m/z ratio has been the matter of a hot debate; a number of parameters of been
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identified to influence the observed number of charges, such as the number of basic
residues: arginine, lysine, histidine and the N terminus (in positive ion mode ESI) combined
with the solvent used, the folding state of the protein, as well as instrumental parameters
such as acceleration voltages or pressure of cooling gas used within the mass spectrometer.
It is well established that an upper limit for the number of charges carried by a denatured
protein in vacuum is the number of basic residues [16]:
protein  NH2 + H 3O+  protein  NH 3+ + H2O
However, the mass spectrum of a protein displays a statistical bell-shape charge
state distribution (CSD) whose mean value is not straightforwardly understandable from
liquid-phase chemistry: just to name an example, Wang and Cole found that the ratio
[M+2H]2+/[M+H]+ do not change in mass spectra of gramicidin S and bradykinin when the
solution pH is varied from 3 to 11, whereas the acid-base chemistry predicts a change in this
ratio from 105 to 10-2 for gramicidin S and 106 to 10-2 for bradykinin. Moreover, the same
authors found that the ionic strength of the electrosprayed solution has no effect on protein
charge states (as for example, myoglobin mean charge state changes from 14.46 to 14.05
when NH4OAc  concentration is increased from 0 to 0.3 M) [17]. Many other studies
confirmed that neither solution acid-base chemistry nor the ionic strength have impact on
the charge state distributions of proteins in ESI-MS. It is thus obvious that gas-phase
processes play a major role on the number of charges carried by proteins in the gas phase.
In summary, charged droplets are emitted from the apex of the Taylor cone and undergo
coulombic fissions and solvent evaporation. At a certain point, small analytes can escape
from electrospray droplets through columbic repulsion (charge evaporation model);
alternatively, large analytes stay within the droplets until there is only one analyte molecule
in the charged droplet surrounded by cations (charge residue model) (for a more detailed
description of the electrospray process, see Chapter 5). Protein charge in the gas phase thus
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depends on their ability to retain charges (protons in positive ion mode) within the
electrospray droplets through columbic fissions and solvent evaporation. This affinity is
described by the protein gas phase basicity:
M + H +  MH + GB(M ) = G1 (1)
The case of charge ions is more complex, because of the presence of an activation barrier
due to coulombic interactions:
MH + + H +  MH22+ GB(MH + ) = G2 (2)
Schnier et al have proposed a model for gas phase basicity of multiply charged ions [18]:
GBapp = GBint,t  q
2
40( )rri,ti=1
n (3)
Where GBapp is the apparent gas phase basicity of a protonation site t is the difference
between its intrinsic gas phase basicity (GBint,t) and the coulombic interaction experienced
by this site from other protons. Authors further calculated the lowest energy proton
configurations for each charge state using a pseudo random walk algorithm; from the
calculated configurations, the gas phase basicity of each protonation site was calculated,
and the global gas phase basicity of the charged protein was assigned the lowest gas phase
basicity among all the protonation sites. The latest step was to compare the calculated gas
phase basicities of multiply charged proteins within the gas phase basicity of the solvent in
order to determine the highest charge state of a protein ion that would not undergo proton
transfer to the solvent in the gas phase.
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Figure 103. Calculated apparent gas phase basicities as a function of charge state for nine
proteins. From left to right: melittin, ubiquitin, cytochrome C (tuna), cytochrome C
(equine), ribonuclease A, hemoglobin ( chain), myoglobin, carbonic anhydrase, actin, and
bovine serum albumin. The horizontal dashed line correspond to the gas phase of methanol
(174.1 kcal/mol); circled values correspond to the maximal experimental charge states.
Reprinted with permission from [18].
Figure 103 shows the excellent agreement between these calculations and the
experimentally observed maximum charge state (circled values), which is often much lower
than the number of basic residues. However in some cases, charge states higher than the
number of basic residues are observed, such as for ribonuclease A (19 basic residues, 23
charges observed) or carbonic anhydrase (37 basic residues, 44 charges observed); in these
cases, proline, glutamine and tryptophan are believed to retain additional protons. In
summary, the number of basic residues provides an upper limit for the number of charges
carried by a protein in the gas phase in most cases. However, the actual maximum charge
state of a protein depends on its gas phase basicity compared to that of the solvent used for
electrospray. In this case, calculations such as Eq. (3) provide a good estimate of this
maximum number of charge.
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2.2. Effect of conformation on charge state distributions of proteins
The calculations and experiments described above were all carried out with
denatured proteins. However, it was early recognised that the folding state of a protein had
an effect on its charge state distribution in ESI-MS [19]:
Figure 104. Electrospray mass spectra of cytochrome C (equine) at pH 2.6 (a), pH 3 (b)
and pH 5.2 (c). Reprinted with permission from [19].
As shown in Figure 104, at acidic pH, cytochrome C exhibit a unimodal charge state
distribution centred around the 15+ and 16+ peaks; at less acidic pH, a second distribution
appears around the 8+ ion. At near neutral pH, the charge state distribution is centred
around the 10+ ion. This shift in charge state distributions with acid concentration in
methanol containing solutions has been lately correlated to cytochrome C folding states by
circular dichroism [20], namely the full tertiary structure, the protein retaining the
secondary structure with no tertiary structure, and the fully denatured protein.
There is now a clear qualitative consensus about the impact of protein conformation
on charge state distribution in ESI-MS [21]: the more unfolded the protein, the more
charges are retained during electrospray (and thus the lower the mass-to-charge ratio); the
more folded the protein, the less charges are retained (and thus the higher the mass-to-
charge ratio). However, the reasons for this effect are still highly debated. De La Mora
proposed that native protein ions are formed via the charged residue model: proteins retain
charges that would be present on a droplet of a similar charge at its Rayleigh limit [22].
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However, this hypothesis was supported by very limited experimental sets, and did not
provide much rationale to account for differences in mass spectra of folded and denatured
proteins. That is the reason why Grandori recently proposed an alternative hypothesis: the
reduction of charges observed on folded proteins compared to denatured ones would come
from intramolecular neutralisation effects; protein charge states would thus simply be the
difference between the numbers of acidic and basic sites [23]. Despite the decent agreement
between this hypothesis and the experimental evidences presented [23, 24], the fact that
protein charge state depends on intrinsic liquid phase parameters only (contrary to
experimental evidences through years [17, 25-27]) rapidly cast doubts upon this hypothesis.
More recently, Nesatyy and Suter re-established the charged residue model as the main
mechanism for electrospray ionisation of folded proteins [28]:
Figure 105. Correlation between the observed maximal charge state of 79 proteins and the
charge carried by droplets of similar sizes at their Rayleigh limit (see Chapter 5 for more
details). Reprinted with permission from [28].
Authors further established as a rule of thumb that the main charge state of a folded
protein (most intense peak in the charge state distribution) is 0.85 of the calculated
maximum charge state. The overall picture that begins to emerge is that charge state
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distributions of proteins produced by electrospray do not depend on solution phase
chemistry, but proceeds through the charge residue model, into which the protein charge is
determined by the size of the electrosprayed protein: the number of charges carried by a
protein in vacuum is the number of charges carried by a droplet of the same size at its
Rayleigh limit. Differences between folded and unfolded proteins thus come solely from
different sizes; however, if folded proteins can be approximated by charged spheres (and
thus by charged droplets at their Rayleigh limit), unfolded proteins are usually assumed to
adopt linear conformations whose correspondence with charged droplets is more difficult to
delineate. In this prospect, the hyphenation of ion mobility analysers (IMA) with
conventional time-of-flight (TOF) analysers which provides the measurement of collisional
cross sections (IMA) together with charge state distributions (TOF) may allow to establish a
direct correlation between protein conformation and charge state distribution (Carol
Robinson, “Expanding Proteomics”, Annual Meeting of the Swiss Proteomics Society,
December 2005, 5-7, Zurich).
In this chapter a new microfabricated dual channel microsprayer is introduced for
the analysis of intact proteins, with emphasis on the determination of protein conformation
through the measurement of charge state distributions.
3. Materiel and Methods
3.1. Dual microsprayer fabrication
The dual channel microsprayer was fabricated according to the process described in
Chapter 3 and kindly provided by DiagnoSwiss (Monthey, Switzerland). Basically,
microchips consist in polyimide foils; one microchannel is etched on each side of the
Chapter 6. Whole protein analysis by dual channel microsprayers
252
microchip, so that they are superposed on the edge of the chip, where the electrospray is to
be generated.
Figure 106. Left: scheme of the dual channel microsprayer with pasted reservoirs. Right:
scanning electron microscopy picture of a cross section of the dual channel microsprayer.
Microchannels are 120 μm wide, 45 μm deep, and are separated by 20 μm of polyimide.
Lastly, reservoirs are pasted over the inlets of the two microchannels in order to load
samples and solvents.
3.2. Chemicals and reagents
Analytical grade methanol (MeOH) and trifluoroacetic acid (TFA) are from Riedel
de Haen (Darmstaadt, Germany), acetic acid, propranolol-S-hydrochloride are from Fluka
(Buchs, Switzerland), and HPLC grade acetonitrile (ACN) is from SDS (Peypin, France).
Caffeine, reserpine, horse heart cytochrome C, hen egg white lysozyme and bovine
myoglobin are from Sigma (St Louis, MO, USA). Deionised water (18.2 MW.cm) is
obtained from a MilliQ unit (Millipore, Bedford, USA).
3.3. Mass spectrometry
Mass spectrometer is a LCQ Duo ion trap from Thermo Electron (San Jose, CA,
USA). All experiments were done in full scan mode (50-2000 m/z) without any averaging,
the heated capillary is kept at 200 °C, and ion optics parameters are optimized on the
studied compound. The dual channel microsprayer is directly pasted on the x-y-z table with
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double sided adhesive tape, and positioned in front of the heated capillary inlet, typically 3-
5 mm away. The electrospray voltage is applied through a platinum wire plunge into one of
the pasted reservoirs, and typically set between 2 and 3 kV. An additional voltage can be
applied through a second platinum wire in the second reservoir thanks to a home made
floating high power supply.
4. Results
4.1. Mode of operation
The dual channel microsprayer can be used under gravity induced flow alone or
under a combination of gravity induced flow and electrokinetic flow (see Chapter 3). Given
that two different voltages can be applied at two different points on the chip, the mode of
operation is slightly more complex than a single channel microsprayer;
Figure 107. Electrical scheme of the dual channel microsprayer. V1 and V2 are the voltages
applied in the two reservoirs, R1 and R2 the resistances of the two microchannels, Rgap the
resistance of the air gap between the microchip and the mass spectrometer inlet (typically
in the gigaohm range), and Vcap the voltage applied on the heated capillary (typically in the
range –30 to +30 V). The node between the three branches represent the apex of the Taylor
cone where electrospray is generated.
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It is straightforward to calculate the voltage at the node between the three branches:
Vtip =
Vcap
Rgap
+
V1
R1
+
V2
R2
1
Rgap
+
1
R1
+
1
R2
(4)
In most cases Rgap can be assumed to be large compared to R1 and R2, and Vcap to be
small compared to V1 and V2. In this case, if the reservoir 1 is filled with an aqueous
solution containing electrolytes and the reservoir 2 is filled with pure methanol (as is often
the case in the experiments described below), then R1 is small compared to R2. It thus comes
that Vtip is closed to V1, and all U is available to generate electroosmotic flow in
microchannel 2, whereas there is only a negligible electric field to generate electroosmotic
flow in microchannel 1.
4.2. Dual channel microsprayer characterisation
The initial purpose of this dual channel microsprayer was to tune the relative
amounts of the two solutions (coming from the two microchannels) within the Taylor cone
while spraying. In order to test the possibility to tune electrokinetically the flow rates in the
two microchannels, 100 μM of propranolol and caffeine were loaded in pure water in one
reservoir (20 μL), and 100 μM of reserpine is loaded in pure methanol in the other reservoir
(20 μL). Electrospray voltage (3.2 kV) is applied in the reservoir containing reserpine in
methanol, and additional voltage can be applied in the aqueous reservoir.
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Figure 108. Characterisation of the dual channel microsprayer. Left: Total ion
chromatogram with varying voltage applied in the aqueous reservoir (bottom). Right:
resulting mass spectra at additional voltage 0V (bottom) and 400 V (top).
Figure 108 shows the effect of varying the additional voltage in the aqueous voltage:
at 0 V, the total ion count is low and the mass spectrum contains caffein (m/z=195.4),
propranolol (m/z=260.5), and reserpine (m/z=609.6), in comparative amounts. This means
that both microchannels are operated under gravity induced flow, and all analytes are thus
present in equal amounts in the mass spectrum. When the additional voltage in the aqueous
microchannel is shifted to 400 V, the total ion count increases (approximately threefold),
and reserpine almost disappears from the mass spectrum, due to the large increase in
caffeine and propranolol intensities. This corresponds to a large increase in the flow rate
coming from the aqueous microchannel due to the additional electroosmotic flow.
In order to properly measure the gain in sensitivity that can be obtained by tuning
the relative flow rates between the organic sheath flow and the aqueous sample, 50 μM of
reserpine in methanol was loaded in one reservoir (20 μL), and 100 μM of propranolol in
water was loaded in the other reservoir (20 μL). Electrospray voltage was applied to the
organic reservoir (3.0 kV), and the additional voltage (U) to the aqueous reservoir.
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Figure 109. Analysis of aqueous propranolol with reserpine in the organic sheath flow.Left:
selected ion chromatograms of propranolol and reserpine, and U values. Right: ratio
between propranolol and reserpine.
Figure 109 shows the effect of U on the mass spectrum of propranolol and
reserpine: for U=0 V, both propranolol and reserpine are visible in the spectrum (intensity
ratio around 2). When U increases, more aqueous solution is electrokinetically pumped
into the Taylor cone, which results in a large increase in propranolol intensity. Above
U=400 V, the spray became instable, most probably because higher flow rates necessitate
higher electrospray voltage (in this experiment, electrospray voltage was kept at 3.0 kV).
These two experiments show that composition of the electrosprayed solution can be
tuned by electrokinetically varying the flow rate in one of the microchannels. Doing so, it is
possible to inject more aqueous solution containing the sample, and thus adjusting the
relative amount of organic modifier, or alternatively control the amount of organic modifier
injected in a constant flow of aqueous sample.
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4.3. Analysis of intact protein
In order to explore the ability to spray with the dual channel microsprayer in various
solvent conditions, 50 μM of cytochrome C was loaded in water with 40 mM of ammonium
acetate and various amounts of acetic acid in one reservoir (20 μL), and 20 μL of methanol
was loaded in the other reservoir. Electrospray voltage (2.8 kV) was applied in the aqueous
reservoir.
Figure 110. Acid induced denaturation of cytochrome C. Top: no acetic acid; middle: 0.1 %
acetic acid; bottom: 1% of acetic acid.
As shown in Figure 110, when no acid is present, only the high m/z distribution of
cytochrome C (8+ charge state) is visible, which correspond to native cytochrome C.
Analysis of a purely aqueous solution of cytochrome C is completely impossible with a
microchip embedding a single channel of similar dimensions. When acetic acid
concentration increases, the unfolded distribution of cytochrome C, centred around 13+
charge state appears, which is consistent with the literature [20, 29]. In order to validate that
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cytochrome C denaturation is due solely to the presence of acetic acid, and not to
electrospray ionisation itself, cytochrome C was replaced by lysozyme, a protein that is
known to be highly resistant to acid induced denaturation.
Figure 111. Analysis of 50 μM of lysozyme in 40 mM ammonium acetate and various
amounts of acetic acid in the aqueous reservoir. Organic reservoir is pure methanol. Peaks
in the low mass range are internal standards.
Figure 111 testifies that the electrospray process itself cannot account for
cytochrome C denaturation in the experiment above, because lysozyme is always observed
in its folded state, whatever the acetic acid amount added.
If the experiment is done in the other way, i.e. if the aqueous solution is always the
same (50 μM of cytochrome C in 40 mM of ammonium acetate) and various amounts of
acetic acid are added to the organic reservoir, the same kind of results is obtained:
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Figure 112. Cytochrome C denaturation within the Taylor cone. Acetic acid is added to the
organic reservoir: 0% (top), 0.1% (middle) and 1% (bottom).
Again the native distribution of cytochrome C is observed when no acid is present,
and the unfolded distribution appears when acetic acid content increases. The unique feature
is here that protein denaturation takes place within the Taylor cone during electrospray
ionisation: cytochrome C does not meet acetic acid before it reaches the Taylor cone.
The ability to denature proteins within the Taylor cone opens the possibility for
online tuneable protein denaturation during electrospray ionisation: 50 μM of cytochrome C
in 40 mM ammonium acetate was loaded in the aqueous reservoir, into which electrospray
voltage was applied (3.2 kV). Pure methanol was loaded into the organic reservoir, into
which an additional platinum electrode allow to apply an additional voltage.
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Figure 113. On-chip tuneable cytochrome C denaturation.
Figure 113 shows the effect of varying the additional voltage (U) in the methanol
reservoir on the spectrum: at U=0V, minimum amount of methanol is incorporated in the
spray, and cytochrome C remains in its native distribution. When U increases, more
methanol is pumped into the Taylor cone and induces denaturation of cytochrome C [20,
29].
Similarly, the possibility to analyse folded proteins pushes toward the analysis of
non covalent protein complexes: the aqueous reservoir was loaded with holomyoglobin at
50 μM in 40 mM of ammonium acetate, and the organic reservoir with pure methanol.
Electrospray voltage was applied to the aqueous reservoir (2.9 kV).
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Figure 114. Analysis of holomyoglobin (low mass ions are internal standards).
Holomyoglobin exhibits very low intensity, because its isoelectric point is below the
pH used here. The heme group appears alone, as is always the case in myoglobin samples.
However, ion trap isolation of the ion present around m/z= 1950 allows to measure more
precisely the mass-to-charge of the ion, which correspond exactly to the 9+ charge state of
holomyoglobin.
Figure 115. Ion trap isolation of the 9+ ion of holomyoglobin.
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In order to further confirm the identity of this ion, it was subjected to low energy ion
trap collision induced dissociation (CID at 20%):
Figure 116. Low energy CID of holomyoglobin.
The low energy CID of the putative 9+ ion of holomyoglobin results in the release
of heme (at m/z=616) and a major peak in the high mass range that corresponds to the 9+
ion of apomyoglobin.
5. Conclusion and perspectives
In this chapter, a new microfabricated dual channel microsprayer has been
introduced for the analysis of intact proteins in the context of conformational analysis and
for the analysis of non covalent complexes. Though this set of experiments has been limited
by the fact that all experiments were performed on an ion trap instrument with a low mass
range, it demonstrates the potential of this new microsprayer for folding studies. In
particular, the on-chip tuneable denaturation of cytochrome C by methanol opens the way
for full characterisation of protein denaturation: though the example shows only the spectra
of cytochrome C at three different amount of methanol injected into the Taylor cone (see
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Figure 113), it may be feasible to obtain more continuous values from intact cytochrome C
(top row in Figure 113) to full denaturation of cytochrome C. From such an experiment, it
would then be feasible to plot the average charge state of the protein versus U (or ideally
versus the flow rate of methanol). A comparable experiment has been performed by
Grandori et al with multiple off-line experiments for the acid-induced denaturation of
cytochrome C [30]:
Figure 117. Acid-induced denaturation of cytochrome C measured by nanospray ESI-MS
(full line), tryptophan fluorescence (open circles), and Soret absorption (open triangles).
As shown in Figure 117, acid-induced denaturation of cytochrome C as monitored
by ESI-MS provides results in good agreement with other biophysical methods. In order to
gain approval by the community, this methodology still needs to be tested on other proteins,
side by side with reference biophysical methods, such as circular dichroism. If the
generality of the method is proven, mass spectrometry may provide a breakthrough in
routine thermodynamic studies of protein stability, in the measure that it can work with
minute amounts of proteins (nanomole range used above compared to micromole range for
most biophysical methods), with poorly purified proteins, contrary to optical methods, it can
differentiate co-existing conformations by the existence of multimodal charge state
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distributions in the mass spectrum, and does not rely on the presence of any particular probe
within the protein structure (as is the case with tryptophan fluorescence).
More technical applications of such a new device could be for the hyphenation of
liquid chromatography with ESI-MS: one microchannel could be connected to the HPLC
eluent while the other could serve as a tuneable sheath flow for optimal ionisation of
hydrophilic fractions. One other possible application is to perform post-column labelling:
for example, the peptide KCTCCA was loaded in water with 40 mM of ammonium acetate
and 1% acetic acid in one reservoir into which electrospray voltage was applied, and
carboxymethylbenzoquinone in pure methanol in the other reservoir (in acidic conditions,
carboxymethylbenzoquinone reacts selectively with cysteine residues [31, 32]):
Figure 118. Post column labelling of the peptide KCTCCA with
carboxymethylbenzoquinone.
Figure 118 shows the effect of the additional voltage applied in the organic reservoir
to the tagging of the peptide KCTCCA: at U=0V, there is enough
carboxymethylhydroquinone pumped by gravity induced flow to tag the three cysteines,
resulting in three additional peaks. When U is increased to 200 V, more
carboxymethylhydroquinone is pumped into the Taylor cone, resulting in a decrease of the
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untagged KCTCCA peak, whereas adduct peaks increase. If U is further increased, the
untagged peptide peak disappears, giving rise to more intense adduct peaks. This simple
experiment shows that the dual channel microsprayer can also be used for post-column
labelling and tuned depending on the desired tagging effect.
6. References
[1] Benjamin, D. R., Robinson, C. V., Hendrick, J. P., Hartl, F. U., Dobson, C. M.,
Mass spectrometry of ribosomes and ribosomal subunits, Proc. Natl. Acad. Sci. U.
S. A., 1998, 95(13): 7391-7395.
[2] Rostom, A. A., Fucini, P., Benjamin, D. R., Juenemann, R., Nierhaus, K. H., Hartl,
F. U., Dobson, C. M., Robinson, C. V., Detection and selective dissociation of intact
ribosomes in a mass spectrometer, Proc. Natl. Acad. Sci. U. S. A., 2000, 97(10):
5185-5190.
[3] Tito, M. A., Miller, J., Walker, N., Griffin, K. F., Williamson, E. D., Despeyroux-
Hill, D., Titball, R. W., Robinson, C. V., Probing molecular interactions in intact
antibody: Antigen complexes, an electrospray time-of-flight mass spectrometry
approach, Biophys. J., 2001, 81(6): 3503-3509.
[4] Fandrich, M., Tito, M. A., Leroux, M. R., Rostom, A. A., Hartl, F. U., Dobson, C.
M., Robinson, C. V., Observation of the noncovalent assembly and disassembly
pathways of the chaperone complex MtGimC by mass spectrometry, Proc. Natl.
Acad. Sci. U. S. A., 2000, 97(26): 14151-14155.
[5] Hernandez, H., Robinson, C. V., Dynamic protein complexes: Insights from mass
spectrometry, J. Biol. Chem., 2001, 276(50): 46685-46688.
[6] Aquilina, A. J., Benesch, J. L. P., Bateman, O. A., Slingsby, C., Robinson, C. V.,
Polydispersity of a mammalian chaperone: Mass spectrometry reveals the
population of oligomers in alpha B-crystallin, Proc. Natl. Acad. Sci. U. S. A., 2003,
100(19): 10611-10616.
[7] Sobott, F., Robinson, C. V., Characterising electrosprayed biomolecules using
tandem-MS - the noncovalent GroEL chaperonin assembly, Int. J. Mass Spectrom.,
2004, 236(1-3): 25-32.
[8] Keller, K. M., Brodbelt, J. S., Hettich, R. L., Van Berkel, G. J., Comparison of
sustained off-resonance irradiation collisionally activated dissociation and multipole
storage-assisted dissociation for top-down protein analysis, J. Mass Spectrom.,
2004, 39(4): 402-411.
[9] Sze, S. K., Ge, Y., Oh, H., McLafferty, F. W., Top-down mass spectrometry of a 29-
kDa protein for characterization of any posttranslational modification to within one
residue, Proc. Natl. Acad. Sci. U. S. A., 2002, 99(4): 1774-1779.
[10] Patrie, S. M., Charlebois, J. P., Whipple, D., Kelleher, N. L., Hendrickson, C. L.,
Quinn, J. P., Marshall, A. G., Mukhopadhyay, B., Construction of a hybrid
quadrupole/Fourier Transform Ion Cyclotron Resonance Mass Spectrometer for
Chapter 6. Whole protein analysis by dual channel microsprayers
266
versatile MS/MS above 10 kDa, J. Am. Soc. Mass Spectrom., 2004, 15(7): 1099-
1108.
[11] Zubarev, R. A., Electron-capture dissociation tandem mass spectrometry, Curr.
Opin. Biotechnol., 2004, 15(1): 12-16.
[12] Wu, S. L., Jardine, I., Hancock, W. S., Karger, B. L., A new and sensitive on-line
liquid chromatography/mass spectrometric approach for top-down protein analysis:
the comprehensive analysis of human growth hormone in an E. coli lysate using a
hybrid linear ion trap/Fourier transform ion cyclotron resonance mass spectrometer,
Rapid Commun. Mass Spectrom., 2004, 18(19): 2201-2207.
[13] Du, Y., Meng, F. Y., Patrie, S. M., Miller, L. M., Kelleher, N. L., Improved
molecular weight-based processing of intact proteins for interrogation by
quadrupole-enhanced FT MS/MS, J. Proteome Res., 2004, 3(4): 801-806.
[14] Patrie, S. M., Robinson, D. E., Meng, F. Y., Du, Y., Kelleher, N. L., Strategies for
automating top-down protein analysis with Q-FTICR MS, Int. J. Mass Spectrom.,
2004, 234(1-3): 175-184.
[15] Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., Whitehouse, C. M., Electrospray
ionization for mass-spectrometry of large biomolecules, Science, 1989, 246(4926):
64-71.
[16] Covey, T. R., Bonner, R. F., Shushan, B. I., Henion, J., Rapid Commun. Mass.
Spectrom., 1988, 2(249-256.
[17] Wang, G., Cole, R. B., Effect of solution ionic strength on analyte charge state
distributions in positive and negative electrospray mass spectrometry, Anal.Chem.,
1994, 66(21): 3702-3708.
[18] Schnier, P. D., Gross, D. S., Williams, E. R., On the maximum charge-state and
proton-transfer reactivity of peptide and protein ions formed by electrospray-
ionization, J. Am. Soc. Mass Spectrom., 1995, 6(11): 1086-1097.
[19] Chowdhury, S. K., Katta, V., Chait, B. T., Probing conformational-changes in
proteins by mass-spectrometry, J. Am. Chem. Soc., 1990, 112(24): 9012-9013.
[20] Konermann, L., Douglas, D. J., Acid-induced unfolding of cytochrome c at different
methanol concentrations: Electrospray ionization mass spectrometry specifically
monitors changes in the tertiary structure, Biochemistry, 1997, 36(40): 12296-12302.
[21] Kaltashov, I. A., Eyles, S. J., Studies of biomolecular conformations and
conformational dynamics by mass spectrometry, Mass Spectrom. Rev., 2002, 21(1):
37-71.
[22] de la Mora, J. F., Electrospray ionization of large multiply charged species proceeds
via Dole's charged residue mechanism, Anal. Chim. Acta, 2000, 406(1): 93-104.
[23] Grandori, R., Origin of the conformation dependence of protein charge-state
distributions in electrospray ionization mass spectrometry, J. Mass Spectrom., 2003,
38(1): 11-15.
[24] Samalikova, M., Grandori, R., Role of opposite charges in protein electrospray
ionization mass spectrometry, J. Mass Spectrom., 2003, 38(9): 941-947.
[25] Wang, G. D., Cole, R. B., Disparity between solution-phase equilibria and charge-
state distributions in positive-ion electrospray mass-spectrometry, Org. Mass
Spectrom., 1994, 29(8): 419-427.
[26] Wang, G. D., Cole, R. B., Effects of solvent and counterion on ion pairing and
observed charge states of diquaternary ammonium salts in electrospray ionization
mass spectrometry, J. Am. Soc. Mass Spectrom., 1996, 7(10): 1050-1058.
[27] Wang, G., Cole, R. B., Solution, gas-phase, and instrumental parameters influences
on charge-state distributions in electrospray ionization mass spectrometry. In
Microfluidic front-end technologies for protein electrospray mass spectrometry
267
Electrospray ionization mass spectrometry. Ed. Cole, R. B. 1997. John Wiley &
Sons, New-York, pp 137-174.
[28] Nesatyy, V. J., Suter, M. J. F., On the conformation-dependent neutralization theory
and charging of individual proteins and their non-covalent complexes in the gas
phase, J. Mass Spectrom., 2004, 39(1): 93-97.
[29] Babu, K. R., Moradian, A., Douglas, D. J., The methanol-induced conformational
transitions of beta- lactoglobulin, cytochrome c, and ubiquitin at low pH: A study by
electrospray ionization mass spectrometry, J. Am. Soc. Mass Spectrom., 2001, 12(3):
317-328.
[30] Samalikova, M., Matecko, I., Muller, N., Grandori, R., Interpreting conformational
effects in protein nano-ESI-MS spectra, Anal. Bioanal. Chem., 2004, 378(4): 1112-
1123.
[31] Roussel, C., Dayon, L., Lion, N., Rohner, T. C., Josserand, J., Rossier, J. S., Jensen,
H., Girault, H. H., Generation of mass-tags by the inherent electrochemistry of
electrospray for protein mass spectrometry, J. Amer. Soc. Mass Spectrom., 2004,
15(12): 1767-1779.
[32] Dayon, L., Roussel, C., Prudent, M., Lion, N., Girault, H. H., On-line counting of
cysteine residues in peptides during electrospray ionisation by electrogenerated tags
and its application to protein identification, Electrophoresis, 2005, 26(1): 238-247.
Chapter 6. Whole protein analysis by dual channel microsprayers
268
Microfluidic front-end technologies for protein electrospray mass spectrometry
269
Chapter  7 . Evaluat ion of  mass
spectrometric front-end technologies to
increase peptide uniqueness in shotgun
proteomics
1. Introduction
Protein identification by mass spectrometry mostly proceeds through bottom-up
strategies, in which protein identification is derived from the analysis of proteolytic
peptides, contrary to top-down strategies in which the analysis proceeds from intact
proteins. Since top-down strategies are beyond the scope of this work, and necessitate the
development of dedicated instrumentation based on FT-ICR-MS, this section focuses on
bottom-up approaches (the reader is referred to references [1-7] for more details on the top-
down strategy). In bottom-up approaches, proteins are enzymatically digested (most often
by trypsin [8]) and the resulting peptides are subjected to mass spectrometric analysis. If the
tryptic peptide mixture comes from very simple protein mixtures, their mass alone is
sufficient to identify their parent proteins. This is the peptide mass fingerprinting approach
[9], which is mostly used with MALDI-TOF-MS after protein separation by two
dimensional gel electrophoresis (2D-GE). As summed up in chapter 1, another approach has
been introduced recently to circumvent the caveats of protein separations: the whole protein
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mixture is digested by trypsin to produce a peptide mixture that is more complex in terms of
component number, but more homogeneous in terms of physical properties
(hydrophobicity, charge, size…) and can thus be handled more easily. This approach is the
shotgun strategy pioneered by John Yates [10-12], and Ruedi Aebersold [13-15] for its
quantitative aspects. Unfortunately, the peptide mass fingerprinting approach (identification
of a protein from the measurement of its tryptic peptide masses alone) proved to be
inefficient when dealing with complex protein mixtures (and thus even more complex
tryptic peptide mixtures), and online MS/MS peptide sequencing is necessary to
complement the peptide masses information with partial sequence information to
interrogate genomic or proteomic databases. This shotgun approach is best implemented
with ion trap instruments that allow fast MS/MS sequencing with decent mass accuracy, in
the context of discovery proteomic experiments. One caveat of such experimental procedure
is that it requires long acquisition times (typically 24 hour run of LC/LC-MS/MS [11]
followed by days to weeks of database interrogation). The second drawback of the method
is that it leads to complete re-identification of proteins even when the protein content of a
sample is known (as is the case when one wants to compare a disease sample to a reference
one).
Recently Richard Smith has introduced a new methodology called Accurate Mass
Tags approach, in which a proteome is first analysed in a discovery mode by “traditional”
shotgun techniques (LC-MS/MS) on an ion trap instrument. The set of identified peptides is
then analysed to mine out those peptides that are unique in the digested proteome (i.e. that
do not have any isobar) at high mass resolution. Other comparable samples (such as a
disease sample) can thus be run on fast LC-FT-ICR-MS (without any MS/MS): only the
peptides previously identified as unique are looked for by the mass spectrometer and leads
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to protein presence confirmation [16-20]. A simulation of the number of unique peptides
based on high mass resolution measurements is shown in Figure 119:
Figure 119. Calculation of unique peptides in A) yeast and B) C. Elegans (from NCBI
GenBank database) at various mass accuracies. Reprinted with permission from [16].
Unique peptides are here defined as peptides whose sequence can be unambiguously
assigned from mass spectral measurement and database knowledge, be it a comprehensive
community database such as SwissProt or Trembl, or an in-house experimental database.
The goal of all shotgun approaches is to acquire as much information as possible before
database interrogation in order to limit the number of protein candidates that would match
the experimental data. Acquiring MS/MS data is one way to limit the search space within
the protein database, as well as working with accurate mass tags at high mass accuracy and
high mass resolving power allows to provide more stringent information to database search.
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High mass accuracy and resolving power, and partial sequence information are not
the only ways to add discriminating information to database search, and additional
methodologies are being examined in order to complement mass spectrometric information.
2. Complementary technologies in shotgun proteomics
Two main methodologies have been investigated to complement mass spectrometric
information: peptide retention time in reverse phase liquid chromatography, and isoelectric
point measurement.
2.1. Peptide retention times
Richard Smith’s group has attempted to complement the AMT strategy based on
high resolution mass spectrometry with peptide retention times in reverse phase liquid
chromatography. In order to evaluate the potential of the approach, Petritis et al have
developed a model for the prediction of peptide retention times based on a neural network
trained on a set of 42378 tryptic peptides from S. Oneidensis [21]:
Figure 120. Predicted Net Retention Time versus observed Net Retention Time. Reprinted
with permission from [21].
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Authors then used the predicted net retention time to re-analyse the number of
accurate mass tags based on high mass accuracy previously measured in D. Radiodurans:
Figure 121. Small region of a 2D map of a TOF-MS analysis of D. Radiodurans. Each spot
corresponds to an observed peptide; boxes represent the expected elution times (with
tolerance derived from experimental variance). Reprinted with permission from [22].
The addition of LC retention times allows to discriminate between peptides that
have nominal same masses at a given resolution (spots spanned on the same horizontal
line): for example peptides FGLEGGESFIPLMDR and VYIDNTDPTVNFNR have masses
differing by 4.2 ppm only, but differ in retention time and are thus clearly resolvable. The
main drawback of this approach is that peptide retention times are not truly orthogonal to
peptide masses, as shown below:
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Figure 122. Predicted molecular weight and Net Retention Times of tryptic peptides from
D. Radiodurans. Reprinted with permission from [23].
The use of peptide retention times to increase the number of unique peptides in
whole digested proteomes is shown in Figure 123:
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Figure 123. Percentage of unique peptides in whole proteomes based on mass accuracy
alone (left) and different peptide retention time stringency (middle and right). HMEC is a
Human Mammary Epithelial Cells proteome. Reprinted with permission from [23].
The addition of the retention time information allows to increase the percentage of
unique peptides in each proteome. However, as the methodology does not lead to a dramatic
increase in the number of unique peptides, authors conclude that this methodology can
prove efficient for low complexity proteomes or for sub-proteomes only, and that the
measurement of higher organisms’ proteomes by this methodology is still out of reach.
2.2. Isoelectric point
Similarly to peptide retention times, Stephenson’s group has investigated the use of
isoelectric point to increase the number of unique peptides in shotgun proteomics [24].
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Tryptic peptide molecular weight and isoelectric points were computed and the number of
unique peptides was counted:
Figure 124. Percentage of unique peptides versus mass and isoelectric point accuracies for
E. Coli (a) and R. Norvegicus (b). Reprinted with permission from [24].
Mass accuracies are varied between 0.1 and 100 ppm and isoelectric point
accuracies between 0.01 and 2. Results are similar to those exposed below, and were further
exploited experimentally with in-gel isoelectric focusing [25]. The limit of the approach
was the actual resolution of the IEF, which was unknown. In practice, 28 fractions were cut
over the IPG strip (pH 3-10), corresponding to a theoretical pH= 0.25. Authors failed to
identify one source of error that was misinterpreted as diffusion of peptides within the gel
once the voltage was switched off: in fact some peptides have a charge derivative at
isoelectric point close to zero, which means that they will focus very slowly compared to
other peptides. Hence, they will produce broad bands unless infinite focusing time is
applied [26] (see below for a further discussion on the limits of isoelectric point
measurements).
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3. Online electrochemical tagging of cysteine residues:
eTag(Cys)
Our laboratory has recently introduced an online tagging technology [27] that allows
counting of cysteines contained in a peptide from a simple MS spectrum [28]. Basically,
neutral hydroquinones are injected together with the sample to analyse. Due to their low
electrochemical potential, hydroquinones are converted into benzoquinones on the
electrospray electrodes, and reacts specifically with cysteine residues:
Figure 125. Scheme of the electrochemical tagging: the hydroquinone A is converted into
benzoquinone B onto the electrospray electrode, then reacts with the cysteine containing
peptide X to give the adduct C that can be further reoxidised into E. Reprinted with
permission from [29].
The overall reaction is an ECE (electrochemical-chemical-electrochemical)
mechanism that has been studied in details [30]:
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Figure 126. Mechanism of the ECE reaction. Reprinted with permission from [30].
The addition of benzoquinone onto the cysteine residue proceeds through a Michael
addition that is specific in acidic conditions. Both the design of the microspray emitter
(whose geometry plays a role on the overall tagging efficiency) [29] and the choice of the
hydroquinone probe [31] have been optimised to reach good tagging conditions, in which
the tagging reaction is not quantitative, but is efficient enough to tag several cysteine
residues in the same peptide. The typical tagging result is depicted in Figure 127:
Figure 127. Tagging of the ACKCTCM peptides by hydroquinone (a) and
carboxymethylhydroquinone (b). Reprinted with permission from [28].
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The tagging process proved efficient even with consecutive cysteines [28], and
allows direct counting of cysteines in a peptide by examining the number of additional
peaks in the mass spectrum [32]. When used for database interrogation for protein
identification by peptide mass fingerprinting, this additional information was shown to
result in a dramatic increase in protein identification scores [28].
4. Off-Gel electrophoresis of peptides and proteins
Our laboratory has introduced a new technology for liquid-phase separation of
peptides and proteins based on isoelectric focusing [33, 34]. Basically, wells are put over an
immobilised pH gradient (IPG) strip, in which the solution to fractionate is sampled. Upon
application of an electric field, peptides or proteins moves within wells according to their
charge until they reach their isoelectric point, and enter the IPG gel only to jump from one
well to another.
Figure 128. Scheme of the Off-Gel electrophoresis device. Reprinted with permission from
[34].
The clear advantage of this separation procedure over in-gel separations is that
peptides or proteins can be directly recovered from solution. Its advantages over capillary
isoelectric focusing are a higher loading capacity and an easier fraction recovery. Recently,
this technique has been used for human plasma proteome fractionation and subsequent
tryptic peptide separation prior to LC-MS/MS [35]. In this work, the peptide pI was used to
validate MS/MS spectra by comparing the pI predicted from the sequence obtained by
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MS/MS with the experimental one. The resolution of Off-Gel electrophoresis depends on
the IPG pH gradient and on the number of wells placed over the IPG strip. Depending on
the IPG strip used and the focusing time applied, resolutions of 0.2 can be reached in
routine and 0.05 in particular experiments.
5. Computing of peptide uniqueness
In order to evaluate the potential interest of online cysteine tagging (eTag(Cys)) and
isoelectric separation (Off-Gel) for accurate mass tag approaches, a program was written
using Igor software to simulate whole proteome digestion, compute peptide molecular
weights and pIs, and count the number of unique peptides within the whole digested
proteome according to the mass accuracy used, pI accuracy, and number of cysteines.
5.1. Material and methods
The program was written using Igor (WaveMetrics, Portland, USA) and run on an
Apple PowerBook G4 (1.33 GHz and 512 Mo SDRAM) or on an Apple iMac G5 (2 GHz
and 1 Go SDRAM). Proteomes of Deinococcus Radiodurans, Saccharomyces Cerevisiae,
and Homo Sapiens were downloaded from SwissProt in the fasta format. The program can
simulate protein digestion by trypsin (cleavage at lysine or arginine) or by pepsin (cleavage
probability of 0.8 at F, L, and E and user-defined probability at other residues). Other
digestion parameters, such as the number of allowed tryptic miscleavages, the minimal
peptide length, the pepsin cleavage frequency… are user-defined and can be adjusted for
each simulation. Proteins and peptides molecular weight and pI are computed from the
following values:
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Amino acid COOH
pKa
NH3
pKa
Side
chain
pKa
Monoisotopic
molecular weight
(Da)
Average
molecular
weight (Da)
Alanine (A) 2.4 9.9 71.03711 71.0788
Arginine (R) 1.8 9.0 12.2 156.10111 156.1875
Asparagine (N) 2.0 8.8 114.04293 114.1038
Aspartic acid (D) 2.0 10.0 3.9 115.02694 115.0886
Cysteine (C) 1.9 10.3 8.4 103.00919 103.1388
Glutamine (Q) 2.2 9.1 128.05858 128.1307
Glutamic acid (E) 2.1 10.0 4.3 129.04259 129.1155
Glycine (G) 2.4 9.8 57.02146 57.0519
Histidine (H) 1.8 9.2 6.1 137.05891 137.1411
Leucine/Isoleucine
(I/L)
2.3 9.7 113.08406 113.1594
Lysine (K) 2.2 9.2 10.8 128.09496 128.1741
Methionine (M) 2.2 9.3 131.04049 131.1926
Phenylalanine (F) 2.6 9.2 147.06841 147.1766
Proline (P) 2.0 10.6 97.05276 97.1167
Serine (S) 2.2 9.4 87.03203 87.0782
Threonine (T) 2.1 9.1 101.04768 101.1051
Tryptophane (W) 2.4 9.4 186.07931 186.2132
Tyrosine (Y) 2.2 9.1 10.1 163.06333 163.1760
Valine (V) 2.3 9.7 99.06841 99.1326
Table 18. Physicochemical parameters of amino acids.  Monoisotopic mass of a water
molecule is 18.01056 Da, average mass of a water molecule is 18.01524.
5.2. Program validation
The program was validated manually on a small set of proteins indicated below
against the online tool MS Digest (http://prospector.ucsf.edu):
Sequence
Or SwissProt
reference
Number of tryptic peptides
from MS digest
Number of tryptic peptides from the
in-house software
E(31) 1 1
P39687 65 65
P38903 216 221
P31383 162 162
Q00362 151 159
Table 19. Validation set of the in-house software.
Differences in the number of tryptic peptides produced by the two programs
correspond to the fact that trypsin cleavage inhibition by proline is not taken into account in
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the in-house program. From the validation set, it is estimated that this results in an
additional 5% of tryptic peptides. All other tryptic peptides are identical. Monoisotopic and
average molecular weights were found to be equal to those calculated by MS Digest. pIs
were validated against the online tool pI/MW Compute (http://www.expasy.ch): due to
differences in pKas used (in particular the influence of amino acids adjacent to the N-ter or
C-ter on N-ter or C-ter pKas), the pI values were slightly different, but never differed by
more than 0.5 pH unit.
5.3. Note on mass accuracy and mass resolution
Mass accuracies are expressed below in part per million (ppm) and are defined as:
MA =
mmeasured  mtheoretical
mtheoretical
106
Mass accuracy solely expresses the trueness of mass measurements, but does not
relate to resolving power (peak sharpness), which is defined as:
MRP =
mmeasured
FWHH
where FWHH stands for full width at half height. In order to give an idea of the separation
power of mass analysers, a peak capacity (PC) can be defined as:
PC =
mmax  mmin
FWHH
 State-of-the-art mass accuracies and mass resolving power and peak capacities of
various instruments are given in Table 20:
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Mass accuracy
(ppm)
Mass resolving
power
Peak capacity
Ion trap 100-200 2000 20000-40000
TOF 5-50 >10000 
Orbitrap <10 ppm >50000 >200000
FT-ICR 1-10 ppm >100000 >400000
Table 20. State-of-the-art performances of various analysers. Ion trap and TOF data are
from our lab, Orbitrap data is from [36] and FT-ICR from chapter 5.
All simulations performed below are based on mass accuracy alone; effects due to
limitations of peak capacities are not taken into account.
5.4. Whole protein analysis
The three proteomes tested come from different taxonomic species (bacteria, yeast
and primates):
D. Radiodurans S. Cerevisiae H. sapiens
Number of proteins 3084 6229 12860
Table 21. Number of proteins for each organism.
Protein molecular weights are distributed over a wide range, as shown in Figure 129.
Figure 129. Protein molecular weight histograms for Deinococcus Radiodurans (top left),
Saccharomyces Cerevisiae (top right) and Homo sapiens (bottom).
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Protein isoelectric point distributions display the well-known bimodal distribution,
as shown below:
Figure 130. Protein isoelectric point histograms for Deinococcus Radiodurans (top left),
Saccharomyces Cerevisiae (top right) and Homo sapiens (bottom).
These bimodal distributions were primarily thought to be the result of evolution to
intracellular pHs. Interestingly, Weiller et al have recently shown that this bimodal
distributions are a result of amino acids pKas only [37].
5.5. Simulation of trypsin digestions
The three above-mentioned proteomes were digested by trypsin, with two
miscleavage sites per peptide allowed and a minimal peptide length of four residues.
D. Radiodurans S. Cerevisiae H. Sapiens
Number of tryptic
peptides
254133 884737 2047516
Average number of
tryptic peptides per
protein
82.4 142.0 159.2
Table 22. Results of whole proteome tryptic digestions.
Tryptic peptides isoelectric point span over the whole pH range, as shown below:
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Figure 131. Isoelectric points of tryptic peptides from whole proteomes for D. Radiodurans
(top left), S. Cerevisiae (top right) and H. Sapiens (bottom).
5.6. Peptide uniqueness based on mass accuracy alone
The number of unique peptides in each whole proteome was computed based on
mass accuracy alone. Figure 132 shows the percentage of unique peptides for each zone of
10 Da at various mass accuracies.
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Figure 132. Percentage of unique peptides for each 10 Da bin for D. Radiodurans (top), S.
Cerevisiae (middle) and H. Sapiens (bottom).
The noisy parts of the curves at high mass are due to the fact that there are few
peptides in each 10 Da bin. As expected, the higher the mass resolution, the more unique
peptides. Figure 133 present the average number of unique peptides per protein for each
proteome.
Figure 133. Average number of unique peptides per protein based on mass resolution for D.
Radiodurans (top left), S. Cerevisiae (top right) and H. Sapiens (bottom).
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As can be seen in Figure 133, even at 10 ppm mass accuracy which is achievable
only on best instruments in routine (see Table 20), no more than approximately 5 unique
peptides per protein can be found. And as the mass accuracy decreases (above 10 ppm), the
average number of unique peptide per protein rapidly falls down to zero.
5.7. Effect of cysteine count on peptide uniqueness
Digested proteomes contain a large number of peptides free of cysteines (225327 in
D. Radiodurans, i.e. 88.6 % of tryptic peptides, 719126 in S. Cerevisiae, i.e. 81.3% of
tryptic peptides, and 1454607 in H. Sapiens, i.e. 71.0% of tryptic peptides). This low
number of cysteine containing tryptic peptides is at the core of the Isotope Coded Affinity
Tags (ICAT) approach developed by Ruedi Aebersold to simplify tryptic peptides complex
mixtures, since selecting only those peptides leads to a 5 to 10 fold simplification of the
mixture [13-15]. Figure 134 shows the orthogonality between the number of cysteines per
peptide and the peptide molecular weights. Surprisingly, it does not appear to be any
correlation between the number of cysteines and the peptide molecular weight.
Figure 134. Orthogonality of molecular weight and number of cysteines information for D.
Radiodurans (a), S. Cerevisiae (b) and H. Sapiens (c).
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However, the maximum number of cysteines contained in a single tryptic peptide
exceeds by far the potential of the online electrochemical tagging presented above:
D. Radiodurans S. Cerevisiae H. Sapiens
Max number of
cysteine per tryptic
peptide
9 22 56
Average number of
cysteines per peptide
0.14 ± 0.44 0.25 ± 0.61 0.46 ± 0.99
Table 23. Statistics of cysteine content in tryptic peptides.
However the simulation was performed as if the technology was able to count the
number of cysteines without any limitation. The percentage of unique peptides per bin of 10
Da is presented in Figure 135 when the number of cysteines is taken into account.
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Figure 135. Percentage of unique peptides for each 10 Da bin for D. Radiodurans (top), S.
Cerevisiae (middle) and H. Sapiens (bottom).
For ultrahigh mass accuracy (0.1 ppm that may be reachable only on FT-ICR, see
Table 20), the information about the number of cysteines does not bring much; but for
lower accuracies, the number of cysteines increases the number of unique peptides and
tends to level the effect of mass accuracy: there is indeed not much difference in H. Sapiens
between the percentage of unique peptides at 200 ppm (typical of an ion trap instrument)
and 5 ppm (more in the range of a good TOF instrument). Figure 136 shows the average
number of unique peptides per protein for each proteome:
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Figure 136. Average number of unique peptides per protein based on mass resolution and
cysteine number per peptide for D. Radiodurans (top), S. Cerevisiae (middle) and H.
Sapiens (bottom).
Interestingly, at high mass accuracy, there is no clear increase in the number of
unique peptides per protein compared to using mass accuracy alone for D. Radiodurans,
whereas for S. Cerevisiae and H. Sapiens there is a clear increase in unique peptides even at
very high mass accuracy (see Figure 133 for comparison). At low mass accuracy, the
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addition of the amount of cysteine in each peptide dramatically increases the number of
unique peptides; not only is it improved, it plateaus at approximately 18 peptides per protein
for D. Radiodurans, 40 peptides per protein for S. Cerevisiae, and 55 peptides per protein in
H. Sapiens.
Given the results presented above, the eTag(Cys) methodology has the potential to
greatly improve peptide identification and is especially efficient when combined with
relatively low mass accuracy mass analysers (such as ion traps). The great advantage of the
method is that it does not add any additional experiment: it only requires the addition of
carboxymethylhydroquinone to the solution delivered to the mass spectrometer.
5.8. Effect of pI on peptide uniqueness
Isoelectric point of proteins is known to be orthogonal to mass for proteins (which is
a great strength of two-dimensional gel electrophoresis), but there is not much
documentation at the peptide level.
Figure 137. Distribution of peptide isoelectric point versus peptide molecular weight for D.
Radiodurans (a), S. Cerevisae (b) and H. Sapiens (c).
Contrary to peptide retention times in liquid chromatography (see Figure 122), pIs
are independent of molecular weights. The percentage of unique peptides for each 10 Da
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bin is presented in Figure 138, based on mass accuracy and peptide isoelectric point (for a
pI accuracy of 0.5 pH unit) .
Figure 138. Percentage of unique peptides for each 10 Da bin for D. Radiodurans (top), S.
Cerevisiae (middle) and H. Sapiens (bottom) based on mass accuracy and peptide pI.
As can be seen in Figure 138, the addition of isoelectric point for the discrimination
of isobaric peptides has a dramatic effect on the percentage of unique peptides (see Figure
132 for comparison). At all mass accuracies the percentage of unique peptides is increased
and is in the range 60-80% above 2000 Da in all digested proteomes. The translation of this
increase in terms of average number of unique peptides per protein is shown in Figure 139:
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Figure 139. Average number of unique peptides per protein, taking into account mass
accuracy, number of cysteine per peptide and isoelectric point for D. Radiodurans (top), S.
Cerevisiae (middle) and H. Sapiens (bottom).
As clearly visible from Figure 139, the addition of isoelectric point to discriminate
peptides greatly increases the average number of unique peptides per protein: even at low
mass accuracy, there are approximately 55 unique peptides per protein for D. Radiodurans,
85 for S. Cerevisiae and 95 for H. Sapiens. Moreover, the addition of the number of
cysteines as a discriminating parameter further increases the number of unique peptides.
The pI accuracy of 0.5 pH unit can be reached in routine with Off-Gel electrophoresis or
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other techniques, and one can push to better resolutions. Figure 140 shows the influence of
isoelectric point accuracy on the percentage of unique peptides:
Figure 140. Percentage of unique peptides for each 10 Da bin in H. Sapiens digested
proteome for various pI resolution at different mass accuracies: 1 ppm (top), 10 ppm
(middle) and 100 ppm (bottom).
The first important result is that even when working with high mass accuracy,
adding the isoelectric point information increases the percentage of unique peptides, as
shown in the top row of Figure 140. The second result is that adding isoelectric point
information to low mass accuracy measurements (e.g. 100 ppm, which is a good mass
accuracy for an ion trap analyser) brings the percentage of unique peptides higher than with
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ultrahigh mass accuracy alone (comparison of the 0.1 pI resolution curve in the bottom row
of Figure 140 to the “without pI info” curve in the top row of Figure 140). Lastly, even poor
information (low pI accuracy) has a strong effect on the number of unique peptides.
6. Limitations of the simulation
The simulation presented above calculate the number of unique peptides in whole
digested proteomes downloaded from SwissProt, which means that post-translational
modifications are not taken into account. Introducing possible post-translational
modifications would increase the total number of peptides, and thus statistically decrease
the number of unique peptides. Furthermore, unique peptides identified above may not be
readily observable due to poor ionisation efficiency or ion suppression phenomena.
Numbers of unique peptides presented above are thus a maximal number of theoretical
unique peptides and it is thus of utmost importance to maximise these numbers in order to
cope with experimental complexity and limitations.
7. Meaning of peptide uniqueness and the protein inference
problem
All the work presented above deals with the identification of unique peptides within
digested proteomes based on different measurements (be it peptide masses alone at various
mass accuracies, the number of cysteines, peptide isoelectric point…). Unique peptides are
peptides whose sequence can be unambiguously assigned given experimental measurements
(mass, pI, LC retention time, number of cysteines…) within a proteome database (be it
Chapter 7. Evaluation of mass spectrometric front-end technologies to increase peptide uniqueness
in shotgun proteomics
296
SwissProt, Trembl or an experimental database)5. Unique peptides can be compared as
peptides sequenced by MS/MS in a more traditional shotgun approach, whose sequence is
known and can be used for protein identification. But identifying peptides is only the first
step in protein identification, and matching experimental data at the peptide level to protein
candidates is a difficult task, known as the protein inference problem. There is no
fundamental difference in inferring protein identification from unique peptides (or accurate
mass tags) or from partial sequence information obtained by MS/MS. The limitations of
protein inference have been reviewed recently by Nesvizhskii and Aebersold [38].
First, different proteins can share a high degree of homology, as for splice variants;
for example, human F actin capping protein beta subunit has two known splice variants that
share 99.6% of homology, as shown in Figure 141:
Figure 141. Sequence homology of the two F actin human variants.
                                                 
5 Please note that with the chosen algorithm, similar peptidic sequences coming
from different SwissProt entries (known as shared or degenerate peptides) are not counted
as unique peptides.
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They differ only in the terminal sequence IDAIPDNQKFKQLQRELSQVLTQRQ
(variant 1) and VQTFADKSKQEALKNDLVEALKRKQ (variant 2) and the only way to
discriminate between the two variants is to measure a tryptic peptide coming from one of
these two sequences. Unfortunately, none of the possible tryptic peptides coming from these
two sequences is a unique peptide in our simulations, that is to say that the unique peptide
approach fails to discriminate between these two protein splice variants.
A more challenging situation is when splice forms originate from skipped exons at
the 3’ or 5’ end: discrimination between different splice forms thus relies on the absence of
a given peptide in the experimental dataset, which is always questionable. In practise it is
impossible to discriminate between such variants without information about the intact
protein (molecular weight or isoelectric point for example).
An even more complex problem is when a whole protein family shares a high
degree of homology. Figure 142 shows an example taken from reference [38], in which 11
peptides belonging to proteins from the alpha-tubulin family were identified, but could not
be assigned to a particular protein:
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Figure 142. Assignment of measured peptides to proteins belonging to the alpha-tubulin
family. Reprinted with permission from [38].
In fact given the experimentally identified peptides, it is impossible to identify
which members of the family are present in the sample.
Another challenge in assembling large scale peptide information into protein
identifications is the presence of redundancy in databases (same proteins listed under
different names or accession numbers) as well as sequence variations that can be due
whether to DNA sequencing errors or to real single nucleotide polymorphisms.
The simulations reported in this chapter show that acquiring more physico-chemical
information at the peptide level (number of cysteines, isoelectric point, retention time in
LC…) can dramatically improve the number of unique peptides per protein (see Figure
139), and thus the sequence coverage, which is a key criteria to increase the probability of
discrimination between variants. For the sake of comparison, it is estimated that 30% of
identified proteins in a traditional shotgun experiment (based on MS/MS sequencing of
peptides) are identified by one peptide only [38]. Classical shotgun approaches as well as
accurate mass tags or unique peptides approaches consists more in a gene-product
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identification than in true protein identification [39]. In order to convert them into true
protein identification technologies, it is of utmost importance to increase the number of
peptides identified per protein; Figure 139 shows that combining eTag(Cys) and Off-Gel
technologies with 100 ppm mass accuracy measurements has the potential to switch from
less than five identified peptides per protein (mass measurement alone) to 100 peptides per
protein (mass measurement combined with measurement of the number of cysteines and
upstream isoelectric point measurement).
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Chapter 8. Conclusion and perspectives
In the present work, a polymer microspray interface has been tested and
characterised for biological mass spectrometry. The primary objective was to validate its
use for the analysis of various biomolecules when interfaced with different electrospray ion
sources. It has been successfully applied to the analysis of peptides, proteins and
glycoconjugates (both purified and from biological sources) on the in-line electrospray ion
source of the LCQ Duo ion trap (Thermo Electron), Z-spray source of the LCT Q-TOF
(Micromass), the Apollo source of the Apex FT-ICR (Bruker), and a home-made source of
an FT-ICR (Alan Marshall’s group, National High Magnetic Field Laboratory, Tallahassee,
Florida, USA), both in positive and negative ion mode.
Once demonstrated the versatility of this new device, a thorough investigation
demonstrated that it performs equally or better than pulled capillary nanosprays, which are
usually considered as the most sensitive interface to deliver samples to a mass spectrometer
by electrospray. In particular, the polymer microspray showed comparable sensitivity and
stability even in the low flow rate range (150-300 nL/min) but a much wider applicable
range of flow rates (up to 5 or 7 μL/min depending on the solvent used); above 1 μL/min, it
performs better than in the low flow rate range, both in terms of sensitivity and stability.
These better performances have been also observed with biological samples: the use of the
polymer microspray to ionise sialylated O-glycopeptides from urine has led to reduced
sample degradation within the ion source, and observation of multi-sialylated species that
had never been observed in the same sample by any other electrospray technique (including
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pulled micro- and nanosprays or microfabricated ESI-Chip™ from Advion). This ability to
preserve the integrity of labile moieties during ionisation is of utmost importance in this
biomedical context, since these studies aim at mapping glycoconjugates present in urine (or
other biological tissues, such as brain) in order to understand deficiencies or alteration in the
systemic processing of glycoconjugates in particular diseases (such as glycopeptides and
glycoproteins in Schindler disease or gangliosides in primary central nervous system
tumours). Alleviating instrumental biases in this context can thus prove to be of utmost
biomedical relevance. The rationale for these very good performances of the polymer
microspray (which are somehow in contradictions with the “rules of thumb” in electrospray
mass spectrometry, which states that the smaller the capillary or microchannel used, the
better the performances) is not completely clear. On one part, it is not surprising that the
polymer microspray can accommodate high flow rates, because its tip shape may be able to
accommodate small and large Taylor cones (potentially bigger than the outlet itself by
wetting of the smooth outer surface of the microchip). Its good performances at low flow
rate and its better softness are more difficult to explain. One possible explanation is that its
particular shape leads to the formation of smaller electrospray droplets compared to a
circular outlet of comparable dimensions (and hence to more efficient ionisation). But since
even the parent droplets are very small, their observation on the flight is a difficult task.
One possible line of investigation would be to indirectly measure the internal energy of ions
entering the mass spectrometer; if ions generated from the polymer microspray have lower
energies than those generated in the same conditions from pulled micro- or nanosprays, it
would first provide a rationale for the observed softer ionisation of sialylated O-
glycopeptides, and secondly provide some evidence that the primary electrospray droplets
formed are smaller than expected with such a device. However, as there are only very few
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groups working on such physical characterisation of electrospray in terms of chemical
kinetics, there is a crucial lack of reference works to compare with.
One other direction that has been explored in this work concerns more technical
developments of the polymer microsprayer itself. First, a polymeric hydrophobic phase has
been integrated on the microchip to perform sample clean-up. Though the approach has
been willingly kept very crude technically speaking, it proved efficient for peptides and
proteins desalting. It is also possible to get rid of other co-solvents usually encountered in
protein sample preparation, such as chaotropic (thiourea and urea) and reducing agents. As
a stand-alone device, this sample clean-up microchip can be useful in routine mass
spectrometric analysis, just as derivatised pipette tips such as ZipTips™ are. It also has the
potential of relatively straightforward automation; one possible integration would be to cut
PVDF membranes on which proteins have been electroblotted after gel electrophoresis, and
put them on the chip just as was done for sample clean up. On-membrane sample
processing (clean-up, reduction, proteolysis, enzymatic processing, chemical tagging…) can
then be performed with great versatility before mass spectrometric analysis. One other
possible approach could be to use membranes with different functionalities; the recent
commercial release of membranes for covalent attachment of proteins or antibodies
(Empore Affinity AZ™ membranes from 3M) opens possible applications in protein
interaction studies or immunoassays, with the advantage of large capture areas compared to
what could be obtained with a solid-phase integrated within the microchannel itself.
The other technical development that has been introduced in close collaboration
with Joël Rossier from DiagnoSwiss, is a dual channel microsprayer, that allows to mix two
solutions within the Taylor cone, just as electrospray droplets are produced. The primary
objective of this new design was to allow the analysis of pure aqueous solutions by
integrating an organic sheath flow. This proved to be feasible, with the additional advantage
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that the organic sheath flow can be kept at a minimum ratio compared to the aqueous
sample, so that analysis of proteins in their native form is possible. Moreover, as the ratio
between the aqueous sample flow rate and the organic sheath flow rate can be easily
controlled, protein conformational studies become feasible by online protein denaturation
by organic or acid modifiers, within the Taylor cone. One possible other route is to heat the
microchip externally in order to observe heat-induced protein denaturation. Obviously there
is still a lot of characterisation to be done, especially given the fact that there is not a
definitive consensus about the correlation between charge state distributions observed in
mass spectra and the protein conformation state. This lack of consensus is largely due to the
fact that there are relatively little data available in the literature (and mostly about model
proteins) because such experiments are tedious and difficult to perform with current
technologies. If the dual channel microsprayer is improved in terms of robustness and ease
of use, which seems at hand, it would enable more comprehensive studies about
conformational effects; in this respect, the hyphenation of an ion mobility analyser with a
time-of-flight analyser would allow to measure protein collisional cross sections and charge
state distributions at the same time, which would allow to confirm or infirm if charge state
distributions in ESI-MS truly reflects the conformation of proteins. If so, ESI-MS could
become a workhorse for protein thermodynamic characterisation, and a first tool in high-
throughput protein structure determination projects.
The last part of this work was devoted to the in silico evaluation of the integration of
different analytical tools developed in the laboratory in the last three years: on hone hand,
Off-Gel electrophoresis allows the separation of complex proteins and peptides mixtures
and the measurement of their isoelectric point with very good resolution (down to 0.1 pH
unit in routine). Off-Gel electrophoresis combines the power of isoelectric fractionation,
such as high resolution and large preconcentration effect) with high loading capacity in
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reduced volumes of the order of 0.5-3 mL. On the other hand, a procedure for online
counting of cysteine residues within peptides by mass spectrometry without any MS/MS
has been developed. The goal of this last part was thus to evaluate how these technologies
could perform in the context of high-throughput proteome profiling. There is indeed a clear
need to speed-up proteome analysis to enable clinical studies or even clinical use of
proteomic technologies, which are still relatively slow and complex to operate. One
possible route could be to seek for proteolytic peptides that are unique (in terms of their
measured physical properties) within the whole digested proteome. If peptide mass only is
measured, even ultrahigh resolution and mass accuracy mass spectrometers can hardly
provide useful information, because there are very few unique peptides in terms of mass in
whole digested proteomes; on the contrary, if peptides isoelectric point is measured, as well
as the number of cysteines within each peptide, there are much more unique peptides, and
fast proteome profiling can be envisaged even in complex proteomes such as human
proteomes.
From a more general point of view, it is interesting to put this work in perspective
with the development of proteomics itself; it indeed started from relatively technical work,
namely the development of new electrospray interfaces, and evolved in various directions:
on one hand the development of relatively simple tools such as the online SPE microspray,
or the dual microsprayer with the initial idea to ease the analysis of aqueous solutions… on
the other hand the dual microsprayer turned out to open new possibilities for protein
structural characterisation, and the integration of different tools that were purely analytical
chemistry projects allows to envision an entirely new proteomic platform. Bioinformatics
came into play to evaluate the feasibility of such a platform for fast proteome profiling. And
indeed the development of proteomics has followed such a trend, from very analytical work
to build the analytical tools to study protein on a larger and larger scale. The availability of
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separation methods and mass spectrometers has progressively allowed researchers to
imagine an entirely new scale of research, which in turn has generated needs for new
instruments and methodologies. Whereas it is certain that progress will still be made on the
instrumental side, and in particular that high resolution mass spectrometers will become
more and more affordable, one can hypothesise that methodology development allied with
more robust data analysis tools will drag the field of proteomics in the very next few years.
This also implies that further developments in the field will require larger and larger
facilities, and more integrated work between instrument developers, database developers,
software engineers and statisticians. It is not certain yet how much of new biological
knowledge will come out from the massive efforts undertaken worldwide; when data
robustness is acquired, biological modelling will have to play a role to interpret such
massive data, and extract some relevant information for diagnosis, prognosis, treatment
follow-up and drug design, and this will consist in a new revival for theoretical biology.
How much can we hope from this new revolution in biology? It will probably take no less
than a few decades to find the answer.
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